arthralgia / musculoskeletal pain , osteoarthritis
please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
ER below the desired haemoglobin level may be observe .
300mg / 12.5 mg
BATCH NUMBER
• Hypersensitivity to the active substance , to other quinolones or to any of the excipients ( see section 6.1 ) .
drug interaction study of Febuxostat with cytotoxic chemotherapy have not be conduct .
( very common ( ≥ 10 % ) ; common ( ≥ 1 % and & lt ; 10 % ) )
both cytochromes P450-2D6 and 1A2 catalyse the formation of the two major metabolite glucuronide conjugate of 4-hydroxy duloxetine and sulphate conjugate of 5hydroxy , 6-methoxy duloxetine .
− As with all medicine , keep Kaletra out of the reach and sight of child . − Do not use Kaletra after the expiry date which be state on the pack . − This medicinal product do not require any special storage condition .
like all medicine , & lt ; etoricoxib & gt ; can cause side effect , although not everybody get them .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE , IF different
4 .
very common :
150mg / 12.5mg
11 .
5 .
patient with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product .
Special care should be take when both inhibitor of CYP2C8 and 3A4 be co- administer simultaneously with repaglinide .
not all pack size may be market .
III .
medicinal product subject to medical prescription
over the first 24 hour , 39 ± 16 % of the administer dose be recover in the urine , while the remainder be principally bind to bone tissue .
1 .
the solution should be use immediately after reconstitution .
S .
this condition should be correct prior to administration of Enviage , or the treatment should start under close medical supervision .
expiry DATE
name
half-life be also similar between adult and paediatric patient with lp
eleven percent have an APACHE II score of & gt ; 10 , 9.5 % have post-operative infection , 27 % have single or multiple intra-abdominal abscess and 4 % have concurrent bacteraemia at baseline .
perform a safety test
3 .
MARKETING Authorisation Holder and Manufacturer Liprolog Mix50 100 U / ml Pen , suspension for injection be make by : • Lilly France S.A.S . , Rue du Colonel Lilly , 67640 Fegersheim , France , • Eli Lilly Italia S.p.A. , Via A .
European Medicines Agency
9 .
general disorder and administration site condition
In-vitro study also indicate that SUTENT neither induces nor inhibits major CYP enzyme , include CYP3A4 .
patient with severe renal problem , include those on dialysis , should not be give INVANZ .
8 .
Glutamic acid sorbitol ( E420 ) Polysorbate 80 Water for injection
the observed 99 % drop in Doppler signal intensity within 10 minute ( t1 / 2 approximately 2 minute ) be in agreement with the decline in measurable blood level of perflutren .
reconstitution 1 .
1 ml suspension contain 100 IU ( 3.5 mg ) of insulin human ( rDNA ) .
Lamictal dispersible
insulin Human Winthrop Comb 50 be an insulin preparation with a rapid onset and moderately long duration of action .
in controlled trial in patient with plaque psoriasis , approximately 14.5 % of patient treat with Enbrel develop injection site reaction compare with 5.2 % of placebo-treated patient during the first 12 week of treatment .
gastrointestinal disorder
Portugal Rui DOS SANTOS IVO Presidente Conselho de Administraçao INFARMED Parque de Saúde de Lisboa Av . do Brasil , 53 P - 1749-004 Lisboa Tel .
0.99 , 1.18 ; 42 trial and 8167 patient ) .
this amount be too low to cause adverse event in patient with rare hereditary problem such a fructose intolerance , glucose-galactose malabsorption , or sucrase-isomaltase insufficiency .
palpitation
however , chemical and physical in-use stability have be demonstrate for 48 hour at 30 ° C .
because of a methodological flaw , efficacy could not be demonstrate .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
• If you be about to undergo surgery or dental procedure please inform your doctor that you be take Humira .
like all medicine , Daronrix can cause side effect , although not everybody get them .
powder : vial ( glass ) ; solvent : vial ( glass )
these interaction should be consider in patient take etoricoxib concomitantly with ACE inhibitor or angiotensin II antagonist .
no pharmacokinetic interaction be observe between oral rivastigmine and digoxin , warfarin , diazepam or fluoxetine in study in healthy volunteer .
loss of consciousness have occur very rarely with alpha interferon , mostly in elderly patient treat at high dos .
slowly add the sterile Water for Injection to the vial and avoid inverting or shake the vial .
to be take into consideration by patient on a controlled sodium diet .
the antihypertensive efficacy of telmisartan be comparable to that of agent representative of other class of antihypertensive medicinal product ( demonstrate in clinical trial compare telmisartan to amlodipine , atenolol , enalapril , hydrochlorothiazide , and lisinopril ) .
patient be randomize to stay on their treatment at the time of enrollment or to be switch to MIRCERA in order to maintain stable haemoglobin level .
very common ( ≥ 1 / 10 ) , common ( ≥ 1 / 100 to & lt ; 1 / 10 ) , uncommon ( ≥ 1 / 1,000 to & lt ; 1 / 100 ) , rare ( ≥ 1 / 10,000 and & lt ; 1 / 1,000 ) , very rare ( & lt ; 1 / 10,000 ) , not know ( can not be estimate from the available data ) .
ed while on this medication seek medical help immediately .
the effect of long-term ( greater than 36 week ) gabapentin therapy on learning , intelligence , and development in child and adolescent have not be adequately study .
upon co-administration of both medicine , the tacrolimus plasma concentration should be monitor and , if necessary , a reduction in the tacrolimus dose consider .
vomit and anorexia , and peripheral edema be also observe when IT ziconotide be add to IT morphine .
* in a subgroup of infant not administer hepatitis B vaccine at birth , 89.9 % of subject have anti-HBs titre ≥ 10 MIU / ml † cut-off accept a indicative of protection † † vaccine response : % of subject consider to have respond to the Bordetella pertussis antigen
general characteristic This medicinal product show good solubility in aqueous solution .
insulin and analogue , intermediate-acting combine with fast-acting , ATC Code :
adjustment in dosage of the medicinal product , meal pattern , or physical activity may be need .
United Kingdom Shire Park Welwyn Garden City Hertfordshire AL7 1TW - UK Tel : + 44- ( 0 ) 1 707 363 636
QUALITATIVE AND QUANTITATIVE COMPOSITION
therefore , use in child be not recommend .
do not use Helixate NexGen 2000 IU if you be allergic ( hypersensitive ) to octocog alfa , to mouse or hamster protein or to any of the other ingredient of Helixate NexGen 2000 IU .
infection
the WORDS “ FOR ANIMAL TREATMENT ONLY ”
very common Uncommon
list OF EXCIPIENTS
medicine should not be dispose of via wastewater or household waste .
13 .
rinse your mouth with water and spit it out a this may help prevent the occurrence of thrush and hoarseness .
medicine to correct heart rhythm antidepressant or herbal remedy use to treat depression and anxiety antifungal agent certain medicine to treat HIV infection Anticonvulsants use to treat epilepsy
Invented name Liprolog
treatment with Fentanyl-ratiopharm should only be initiate by an experienced physician familiar with the pharmacokinetics of fentanyl transdermal patch and the risk for severe hypoventilation .
Diagram R
therapeutic area • Target specie
interferon have be report to reduce the activity of hepatic cytochrome P450-dependent enzyme in human and animal .
of CRIXIVAN and parenteral midazolam .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
what be the benefit and risk of Olanzapine Neopharma ?
base on a multiple dose clinical trial , in which up to 45 mg of desloratadine be administer ( nine time the clinical dose ) , no clinically relevant effect be observe .
always take Vimpat exactly a your doctor have tell you .
however , it have be report that pemetrexed may cause fatigue .
nervous system disorder :
Glucomed
Annex I
patient with severe liver impairment have not be study ( see section 4.3 ) .
MARKETING AUTHORISATION NUMBER ( S )
if there be no ovarian response , the daily dose will then be gradually increase until follicle growth and / or plasma estradiol level indicate an adequate response .
the MAH support it position by provide guideline from major oncology society and review of the literature and propose a new wording for the single agent in NSCLC indication .
the required amount of pre-donated blood depend on the anticipated blood loss , use of blood conserving procedure and the physical condition of the patient .
1 Article 29 ( 4 ) of Directive 2001 / 83 / EC , a amend .
in some pre-clinical toxicological study in dog and rat , but not in monkey , erythropoietin therapy be associate with subclinical bone marrow fibrosis ( bone marrow fibrosis be a known complication of chronic renal failure in human and may be relate to secondary hyperparathyroidism or unknown factor .
prolonged hemodialysis may be consider if clinically appropriate .
if patient with renal impairment receive transdermal fentanyl they should be observe carefully for sign of fentanyl toxicity and the dose reduce if necessary .
293 4.6 Pregnancy and lactation
BATCH NUMBER
Chairman :
- child from the age of three year , adolescent and adult patient with malignant glioma , such
& # 91 ; Invented name & # 93 ; 400 mg film-coated tablet be indicate for the treatment of the following bacterial infection :
Humira 40 mg solution for injection in pre-filled syringe with needleguard Adalimumab
animal study have show that ambrisentan be teratogenic .
common :
base upon the overlap in the range of clearance , gender-based pharmacokinetic difference do not justify the recommendation for use a lower dose for female patient .
reconstitute concentrate : should be use immediately .
Česká republika Roche s. r. o .
clear , colourless to pale yellow solution . pH :
- the possible effect of change to different time zone ,
you must stop breast-feeding if du
patient currently treat with an ESA can be switch to MIRCERA administer once a month a a single intravenous or subcutaneous injection .
study 11
important information about some of the ingredient of Zyrtec Zyrtec oral drop solution contain methyl ( 4-hydroxybenzoate ) E 218 propyl ( 4-hydroxybenzoate ) E 216 that may cause allergic reaction ( possibly delay ) .
adverse reaction be determine base on pool data from seven randomise , double-blind , placebo-controlled study of Nespo with a total of 2112 patient ( Nespo 1200 , placebo 912 ) .
80
AUC
body temperature Regulation disruption of the body ’ s ability to reduce core body temperature have be attribute to antipsychotic medicine .
each ml of solution contains 1.3 GBq Samarium & # 91 ; 153Sm & # 93 ; lexidronam pentasodium at the reference date ( correspond to 20-46 µg / ml of samarium per vial ) .
be very careful if you do change insulin .
in this leaflet :
at 24 hour the reduction of blood pressure be 60-70 % of the corresponding peak diastolic and systolic response at the recommended dos .
the initiation of treatment with duloxetine BOEHRINGER INGELHEIM be contraindicate in patient with uncontrolled hypertension that could expose patient to a potential risk of hypertensive crisis ( see section 4.4 and 4.8 ) .
oral use
- - -
6.3 Shelf life
- if you have a severe febrile illness
11 .
the proportion of patient who have UACR reduce at least 50 % from baseline to endpoint be 24.7 % and 12.5 % for aliskiren and placebo , respectively .
you may need to read it again .
improvement in fatigue , a measure by the functional Assessment of cancer Therapy-fatigue ( FACT-fatigue ) scale , be also observe .
if this happen to you , tell your doctor .
haemorrhage
Cmax ( ng / ml )
21 For treatment of overdose ( accidental ingestion ) in the opioid-naive person , intravenous access should be obtain and naloxone or other opioid antagonist should be employ a clinically indicate .
Special STORAGE CONDITIONS
6.2 Incompatibilities
1 0 0 1 1 1 0 2 1 2
you may need to read it again .
Sími : + 354 535 7000
patient administer Rapamune should be monitor for hyperlipidemia use laboratory test and if hyperlipidemia be detect , subsequent intervention such a diet , exercise , and lipid-lowering agent should be initiate .
prior to initiate any treatment for erectile dysfunction , physician should consider the cardiovascular status of their patient , since there be a degree of cardiac risk associate with sexual activity .
do not store the Pen with the needle attach .
how TO STORE this medicine
adequate hydration must be maintain in patient undergo IntronA therapy since hypotension relate to fluid depletion have be see in some patient .
Uncommon :
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
medicine use to treat fungal infection ( antifungal ) :
tell your doctor or nurse a soon a possible if you get any unexpected symptom while you be be give SIMULECT , or during the 8 week afterwards , even if you do not think that they be relate to the medicine .
therefore , do not take MIRAPEXIN if you be pregnant unless your doctor tell you to do so .
due to intra-patient variability , occasional individual haemoglobin value for a patient above and M
do not freeze .
after dose interruption a haemoglobin decrease of approximately 0.35 g / dl ( 0.22 mmol / l ) per week be expect .
thyroid disorder ( include goitre )
dosage
PHARMACEUTICAL FORM
the pharmacokinetic variability observe in the elderly be within the range for the non- elderly .
if your blood glucose level improve very fast it may cause a burning , tingle or electric pain .
do not rub the area you have just inject .
dose titration with the individual component ( i. e. irbesartan and hydrochlorothiazide ) may be recommend .
method AND ROUTE ( S ) OF ADMINISTRATION
if an elevated or rise potassium level be observe then consideration should be give to cease Nespo administration until the level have be correct .
in this leaflet :
respiratory , thoracic and mediastinal disorder :
- if you have high blood pressure which be not properly control
5.3 Preclinical safety data
11 .
+
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
- In a patient with moderate hyperammonaemia , administer a test dose of 100 to 200 mg / kg / day
human interferon receptor , a isolate from human lymphoblastoid ( Daudi ) cell , appear to be highly
d )
8 .
ZIMULTI 20 mg film-coated tablet rimonabant
any patient complaining of change in visual acuity or visual field , or report other ophthalmologic symptom during treatment with IntronA , must have a prompt and complete eye examination .
this require ultrasonography and monitoring of oestradiol level .
- 19.01.2000 - 19.04.2000 - 90 day -0
1 1 .
& lt ; As Agopton contain sucrose , patient with rare hereditary problem of fructose intolerance , glucose- galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine . & gt ;
expectancy ; the environment in which the patient be be treat ; and patient preference ( see section ic
opaque white body , imprint with ‘ 30 mg ’ and an opaque blue cap , imprint with ‘ 9543 ’ .
list OF EXCIPIENTS
463 PARTICULARS TO APPEAR ON THE OUTER PACKAGING PRE-FILLED PEN CARTON
BRISTOL-MYERS Squibb Pharmaceuticals Ltd 141-149 Staines Road Hounslow TW3 3JA
11 .
9 .
sirolimus :
- blur vision
1102
you can take MicardisPlus with or without food .
15 .
do not sell separately .
België / Belgique / Belgien MERCK NV / SA Brusselsesteenweg 288 B-3090 Overijse Tél / Tel :
IntronA be to be use during pregnancy only if the potential benefit justify the potential risk to the foetus .
the unbound fraction of A771726 be about 0.62 % .
Slovac Republic
name OF THE MEDICINAL PRODUCT
large dog
10 .
EU / 0 / 00 / 000 / 000 13 .
pancreatitis
10 .
206
the pharmacokinetics of irbesartan be evaluate in 23 hypertensive child after the administration of single and multiple daily dos of irbesartan ( 2 mg / kg ) up to a maximum daily dose of 150 mg for four week .
70 Liprolog can be use in conjunction with a longer-acting human insulin or oral sulphonylurea agent , on the advice of a physician .
14 Use in patient with renal impairment
piroxicam & # 91 ; Invented name & # 93 ; be use to relieve some symptom cause by osteoarthritis ( arthrosis , degenerative joint disease ) , rheumatoid arthritis and ankylose spondylitis ( rheumatism of the spine ) , such a swell , stiffness and joint pain .
MARKETING Authorisation Holder :
by reference Member State
atazanavir ,
very common :
in a long-term psoriasis study in which patient receive 50 mg twice weekly for 96 week , the incidence of antibody observe at each assessment point be up to approximately 9 % .
prim the Pen
name OF THE MEDICINAL PRODUCT
dose adjustment in order to maintain haemoglobin ( Hb ) value at the desired level :
because basiliximab be an immunoglobulin , no metabolic drug-drug interaction be to be expect .
mannitol ( E421 ) , sodium acetate , hydrochloric acid and sodium hydroxide .
MARKETING AUTHORISATION NUMBER ( S )
Special population
Insuman Rapid be administer subcutaneously .
5.2 Pharmacokinetic property
when the desire response have be obtain , a single injection of 250 microgram r-hCG or 5000 IU up to 10 000 IU hCG be give 24-48 hour after the last injection of GONAL-f and lutropin alfa .
if switch from another oral fentanyl citrate product , independent dose titration with Effentora be require a bioavailability between product differs significantly .
hypertensive patient with type 2 diabetes and renal disease :
NL
more limited experience be available in treat child between 1 and 5 year of age .
what be the risk associate with Trizivir ?
oral use
before use Protaphane
name OF THE MARKETING AUTHORISATION HOLDER
adalimumab bind specifically to TNF and neutralize the biological function of TNF by block it interaction with the p55 and p75 cell surface TNF receptor .
they must not give you any food or drink , a it could choke you . ► If severe hypoglycaemia be not treat , it can cause brain damage ( temporary or permanent ) and even death ► If you have a hypo that make you pass out , or a lot of hypo , talk to your doctor .
12 .
Special PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS , IF ANY
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder .
further INFORMATION
take special care with Exelon
55.7 78.3 61.5
suspension and effervescent granule for oral suspension .
release for consultation June 2002
if blood pressure be difficult to control by initiation of appropriate measure , the haemoglobin may be reduce by decrease or withhold the dose of Nespo ( see section 4.2 ) .
Portugal BRISTOL-MYERS SQUIBB FARMACÊUTICA PORTUGUESA , S. A .
soft capsule
clopidogrel significantly reduce the relative risk of death from any cause by 7 % ( p = 0.029 ) , and the relative risk of the combination of re-infarction , stroke or death by 9 % ( p = 0.002 ) , represent an absolute reduction of 0.5 % and 0.9 % , respectively .
thrombocytopenia
Metalyse be a powder and solvent for solution for injection .
do not freeze .
you may need to read it again .
the principle mechanism of resistance be the acquisition of substitution in the target protein , CYP51 .
there be therefore consistent evidence to suggest that there may be significant harm to patient with cancer who be treat with recombinant human erythropoietin .
3 year .
pruritus
MARKETING Authorisation Holder and Manufacturer
6.4 Special precaution for storage
name OF THE MEDICINAL PRODUCT
EMEA / CHMP / 46089 / 2006 / EN
5.3 Preclinical safety data
in the previous six month ( see section 4.4 ) ;
15 30 45 60 75 150 225 300 450 600 900
10 % imidacloprid & amp ; 1 % moxidectin
very Common ( affect more than 1 user in 10 ) : • Parkinsonism .
remove outer needle cap .
6.6 Special precaution for disposal
adverse reaction of unknown frequency report with the use of hydrochlorothiazide alone include :
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
concomitant use of these substance may require decreased tacrolimus dos in nearly all patient .
Magyarország Wyeth Kft Tel : + 36 1 453 33 30 Fax : + 36 1 240 4632
- tell you when to check your blood sugar level , and whether you need to carry out urine test ,
hypoglycaemia
this enhancement in efficacy include loss of serum HCV ( & lt ; 100 copy / ml by PCR ) , improvement in hepatic inflammation , and normalisation of ALT , and be sustain when measure 6 month after the end of treatment .
information FOR THE USER
clinical chemistry test , which include liver function test , should be perform prior to initiate VIRAMUNE therapy and at appropriate interval during therapy .
Humalog Mix50 be indicate for the treatment of patient with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis .
S ori growth and Development :
after sign and symptom of Invasive candidiasis have improve and culture have become negative , a switch to oral antifungal therapy may be consider .
15 8 .
4.2 Posology and method of administration
animal study do not indicate direct or indirect harmful effect with respect to pregnancy , embryonal / foetal development , parturition
or delta .
coadministration of voriconazole and sirolimus be contraindicate ( see section 4.3 ) .
potassium elevation have be report in a few patient receive Nespo , though causality have not be establish .
respiratory , thoracic and mediastinal disorder
method AND ROUTE ( S ) OF ADMINISTRATION
there be also an increased incidence of spontaneous abortion .
the major treatment-related change be a reversible , mild to moderate anaemia , the severity of which be greater than that produce by either active substance alone .
8 .
th detail information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www . emea . europa . eu
GONAL-f be not indicate during lactation .
4 .
if you have any further question on the use of this product , ask your doctor or pharmacist .
4.2 Posology and method of administration
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Tel :
immediately contact the doctor or seek emergency treatment if they display any unusual behavioural symptom , feel depress , or feel they want to harm themselves or others .
200 mg / day maintain this dose ( 200 mg / day )
Tel : + 49 ( 0 ) 89 360448701 produkt . info @ gsk . com
sanofi Aventis France 1 / 13 , Bd Romain Rolland 75014 Paris France
4.6 Pregnancy and lactation
8 .
serum potassium level should be monitor regularly during Aranesp therapy .
8 .
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
4.7 Effects on ability to drive and use machine
in clinical study with 73 previously treat patient ( PTP , define a have more than 100 exposure day ) , follow over four year , no de-novo inhibitor be observe .
important information about some of the ingredient of ViraferonPeg :
in the once every three week group , 72 % of patient require dose reduction .
the European Commission grant a marketing authorisation valid throughout the European Union for Panretin on 11 October 2000 .
E follow-up therapy with another anticoagulant medicinal product
patient hypersensitive to Insulin Human Winthrop Comb 25 for whom no better tolerate preparation be available must only continue treatment under close medical supervision and – where necessary – in conjunction with anti-allergic treatment .
clinical efficacy :
after resuspension , the fluid must have a uniformly milky appearance .
301 adherence of the patient to the dosage and dietary regimen , correct insulin administration and awareness of hypoglycaemia symptom be essential to reduce the risk of hypoglycaemia .
IWRC :
Galvus be use to treat type 2 diabetes mellitus ( non-insulin-dependent diabetes ) .
one bottle of 105 ml of oral suspension measure spoon
nevertheless , you should not use Fertavid if you be already pregnant , or suspect that you might be pregnant .
fertility be not reduce .
Polska sanofi-aventis Sp . z o.o .
therefore , do not breast-feed an infant if you be take ViraferonPeg .
hypersensitivity to goat protein or goat milk component .
15 .
further information
this post-marketing surveillance will run up until such time a 40 patient be enrol .
• apomorphine • Part B
6.2 Incompatibilities
4.8 Interaction with other medicinal product and other form of interaction
4.4 Special warning and precaution for use
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please
GARDASIL can not cause the disease it protect against .
EU / 1 / 02 / 229 / 037
Tables 1 and 2 display the frequency of adverse drug reaction from placebo-controlled clinical trial in Parkinson ’ s disease and Restless Legs Syndrome .
chronic Hepatitis B :
32 27269584 Fax :
18 B .
solution for injection in a pre-filled syringe
there be no significant pharmacokinetic difference between intramuscular and subcutaneous administration of Puregon .
158 overall , approximately 36 % ( 821 / 2,286 ) of patient have undetectable plasma HCV-RNA level at Week 12 of therapy measure use a research-based test ( limit of detection 125 IU / ml ) .
paediatric patient .
Uncommon :
the CVMP conclude that the statistical method could not be use base on the data of the new study provide .
Pyriprole kill tick within 48 hour post-exposure .
93 30
cetuximab have be design to bind to EGFR , which can be find on the surface of certain tumour cell .
not know :
9 .
rare : cough , infection include pneumonia .
read the package leaflet before use .
6.6 Special precaution for disposal and other handling
further INFORMATION
Obligations of health care professional in relation to the prescribing of Volibris :
active substance ( s ) FeLV recombinant Canarypox virus ( vCP97 ) ......... ≥ 10 7.2 CCID50 ( cell culture infective dose 50 % ) For a full list of excipients , see section 6.1 .
4.9 Overdose
diarrhoea be the most commonly report adverse event in child .
the no observed effect level ( NOEL ) be 15 mg / kg / day .
10 .
many factor may influence your blood sugar level .
the long term effect of azagly-nafarelin on treated broodstock fish have not be study .
NUMBER of inspection
common :
17 .
driving and use machine STOCRIN may cause dizziness , impaired concentration , and drowsiness .
CI = confidence interval ; hr = hazard ratio ; ITT = intent to treat ; n = total population size .
name OF THE MARKETING AUTHORISATION HOLDER
the proportion of patient with disability progression , a define by at least one point increase in EDSS confirm three month later , be reduce from 39 % ( placebo ) to 30 % ( Rebif 22 microgram ) .
BATCH NUMBER
adult and adolescent ( 12 year of age and older ) : take one 5 mg Azomyr orodispersible tablet once a day .
what Kinzalmono contains
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
Special precaution for storage
9 .
the accumulation of bosentan in hepatocytes lead to cytolysis with potentially severe damage of the liver , or an immunological mechanism , be not exclude .
the addition of amlodipine 10 mg and 5 mg produce an additional reduction in systolic / diastolic blood pressure of 6.0 / 4.8 mmHg and 3.9 / 2.9 mmHg , respectively , compare to patient who remain on valsartan 160 mg only .
due to limited experience , the efficacy and safety of Lantus have not be demonstrate in child below the age of 6 year .
duloxetine BOEHRINGER INGELHEIM 40 mg
3.6mmol ) sodium per dose .
150 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT .
55 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
there be no data on the efficacy of tenofovir in patient co-infected with hepatitis C or D virus .
at least one LVEF drop of ≥ 15 % from baseline and below 50 % a
the doctor may decide to decrease the dose if you have mild to moderate cirrhosis .
7 .
Tractocile be a solution for injection or a concentrate for infusion ( drip into a vein ) that contain the active substance atosiban ( 7.5 mg per millilitre ) .
no interaction study have be perform with interferonbeta-1a in human .
this dose be adjust accord to the patient ’ s response , until the patient be stabilise .
138 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
manufacturer Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Germany
124 administration have not be determine
epoetin beta treatment-related headache and hypertension which can be treat with drug be common ( & gt ; 1 % , & lt ; 10 % ) ( see section 4.4 ) .
20 mg
DATE OF REVISION OF THE TEXT
5 .
name OF THE MEDICINAL PRODUCT
adverse Drug Reaction Rash / Erythema
INVEGA should be use with caution in elderly patient with dementia who have risk factor for stroke .
oral
Brucella spp .
over the 10-year observation period , the cumulative rate of varicella be 7.5 % after 1 dose and 2.2 % after 2 dos .
oral use
- trouble associate with the nervous system such a pain , burning , tingle , numbness and / or
the unreconstituted content of the vial before radiolabelling be not to be directly administer to patient .
never recap a needle • After inject Trudexa , immediately throw away the used syringe in a special container a instruct by your doctor , nurse or pharmacist .
4.8 Undesirable effect
the medicine can only be obtain with a prescription . du
LABELLING
dependence and withdrawal syndrome
3 .
wait for several second to let the powder dissolve .
at clinically relevant concentration , binding of dasatinib to plasma protein be approximately 96 % on the basis of in vitro experiment .
if this recommendation do not result in an appropriate effervescence , then a switch of therapy may be advise .
epoetin alfa IV / SC
7 .
& # 91 ; to be implement nationally & # 93 ;
in vitro , imatinib inhibits proliferation and induces apoptosis in gastrointestinal stromal tumour ( GIST ) cell , which express an activating kit mutation .
dog .
11.5 % & # 91 ; 5.6 % ;
800
Anti-peristaltic drug be contraindicate in this situation .
medicinal product subject to medical prescription .
Malta Charles de Giorgio Ltd .
Advagraf should generally be administer on an empty stomach or at least 1 hour before or 2 to 3 hour after a meal , to achieve maximal absorption ( see section 5.2 ) .
for HCV / HIV co-infected patient , the duration of treatment be 48 week .
chronic myelogenous leukaemia :
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
oral explanation be give by the Marketing Authorisation Holder on 27 June 2006 .
MARKETING AUTHORISATION HOLDER
this result ultimately in the conversion of prothrombin to thrombin .
6.5 Nature and content of container
the most common side effect ( see in more than 1 patient in 10 ) be insomnia ( difficulty sleep ) , tremor ( shake ) , headache ,
palpitation
oedema
ATryn
consequently , the time-action profile of an insulin preparation be determine solely by it absorption characteristic .
United Kingdom Roche Products Ltd .
general CLASSIFICATION FOR SUPPLY
please tell your doctor or pharmacist .
16 .
6.5 Nature and content of container
µg / week ) ( 3 MIU TIW )
information IN BRAILLE
name OF THE MARKETING AUTHORISATION HOLDER
this may damage the mechanism .
the pharmacodynamic property of Yttrium ( 90Y ) -labelled medicinal product prepare by radiolabelling with YTRACIS , prior to administration , will be dependent on the nature of the medicinal product to be radiolabelled .
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
caution should be exercise when darifenacin be use concomitantly with medicinal product that be predominantly metabolise by CYP2D6 and which have a narrow therapeutic window , such a flecainide , thioridazine , or tricyclic antidepressant such a imipramine .
your doctor will check you regularly for any of these side effect and to make sure you be take the lowest dose of Viani to control your asthma .
they decide that Baraclude ’ s benefit be greater than it risk for the treatment of patient with chronic hepatitis B with compensate liver disease .
Musculoskeletal and connective tissue disorder Very common :
ATC code :
Azomyr 2.5 mg orodispersible tablet desloratadine
urea , Sodium chloride , Polysorbate 20 , Sodium dihydrogen phosphate , Disodium hydrogen phosphate , Calcium chloride , Glycine , L-Leucine , L-Isoleucine , L-Threonine , L-Glutamic acid , L-Phenylalanine .
no
use the complete amount of solvent for reconstitution of the Betaferon powder , and inject the full dose 1.0 ml .
among naive patient treat with REYATAZ 300 mg once daily with 100 mg ritonavir once daily for a median duration of 48 week , 39 % have Grade 3-4 total bilirubin elevation ( see section 4.4 ) .
the following agent may enhance the hypoglycaemic effect of nateglinide : angiotensin-converting enzyme inhibitor ( ACEI ) .
list OF EXCIPIENTS
the medicine can only be obtain with a prescription .
rare : very rare :
3 .
the proportion of patient who have UACR reduce at least 50 % from baseline to endpoint be 24.7 % and 12.5 % for Riprazo and placebo , respectively .
tablet container
Viraferon , 18 million IU / pen , solution for injection : lp
2 Laguno M , Murillas J , Blanco J. L et al .
these increase in blood pressure can be treat with medicinal product .
13 .
further INFORMATION
the recommended dosage of IntronA be 4 to 5 million IU / m2 administer daily subcutaneously .
C / I98-580
4 .
EU / 1 / 02 / 229 / 025
- Combination with yellow fever vaccine ( see section 4.4 )
the team tackle a number of important topic , include the Agency ’ s Business planning , management of information , scientific opinion and scientific advice , quality of product information , internal auditing , provision of internal performance indicator , relationship with the Agency ’ s different partner , staff training and appraisal , and also implementation of management decision .
store in the original package .
22 • Second and third trimester of pregnancy ( see section 4.4 and 4.6 ) • Lactation ( see section 4.6 ) • biliary obstructive disorder • Severe hepatic impairment
Dexdomitor be compatible with butorphanol and ketamine in the same syringe at least for two hour .
sadness , dejection , etc ) while on treatment with PegIntron ( see section 4 ) .
both co-primary objective be meet :
150 mg / ml
Combivir have be show to significantly reduce the risk of disease progression .
other SPECIAL WARNING ( S ) , IF NECESSARY ed
psychiatric disorder
very rare :
Semoline be employ a carrier .
quality of Life :
AUC be 24 % lower in patient weigh ≥ 125 kg .
hyperglycaemia ( high blood sugar level )
also , the long-term safety effect concern growth , maturation and cognitive and behavioural development of Remeron in this age group have not yet be demonstrate .
atazanavir be negative in an Ames reverse-mutation assay but do induce chromosomal aberration in vitro in both the absence and presence of metabolic activation .
powder for concentrate for solution for infusion
concomitant use of voriconazole and rifabutin should be avoid unless the benefit outweigh the risk ( see section 4.5 ) .
France Laboratoire GlaxoSmithKline Tél . : + 33 ( 0 ) 1 39 17 84 44 diam @ gsk . com
Self-limiting , mild haemoglobin and haematocrit decrease have be observe on initiate gemfibrozil therapy .
how TO STORE Neupro
in patient with mild hepatic impairment ( Child-Pugh A ) , the mean AUC and Cmax increase 17 % and 22 % respectively , compare to healthy control subject .
expiry DATE
follicular lymphoma :
and the EMEA ( EMEA / MB / 013 / 97 )
liver graft rejection have also be report .
clopidogrel and the main circulating metabolite bind reversibly in vitro to human plasma protein ( 98 % and 94 % respectively ) .
cutaneous spray , solution .
∅ Do not move the pre-filled pen during the injection . ic ed
medicinal product by therapeutic
78 78 45
name OF THE MEDICINAL PRODUCT
however , only very rarely , this will require a change to your insulin dosage .
14 .
Teva UK Ltd Brampton Road , Hampden Park , Eastbourne , East Sussex , BN22 9AG United Kingdom
very rare
nervous system disorder neuralgia , febrile convulsion , neurological disorder , such a encephalomyelitis and Guillain Barré syndrome
lot
in patient with solid tumour or lymphoproliferative malignancy , if the haemoglobin value exceed 12 g / dl ( 7.5 mmol / l ) , the dosage adaptation describe in section 4.2 should be closely respect , in M
30 MIU ( 300 µg / 0.5 ml )
the mean CD4 cell count increase be greater in patient on the Fuzeon + OB regimen than in patient on OB regimen only .
rare :
approximately 25 % , depend on the rate of increase .
breast cancer
g
Ferriprox be originally authorise under ‘ exceptional circumstance ’ , because , a the disease be rare , limited information be available at the time of approval .
EMEND increase the AUC of midazolam 25 % on Day 4 and decrease the AUC of midazolam 19 % on Day 8 and 4 % on Day 15 .
- change in test value such a sodium , cholesterol and triglyceride level
5 .
LABELLING
however , the Committee conclude that CYANOKIT have advantage over alternative antidote because it have a good safety profile in patient who have not be poison .
severe hepatic impairment Dosing adjustment of fondaparinux be not necessary .
43
gastrointestinal effect upper gastrointestinal complication & # 91 ; perforation , ulcer or bleeding ( PUBs ) & # 93 ; , some of them result in fatal outcome , have occur in patient treat with etoricoxib .
6 .
how TO USE ADVATE
in some case , these reaction have progress to severe anaphylaxis .
67 PACKAGE LEAFLET :
12.8 , 46.4 ) , 4 % ( CI : -26.9 , 26.7 ) , 6 % ( CI : -33.5 , 34.3 ) and 14 % ( CI : -31.6 , 44.2 ) , during the 0-1 , 1-3 , 3-6 , 6-9 and 9-12 month study interval , respectively .
4.8 Undesirable effect
8 .
very
the agreed indication remain favourable and the Marketing Authorisations should be maintain accord to revise Summaries of Product Characteristics ( attach in Annex III of the CHMP Opinion ) ,
0.5 ml ( 12 million IU / ml )
possible SIDE EFFECTS
common
Alternatively , in patient not on dialysis , an initial dose of 0.75 μ g / kg may be administer subcutaneously a a single injection once every two week .
renal and Urinary Disorders
no specific frequency for hypoglycaemia be present , since hypoglycaemia be a result of both the insulin dose and other factor e. g. a patient ` s level of diet and exercise .
pull off the outer needle cap ( figure 6 ) .
frequency of administration
CONDITIONS OF THE MARKETING AUTHORISATION
26 A .
these blood test will be in addition to the test , which be normally do to monitor your MS .
therefore health care provider need to assess the benefit and potential risk of administer the vaccine in that population .
Germany
ear and labyrinth disorder
hypoglycaemia may be associate with listlessness , confusion , palpitation , headache , sweat and vomit .
1 .
an increase 3H-thymidine incorporation in the erythroid nucleate spleen cell have be find in vitro ( mouse spleen cell culture ) after incubation with erythropoietin .
6 A .
these factor include drastic change in diet , e. g. from a carnivore to a vegetarian diet , or a massive ingestion of alkalise gastric buffer .
Deafness , vertigo , earache
information IN BRAILLE
irbesartan Krka prevent the binding of angiotensin-II to these receptor , cause the blood vessel to relax and the blood pressure to lower .
overall , report be more common after IV administration .
SELF administration of Fertavid should only be perform by patient who be well-motivated , adequately trained and with access to expert advice .
therefore , this combination be not recommended ( see section 4.4 ) .
not applicable .
5 .
target SPECIES
further INFORMATION
in addition , under the influence of sympatholytic medicinal product such a beta-blockers , clonidine , guanethidine and reserpine , the sign of adrenergic counter-regulation may be reduce or absent .
it be advisable to inject immediately after mix .
CYMBALTA
13 aprepitant undergoes extensive metabolism .
10 .
the lp
4 - Never give your antibiotic to another person ; maybe it be not adapt to her / his illness .
contact your doctor or pharmacist if need .
provide adequate control of the symptom of anaemia . ed
the mean increase in olanzapine AUC be 52 % and 108 % respectively .
follow them exactly and visit your diabetes clinic regularly . • If you change the type of insulin you use ( for example from a human or animal insulin to a Liprolog product ) , you may have to take more or le than before .
ge expiry
a number of medicinal product be know to interact with glucose metabolism .
10 .
Annex 2 EMEA budget Summaries 2001 – 2003system The summarised comparative budget statement for 2001 to 2003 be a follow :
6 .
elderly Hepatic clearance of vardenafil in healthy elderly volunteer ( 65 year and over ) be reduce a compare to healthy younger volunteer ( 18 - 45 year ) .
distribution
Eli Lilly Nederland B.V. , Grootslag 1-5 , 3991 RA Houten , The Netherlands .
Special warning and precaution for use ( SPC section 4.4 ) The CHMP consider that the following warning need to be include in the SPC for Cozaar in all MSs :
- a pen needle for subcutaneous injection .
there be no indication that the safety of Xolair be alter with these other commonly use asthma medication .
Tel : + 351 21 412 95 00 FI.PT @ gsk.com
for further information see section 4.4 , section bleeding .
Orodispersible tablet
when 22 adolescent age 12 to 17 year ( inclusive ) receive a single 0.5 mg and 1 mg dose of varenicline the pharmacokinetics of varenicline be approximately dose proportional between the 0.5 mg and 1 mg dos .
( see section 4.5 and 5.2 )
4.7 Effects on ability to drive and use machine
the mean calculate glomerular filtration rate ( GFR ) at 12 , 24 , 36 , 48 and 60 month be significantly higher for patient receive Rapamune follow ciclosporin elimination than for those in the Rapamune with ciclosporin therapy group .
their symptom be the same a yours .
the use of dosage which be inadequate or discontinuation of treatment , especially in insulin- dependent diabetic , may lead to hyperglycaemia and diabetic ketoacidosis ; condition which be potentially lethal .
in CML , cytopenia ( thrombocytopenia , neutropenia , and anaemia ) be a consistent finding .
epoetin zeta be identical in it amino acid sequence and similar in carbohydrate composition to endogenous human erythropoietin that have be isolate from the urine of anaemic patient .
& lt ; 0.5 x 109 / l
this include medicine , herbal remedy , health food or supplement that you have obtain without a prescription .
the magnitude of analgesic effect of the 40 mg dose be comparable with that of ketorolac 60 mg IM or ketorolac 30 mg IV .
Dr John G .
EU / 1 / 00 / 142 / 009
EU / 1 / 97 / 045 / 001
very common side effect ( more than 1 in 10 patient ) report with Procoralan be luminous visual phenomenon ( brief moment of increased brightness , most often cause by sudden change in light intensity ) .
in diabetic hypertensive patient with chronic renal insufficiency and overt proteinuria , hyperkalaemia ( ≥ 5.5 mEq / L ) occur in 46.3 % of the patient in the irbesartan group and 26.3 % of the patient in the placebo group .
subcutaneous use ( prefer ) or intramuscular use
Ara-C 75 mg / m2 i. v .
Κύπρος Merck Sharp & amp ; Dohme ( middle East ) Limited .
MARKETING Authorisation
5 / 48 8 .
Diltiazem 180 mg QD
Viani 25 / 125
your doctor will closely supervise your therapy with Herceptin .
2 .
Tel : + 44 1276 698370
list OF EXCIPIENTS
discontinuation due to an acute infusion-related reaction occur in 0.4 % of patient receive abatacept and in 0.2 % of placebo-treated patient .
general CLASSIFICATION FOR SUPPLY
GIST be a cancer of the stomach and bowel .
because safety and efficacy data from clinical trial be base upon administration with food , it be recommend that Targretin capsule be administer with food .
in one study in child with juvenile idiopathic arthritis age 4 to 17 year , 43 of 69 ( 62 % ) child experience an infection while receive Enbrel during 3 month of the study ( part 1 open-label ) , and the frequency and severity of infection be similar in 58 patient complete 12 month of open-label extension therapy .
DATE of latest renewal :
inject Humalog Mix25 • Before you make an injection , clean your skin a you have be instruct .
then eat fruit , biscuit , or a Sandwich , a your doctor have advise you and have some rest .
in clinical study of patient with chronic hepatitis B , lamivudine be well tolerate .
how TO USE MYCAMINE
the systemic availability and half-life in dialysis-dependent diabetic patient be comparable with healthy subject .
7 .
BATCH NUMBER
1 .
5 metformin :
dose modification be require in 30 % of patient , most commonly for anaemia and neutropaenia .
some patient have t
not know : injection site complaint ( burn and / or stinging of short duration , eczema , oedema / swell , hive-like rash , hematoma , Induration , lump , vesicle , wheal and flare ) , inflammation , lip abnormality , papillitis , roughness / dryness , stiffness , trauma , varicella-like rash , venipuncture site haemorrhage , warm sensation , warm to touch .
in cytopenic dog , there be no adverse effect on progenitor and proliferate cell in the bone marrow .
patient with rare hereditary problem of fructose intolerance and / or with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine .
information IN BRAILLE
the patient should be advise that in case of sudden visual defect , he should stop take Tadalafil Lilly and consult a physician immediately ( see section 4.3 ) .
the usual dose be 5 million IU ( 3 to 9 million IU ) administer subcutaneously three time a week ( every other day ) .
BATCH NUMBER
a number of substance affect glucose metabolism and may require dose adjustment of human insulin .
it block an enzyme call protease , which be involve in the reproduction of HIV .
2 .
name OF THE MEDICINAL PRODUCT
Special STORAGE CONDITIONS
Tel : + 31 26 37 82 111
the serum concentration of fentanyl that cause a minimal analgesic effect in opioid-naive patient fluctuate between 0.3 – 1.5 ng / ml ; an increased incidence of adverse reaction be observe if serum level exceed 2 ng / ml .
PHARMACEUTICAL FORM AND CONTENTS
supplemental monitoring specific for child and adolescent Thyroid monitoring :
in patient who be enrol in the trial on the sole basis of a recent myocardial infarction , clopidogrel be numerically inferior , but not statistically different from ASA ( RRR = -4.0 % ; CI : -22.5 to 11.7 & # 91 ; p = 0.639 & # 93 ; ) .
31 repeat dose toxicity study in rat identify the liver a the primary target organ for toxicity ( increase in transaminase , bile duct hyperplasia , necrosis ) .
for a full list of excipients , see section 6.1 .
6.3 Shelflife
Alcon Romania S. R. L. : + 40 21 203 93 24
4.4 Special warning and precaution for use
11 .
name OF THE MEDICINAL PRODUCT
ask your doctor about this .
( n = 118 ) 54 ( 46 % ) *
6.5 Nature and content of container
a the risk of an allergic type hypersensitivity reaction can not be exclude , patient should be inform of the early sign of hypersensitivity reaction include hive , generalize urticaria , tightness of the chest , wheeze , hypotension , and anaphylaxis .
please tell your doctor or pharmacist .
this cause severe anaemia , symptom of which would include unusual tiredness and a lack of energy . na
5 .
however , it be possible that the combined hormonal contraceptive be not the cause of more woman have breast cancer .
please tell your doctor if you have serious liver disease .
6.3 Shelf life
if you think you may be allergic to any of these , talk to your doctor before take Icandra .
7 .
effective measure to avoid pregnancy must be take ( see section 4.4 and 4.6 ) .
Fentanyl-ratiopharm 75 µg / h TTS and associate name ( see Annex I )
careful monitoring of glucose control be essential .
UAB Merck Sharp & amp ; Dohme , Tel . : + 370.5.2780.247 Luxembourg / Luxemburg :
over a subsequent two week period where patient be re-randomized to either active medicinal product or placebo , patient on placebo have increase of 2.4 and 2.0 mmHg in SeSBP and SeDBP compare to + 0.1 and -0.3 mmHg change respectively in those on all dos of irbesartan ( see section 4.2 ) .
Taśmowa 7 PL-02-677 Warszawa Tel . : + 48- ( 0 ) 22 478 41 50
check that the dose window show “ 0 ” follow the safety test .
& # 91 ; to be complete nationally & # 93 ;
EU / 1 / 96 / 007 / 019
general disorder and administration site condition
when efavirenz be co- administer with a calcium channel blocker that be a substrate of the CYP3A4 enzyme , there be a potential for reduction in the plasma concentration of the calcium channel blocker .
information regard the pharmacokinetic / pharmacodynamic ( PK / PD ) profile of cinacalcet be give in section 5.1
Suomi / Finland Boehringer Ingelheim Finland Ky Puh / Tel : + 358 10 310 2800
- Patients on metformin and sulphonylurea : when appropriate AVANDAMET may be initiate at
no accumulation be observe for cetirizine follow daily dos of 10 mg for 10 day .
- if you be allergic ( hypersensitive ) to nitisinone or any of the other ingredient of Orfadin .
GlaxoSmithKline Pharmaceuticals S. A. Ul .
Tel : + 420 271 730 661 Danmark Bayer A / S Tlf : + 45-45 23 50 00 Deutschland Bayer vital GmbH Tel : + 49- ( 0 ) 214-30 513 48 Eesti Bayer OÜ Tel : + 372 655 85 65 Ελλάδα Bayer Ελλάς ΑΒΕΕ Τηλ : + 30 210 618 75 00 España Química Farmacéutica Bayer S. L .
Sandwich Kent , CT13 9NJ United Kingdom M
5 .
Anti-PRP ( 0.15 μ g / ml ) † N = number of subject
cleanse swab , disinfect the rubber membrane of both the powder-filled and the solvent-filled vial .
© EMEA 2007
990 mg / 66 ml
it be advisable to test your blood sugar immediately after take glucose to check that you really have hypoglycaemia .
pharmacological PROPERTIES
the re be no evidence of carcinogenic activity after the administration of saquinavir mesilate for 96 to 104 week to rat and mouse .
250 mg
any unused veterinary medicinal product or waste material derive from such veterinary medicinal product should be dispose of in accordance with local requirement .
- Nausea ( sickness )
further information
step 6 .
- the most common adverse reaction which have be describe be : psychotic reaction or
7 / 17 ANNEX III
a be the case with other medicinal product that affect the renin-angiotensin system , black hypertensive patient have notably le response to irbesartan monotherapy .
your blood concentration of phenytoin will need to be monitor during your treatment with VFEND and your dose may be adjust .  you be already be treat with rifabutin ( use for treat tuberculosis ) .
5.3 Preclinical safety data
1 blister card of 14 film-coated tablet in PVC / PVDC / Aluminium blister .
PHARMACEUTICAL FORM AND CONTENTS
if any problem occur while you be have your infusion , the medical staff will be on hand to take any necessary action .
renal impairment : no clinical trial be conduct with Sprycel in patient with decreased renal function ( trial exclude patient with serum creatinine concentration & gt ; 1.5 time the upper limit of the normal range ) .
7 .
these difference be not consider clinically meaningful .
list OF EXCIPIENTS
each Remeron 45 mg orodispersible tablet contain 45 mg of mirtazapine .
11 .
0049 6101 603151
5 .
effect on endocrine active and reproductive system organ be not observe in a chronic cynomolgus monkey toxicity study and reproductive performance be not affect in IL-6 deficient mouse .
a with the work party , these group of specific expert will prepare guideline , give advice to the Committee on particular question relate to medicinal product or general policy on identified topic .
89 Latvija Roche Latvija SIA Tel : + 371 - 7 039831
dog :
meta-analysis of overall survival data produce a hazard ratio point estimate of 1.08 in favour of control ( 95 % CI :
take special care with Ceplene • Ceplene and IL-2 be not to be inject at the same time .
4 .
SUSTIVA 600 mg
Alternatively , epoetin alfa can be administer at an initial dose of 450 IU / kg subcutaneously once weekly .
- cholestasis .
this summary be last updated in 04-2008 .
36 % * * * 39 % * * *
the type of adverse reaction report during post-marketing with CellCept be similar to those see in the controlled renal , cardiac and hepatic transplant study .
PHARMACEUTICAL FORM AND CONTENTS
Levitra 5 mg film-coated tablet vardenafil
the vaccine be a powder for suspension for injection contain in a single-dose vial , which should be mixed with solvent provide .
14 .
atorvastatin ( 80 mg daily ) do not alter the pharmacokinetics of prasugrel and it inhibition of platelet aggregation .
it do not stimulate insulin secretion and therefore do not produce hypoglycaemia .
15 .
tablet core Lactose monohydrate hyprolose Crospovidone Microcrystalline cellulose Magnesium stearate
50.0 ( 6 / 12 ) 12.8 , 87.2
5 .
if test be normal at baseline , routine testing be not need but should be perform if clinical finding of thyroid dysfunction appear ( see section 4.8 ) .
patient who experience erection last 4 hour or more should be instruct to seek immediate medical assistance .
name OF THE MEDICINAL PRODUCT
SoloStar .
life threaten bleeds such a intracranial bleed , throat bleed , severe abdominal bleed Surgery
78
these metabolite have very little or no antisecretory activity .
100 Units / ml
ri talk to your doctor if you have any lung disease such a asthma , emphysema or chronic bronchitis .
5 685 000 9.18 % 1 400 000 2.26 % 824 500 1.33 % 537 000 0.87 % 1 784 500 2.88 %
Tel : + 353 ( 0 ) 1 403 56 00
HCV 2 ≤ 600,000 IU / ml
at therapeutic exposure , there be evidence of CNS clinical sign of hyperactivity and bruxism and some change in growth ( transient body weight gain suppression ) .
15 .
8 .
immunosuppression
8 ground FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS , LABELLING AND PACKAGE LEAFLET
Hadovka office Park Evropská 2590 / 33d CZ-160 00 Praha 6 Tel : + 420 267 292 111
282 Diagram 11
Periodic monitoring of serum potassium be recommend when Rasilez HCT be administer with medicinal product affect by serum potassium disturbance ( e. g. digitalis glycoside , antiarrhythmic ) .
BATCH NUMBER
Tel : + 34-93-495 65 00 France Bayer Santé Tél : + 33 3- 20 20 80 80 Ireland Bayer Limited Tel : + 353 1 299 93 13 Ísland Vistor hf .
2 .
instruction ON USE
it may be suitable for those who be unable to take clarithromycin a part of an eradication therapy , when local resistance rate to metronidazole be low .
further INFORMATION
further INFORMATION
if there be no ovarian response , the daily dose will then be gradually increase until follicle growth and / or plasma estradiol level indicate an adequate response .
Novartis Europharm Limited Wimblehurst Road Horsham West Sussex , RH12 5AB United Kingdom
cat :
BATCH : t uc
what ALIMTA contains
blood and lymphatic system disorder :
VIRAMUNE oral suspension should
erythropoietin should be base on a benefit-risk assessment with the participation of the individual patient , which should take into account the specific clinical context .
5 5.1 Pharmacodynamic property
6.3 Shelf life
4 .
5.3 Preclinical safety data
versus placebo
voriconazole :
within each frequency grouping , undesirable effect be present in order of decrease seriousness . no
Zerene will help you to sleep .
NUMBER of application / semester 15 60
treatment of know or suspect cyanide poisoning .
the emulsion be a whitish homogeneous liquid .
upon regain consciousness , administration of oral carbohydrate be recommend for the patient in order to prevent relapse .
expiry DATE
CIALIS be contraindicate in patient who have loss of vision in one eye because of non-arteritic anterior ischemic optic neuropathy ( NAION ) , regardless of whether this episode be in connection or not with previous PDE5 inhibitor exposure ( see section 4.4 ) .
Sterwin Medicines Limited One Onslow Street Guilford Surrey GU1 4YW UK
expiry DATE
oral use
the vaccine be give a an intramuscular injection ( injection into a muscle ) .
the maximum mean ( 95 % upper confidence bound ) difference in QTcF from placebo be 3.6 ( 6.3 ) and 13.1 ( 15.8 ) for 400 / 100 mg twice daily and supratherapeutic 800 / 200 mg twice daily LPV / R , respectively .
interruption
10 .
the prevalence of ectopic pregnancy after IVF be report to be 2 to 5 % , a compare to 1 to 1.5 % in the general population .
in 44 patient with schizophrenia 65 year of age , dose from 5 to 20 mg / day be not associate with any distinguish profile of adverse event .
result at 48 week be present in the table .
morning AUC : ↑ 18 % ( ↑ 6 to ↑ 33 ) Evening AUC : ↔ morning Cmax : ↑ 24 % ( ↑ 12 to ↑ 38 ) Evening Cmax : ↔ morning Cmin : ↑ 42 % ( ↑ 9 to ↑ 86 ) b Evening Cmin : ↑ 24 % ( ↑ 3 to ↑ 50 ) b Efavirenz :
PHARMACEUTICAL FORM AND CONTENTS
do not take a double dose to make up for a forgotten dose .
but your doctor will have tell you exactly how much to use , when to use it , and how often .
4.9 Overdose
this subgroup have a high degree of Bad prognostic marker , i. e. extensive resistance and high baseline viral load .
nervous system disorder Very common Common Uncommon Cardiac disorder
however , olanzapine ( 5-20 mg ) demonstrate a comparable safety profile in female ( n = 467 ) a in male patient ( n = 869 ) .
- phenothiazine derivative ( use to treat psychiatric disorder ) ,
uth Tel . + 370 52 101868
vardenafil be metabolise predominantly by hepatic enzyme via cytochrome P450 ( CYP ) isoform 3A4 , with some contribution from CYP3A5 and CYP2C isoforms .
the untreated historical cohort be match to the pivotal study population and be derive from a retrospective natural history study ( n = 42 ) in patient with infantile-onset Pompe disease .
possible side effect 5 .
10 / 24 General disorder Common
CellCept 250 mg capsule :
general disorder and administration site
1 2 * 3 * 4 * * if need
chromosome abnormality
Lietuva Pfizer Luxembourg SARL Filialas Lietuvoje Tel . + 3705 2514000
human study with radiolabelled ritonavir demonstrate that the elimination of ritonavir be primarily via the hepatobiliary system ; approximately 86 % of radiolabel be recover from stool , part of which be expect to be unabsorbed ritonavir .
15 .
it be recommend that antiarrhythmic therapy for bradycardia and / or ventricular tachyarrhythmias ( pacemaker , defibrillator ) be available when Metalyse be administer .
after 2 hour , check the injection site for redness , swell , or tenderness .
120 ml
3 .
10 .
4.2 Indications for use , specify the target specie
135 PACKAGE LEAFLET :
EU / 1 / 97 / 030 / 113
- replace the mouthpiece cover .
1 pre-filled syringe
please read these instruction carefully so that you know how to use the solution correctly .
Magyarország GlaxoSmithKline Kft .
42 B .
the most common side effect with Doribax ( see in more than 1 patient in 10 ) be headache .
Inaba Classical biotype ( heat inactivate ) , Inaba EL Tor biotype ( formalin inactivate ) , Ogawa Classical biotype ( heat inactivate ) , Ogawa Classical biotype ( formalin inactivate ) . − Recombinant cholera toxin B subunit ( rCTB ) 1 mg .
Tηλ . : + 357 22 818087
terfenadine be a substance with extensive first-pass metabolism and practically act through it active metabolite carboxy terfenadine .
• Don ’ t stop any anti-HIV medicine prescribe by your doctor when you start Viread if you have both HBV and HIV .
9 .
the risk appear to be relate to the intensity and duration of immunosuppression rather than to the use of any specific agent .
& # 91 ; see Annex I - To be complete nationally & # 93 ;
in these case , ciprofloxacin should be discontinue .
medicine should not be dispose of via wastewater or household waste .
lactose and colorants ( E171 , E172 )
once weekly
5 .
237
11.0 to 15.5 15.6 to 20.0 20.1 to 24.5 24.6 to 29.0 29.1 to 33.5 33.6 to 38.0 38.1 to 42.5 ≥ 42.6
België / Belgique / Belgien GlaxoSmithKline s. a . / n. v .
if you notice any serious effect or other effect not mention in this leaflet , please inform your veterinary surgeon .
Tél / Tel : + 32 ( 0 ) 2 525 82 11
common be hypertension , access relate thrombosis and headache .
6.4 Special precaution for storage
irbesartan / hydrochlorothiazide : the potential toxicity of the irbesartan / hydrochlorothiazide combination after oral administration be evaluate in rat and macaque in study last up to 6 month .
statement OF ACTIVE SUBSTANCE ( S )
3 .
Polska Ul .
Polska Ul .
suicidal ideation and behaviour have be report in patient treat with anti-epileptic agent in several indication .
Pharmacotherapeutic group :
take Baraclude a long a your doctor have tell you .
Tel : + 40 21 206 47 01
fix entertainment allowance
animal behavioral study with olanzapine indicate 5HT , dopamine , and cholinergic antagonism , consistent with the receptor-binding profile .
305 PACKAGE LEAFLET :
BATCH NUMBER
not applicable .
like all retinoids , isotretinoin be teratogen and be contraindicate during pregnancy to avoid congenital defect .
in patient with chronic renal failure , maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommend in section 4.2 .
be excipients : sodium phosphate monobasic , sodium phosphate dibasic , sodium chloride , polysorbate 80 ,
0.5 ml ( 100 IU / ml )
INTERMEDIATE CARTON OF MULTIPACKS ( without BLUE BOX )
Protaphane be often give in combination with fast-acting insulin product .
QT interval be correct for heart rate by Fridericia & apos ; s method .
Grelutamide
25 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Ireland
box of 10 bottle of 50 dos each
combination drug therapy with any other centrally act anorectic agent be contraindicate due to the increase risk of potentially fatal pulmonary artery hypertension .
Magyarország Astellas Pharma Kft .
Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
advice ON CORRECT ADMINISTRATION
lot { number }
20 50
15 .
tell your doctor if you suffer from kidney problem because your dose may need to be adjust .
a with any vaccine , Silgard may not fully protect 100 % of those who get the vaccine .
d .
with long-term exposure ( at least 24 week ) , approximately half of adolescent patient gain ≥ 15 % and almost a third gain ≥ 25 % of their baseline body weight .
how TO STORE Enbrel
lipid alteration Undesirable alteration in lipid have be observe in olanzapine-treated patient in placebo- controlled clinical trial ( see section 4.8 ) .
it be give to you by your doctor or nurse .
the medicine can only be obtain with a prescription .
method OF ADMINISTRATION
BRISTOL-MYERS Squibb Pharma EEIG Uxbridge Business Park , Sanderson Road Uxbridge UB8 1DH United Kingdom
especially of the large tendon at the back of the ankle ( Achilles tendon ) ( see Section 2 :
1.08
take Iscover with food and drink food / meal have no influence .
there have be report of aplastic anaemia and bone marrow depression in patient treat with mycophenolate , some of which have be fatal .
oral use .
Uncommon : nausea , vomit
Norge Boehringer Ingelheim Norway KS Tlf : + 47 66 76 13 00
- Treatment of symptomatic anaemia associate with chronic renal failure ( CRF ) in adult and
the frequency of the side effect list below be define use the following convention :
like all medicine , Ovitrelle can cause side effect , although not everybody get them .
not applicable .
Ireland Cephalon Pharma ( Ireland ) Ltd Unit E , Glencormack Business Park Kilmacanogue IRL- County Wicklow Tel : + 353 ( 0 ) 1 201 4000
0.99 , 1.18 ; 42 trial and 8167 patient ) .
pregnancy and breast-feeding Take special care with Twinrix Adult if you be or think you may be pregnant or if you intend to become pregnant .
list OF EXCIPIENTS
Kornelia Grein , Head of Sector for safety of veterinary medicine ,
CHARACTERISTICS in patient :
Groundwater be also use a a source of drinking water .
11 10 .
4.5 Interaction with other medicinal product and other form of interaction
before you receive Twinrix Adult 3 .
case of aseptic meningitis have be report following measles , mumps , and rubella vaccination .
• OTHER CONDITIONS
in the elderly , progressive deterioration of renal function may lead to a steady decrease in insulin requirement .
metabolism metformin be excrete unchanged in the urine .
if you want to change your “ Patch Change Day ” to a different day of the week talk to your doctor .
MIRAPEXIN
Hepatobiliary Disorders
however , the solution may be use for up to 6 hour when store in the refrigerator ( 2  – 8  C )
oral
Tel : + 43- ( 0 ) 1 711 780
5 .
3.0 5.5 8.0 2.3 3.1 4.8 10.3 NA
keep out of the reach and sight of child .
chronic renal failure patient on erythropoietin should have their haemoglobin ( the part of a red blood cell that carry oxygen ) level measure on a regular basis until a stable level be achieve , and periodically thereafter to minimise the risk of an increase in blood pressure .
treatment with Exforge be not recommend during breast- feeding .
the report be expect to be accompany by legislative proposal .
Uncommon : very rare :
it be possible that the decreased bioavailability in this study be due to delay transit of ribavirin or modify pH .
Table 2 Undesirable Effects in postmarketing Surveillance and Phase IV Clinical Studies
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
treatment of symptomatic anaemia in adult and paediatric chronic renal failure patient
Ι talia Addenda Pharma S. r. l .
Teл . : + 359 800 12 400
therapy continue beyond 12 week do not result in significantly more response ( see section 4.2 ) .
a rise in haemoglobin of greater than 2 g / dl ( 1.25 mmol / l ) over a four week period should be avoid .
renal impairment : no dosage adjustment be necessary in patient with impaired renal function .
743 WARNING symptom of hypoglycaemia
S Evaluation in 60-90 day
VIRAMUNE oral suspension contains methyl parahydroxybenzoate and propyl parahydroxybenzoate , which may cause allergic reaction ( possibly delay ) .
6.4 Special precaution for storage
in preclinical study , olanzapine exhibit a range of receptor affinity ( Ki ; & lt ; 100 nM ) for serotonin 5 HT2A / 2C , 5 HT3 , 5 HT6 ; dopamine D1 , D2 , D3 , D4 , D5 ; cholinergic muscarinic receptor m1-m5 ; α 1 adrenergic ; and histamine H1 receptor .
21 diclofenac 150 mg but be higher for etoricoxib 90 mg compare to diclofenac 150 mg ( statistically significant for 90 mg etoricoxib v .
they be produce and secrete by cell in response to viral infection or various synthetic and biological inducer .
( n = 485 ) response rate of ≥ 60 % in
the main metabolic pathway be glucuronidation of entacapone and it active metabolite , the cis-isomer , which account for about 5 % of plasma total amount .
for the treatment and prevention of flea infestation ( Ctenocephalides felis ) , treatment of ear mite infestation ( Otodectes cynotis ) , prevention of heartworm disease ( L3 and L4 larva of Dirofilaria immitis ) and treatment of infection with gastrointestinal nematode ( L4 larva , immature adult and adult of Toxocara cati and Ancylostoma tubaeforme ) .
reproduction be authorise provide the source be acknowledge .
reduce susceptibility to amprenavir be associate with virus that have develop I50V or I84V or V32I + I47V or I54M mutation .
other SPECIAL WARNING ( S ) , IF NECESSARY
Germany
what IDflu contains
absorption be variable and the mean oral bioavailability of tacrolimus ( investigate with the Prograf formulation ) be in the range of 20 % - 25 % ( individual range in adult patient 6 % - 43 % ) .
wk 12 wk 12 wk
information IN BRAILLE
sign and symptom Very common symptom in overdose ( & gt ; 10 % incidence ) include tachycardia , agitation / aggressiveness , dysarthria , various extrapyramidal symptom , and reduce level of consciousness range from sedation to coma .
- with growth disturbance due to insufficient secretion of growth hormone ( GH ) .
15 .
data on tissue distribution and elimination be obtain in study with radioactively label tenecteplase in rat .
treatment of NSAID associate benign gastric and duodenal ulcer in patient require continue NSAID treatment :
10 .
seek medical help immediately if you develop symptom of a severe allergic reaction ( such a difficulty in breathing , wheeze or hive ) while take this treatment .
however , a it be the case with all antihistamine , it be recommend to avoid concurrent consumption of alcohol .
name and address of the manufacturer responsible for batch release
18 Patients should be monitor closely to ensure that the lowest approve dose of MIRCERA be use to provide adequate control of the symptom of anaemia .
the analysis of all record in vivo recovery in previously treat patient demonstrate a mean rise of 2 % per IU / kg body weight for KOGENATE Bayer .
- you be elderly , if you have have diabetes for a long time or if you suffer from a certain type of
8 .
28
Luxembourg / Luxemburg GlaxoSmithKline s. a . / n. v .
adverse reaction :
typically , such reaction have be observe within the first few week or month of initiation of CART .
( see section 4.4 and 4.5 . )
expiry DATE
it should be consider whether it be advisable to drive or operate machinery in these circumstance .
each cartridge contain three small metal ball to facilitate quick and thorough mixing of the content .
10 .
see the box at the end of this leaflet for further information .
Fujisawa GmbH * * Neumarkter Str .
name STAMARIL
Visudyne have be study in two study last two year and involve 609 AMD patient with CLASSIC subfoveal lesion , where it be compare with placebo ( a dummy treatment ) .
this mean that both of these substance help to stop the blood vessel tighten .
4 pre-filled pen
the percentage of patient who lose 5 % and 10 % of their baseline body weight after 1 year of treatment be give in the table 2 .
sanofi Pasteur MSD SNC , Tél : + 33.4.37.28.40.00 Ireland :
7 .
dyspnoea
27 Clinical efficacy :
of the 573 patient randomise , 335 ( 58 % ) achieve clinical response by week 2 .
adjustment in dosage of the medicinal product , meal pattern , or physical activity may be need .
instruction ON USE
the recommend dose of Emtriva be one capsule once a day for patient who weigh 33 kg or more .
nausea and vomit diarrhoea infection Stomatitis
4.7 Effects on ability to drive and use machine
these study have show a consistent unexplained statistically significant excess mortality in patient who have anaemia associate with various common cancer who receive recombinant human erythropoietin compare to control .
patient add vildagliptin have a fall in HbA1c level of 0.88 % after 24 week from a start level of 8.38 % .
1 %
1 .
a total of 957 patient with urge urinary incontinence be evaluate in three controlled study compare Kentera to either placebo , oral oxybutynin and / or tolterodine long acting capsule .
Extreme care must be take to avoid pregnancy in female patient .
severity of fracture :
asthenia Uncommon :
89 The frequency of the side effect list below be define use the following convention :
- you have recently suffer hypoglycaemia ( for example the day before ) or if it develop slowly ,
weight of dog & # 91 ; kg & # 93 ;
caution require with concomitant use non-steroidal anti-inflammatory medicine ( NSAIDs ) , include selective COX-2 inhibitor , acetylsalicylic acid ( & gt ; 3 g / day ) , and non-selective NSAIDs When angiotensin II antagonist be administer simultaneously with NSAIDs attenuation of the antihypertensive effect may occur .
Amgen Europe B. V .
• in anaemic cat , mortality rate of about 60 % at 4 , 6 , 9 and 12 month be reduce by approximately 30 % follow treatment with interferon . • in non-anaemic cat , mortality rate of 50 % in cat infect by FeLV be reduce by 20 % follow treatment with interferon .
ratiopharm GmbH Graf-Arco-Strasse 3 D-89079 Ulm Germany
further information
read all of this leaflet carefully before you start take this medicine . − Keep this leaflet .
4.7 Effects on ability to drive and use machine
for the purpose of ambulatory use , Aranesp may be remove from storage once for a maximum single period of seven day at room temperature ( up to 25 ° C ) .
caution be recommend for patient perform skilled task .
blood test may show lowered level of potassium and sodium in your blood .
two of the study recruit patient who be be treat with chemotherapy .
dosage adjustment may be necessary when transfer patient from one insulin preparation to another .
Romania
-release dog Oral use Blister -
nicotinic acid-related adverse reaction The following nicotinic acid-related adverse reaction have be see in clinical trial or post-marketing experience with other nicotinic acid medicinal product at unknown frequency or in clinical trial with Trevaclyn ( or the nicotinic acid component of Trevaclyn ) in & lt ; 1 % of the patient treat :
absolute bioavailability average 4 % ( CV 73 % , range :
B .
Tel : + 34 93 306 42 00
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
cancer , gout , or arthritis , and vitamin D supplement .
lot :
Eesti Novartis Pharma Services Inc .
- infection in immune-suppressed patient
Bayer Schering Pharma AG D-13342 Berlin Germany
3.5-4.6 ) .
use other medicine IntronA will add to the effect of substance that slow down your nervous system , possibly cause drowsiness .
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
59 8 .
thrombocytopenia , Leukopenia
intravenous route
at the usual metformin dos and dose schedule , steady state plasma concentration be reach within 24 to 48 hour and be generally le than 1 µg / ml .
be in the dose window .
Merck Sharp & amp ; Dohme Ltd Hertford Road Hoddesdon Hertfordshire EN11 9BU United Kingdom
3 .
270
you may even help bacteria become resistant and therefore delay your cure or decrease antibiotic efficacy if you do not respect appropriate :
in a meta-analysis of six clinical trial , TAMs be not select by regimen contain abacavir without zidovudine ( 0 / 127 ) , but be select by regimen contain abacavir and the thymidine analogue zidovudine ( 22 / 86 , 26 % ) .
CRIXIVAN and oral midazolam should not be coadministered ( see section 4.3 ) .
RELISTOR 12 mg / 0.6 ml solution for injection .
hypoglycaemia ( low blood sugar level )
a there be no in vitro or in vivo system suitable to predict acceptable immunogenicity in man , it be important to note at this stage that the C3H mouse model suggest by the MAH appear to be able to discriminate between Hepatitis B lot which be acceptable and those who be not .
take Baraclude with food and drink In most case you may take Baraclude with or without food .
this serious allergic reaction need immediate medical attention .
if there be no ovarian response , the daily dose be then gradually increase until follicle growth and / or plasma oestradiol level indicate an adequate pharmacodynamic response .
Azomyr may be take without regard to mealtime for the relief of symptom associate with allergic rhinitis ( include intermittent and persistent allergic rhinitis ) and urticaria ( see section 5.1 ) .
Gamma-GT increase creatinine increase
if their symptom be the same a yours .
4 .
in patient with cancer receive chemotherapy the etiology of anaemia be multifactorial .
in this product , emodepside be responsible for the efficacy against Toxocara cati , Toxascaris leonina , and Ancylostoma tubaeforme .
12 .
method AND ROUTE ( S ) OF ADMINISTRATION
store in the original package .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
( 44-20 ) 74 18 84 00 Fax ( 44-20 ) 74 18 84 16 E-mail : mail @ emea . europa . eu http : / / www . emea . europa . eu
- inadequate food intake ,
Dunajska cesta 119 SI 1000 Любляна , Словения Teл : + 386 1 560 3 800
there be no apparent correlation between the presence of anti-adalimumab antibody and the occurrence of adverse event .
solvent 2 needle 1 dose ( 0.5 ml )
for animal treatment only .
your doctor will test your blood and urine for sugar regularly .
method AND ROUTE ( S ) OF ADMINISTRATION
15 / 22
your doctor will tell you how much Parareg you must take .
the risk of thrombosis in factor VII deficient patient treat with NovoSeven be unknown .
Karvezide should not be give to child and adolescent ( under 18 year ) .
common common
16-116 mL / min ) .
there be insufficient experience of the use of oral or intravenous topotecan in patient with severely impaired renal function ( creatinine clearance & lt ; 20 ml / min ) .
if all the condition mention be exclude and the patient have a sudden drop of haemoglobin associate with reticulocytopenia and anti-erythropoietin antibody , examination of the bone marrow for the diagnosis of Pure Red Cell Aplasia ( PRCA ) should be consider .
somatropin may induce a state of insulin resistance and in some patient hyperglycaemia .
10 mg
lo
capsule , hard
other SPECIAL WARNING ( S ) , IF NECESSARY
Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel : + 44- ( 0 ) 1 707 363 636
B .
( ≥ 1 / 1000 to & lt ; 1 / 100 )
your doctor may conduct blood test in order to check how well your liver be work .
always wash your hand prior to perform the following procedure .
4.4 Special warning and precaution for use na
a second course of treatment may be give at the discretion of the treat physician in patient where additional tumour necrosis and removal be deem appropriate , with a recommended minimum interval of 4 week between treatment .
caution should especially be exert when treat elderly patient a they may be at an increase risk of cardiac disorder or when lacosamide be use in combination with product know to be associate with PR prolongation .
n = 96
these may be more common at the start of treatment .
important information about some of the ingredient of Rebif
45 %
myalgia .
after oral administration , desloratadine selectively block peripheral histamine H1- receptor because the substance be exclude from entry to the central nervous system .
dispose of the needle safely , a instruct by your healthcare professional .
20 mg
17 In patient with high viral load at baseline ( & gt ; 100,000 copy / ml ) 7 / 14 ( 50 % ) patient in the lopinavir / ritonavir group and 6 / 19 ( 32 % ) patient in the fosamprenavir with ritonavir group have plasma HIV-1 RNA & lt ; 400 copy / ml .
other SPECIAL WARNING ( S ) , IF NECESSARY
the in vitro data and in vivo interaction data on oral contraceptive , digoxin and warfarin indicate that no significant enzyme 58 induction be expect in vivo .
Veralipride treatment be contra-indicated in patient with prolactin- dependent tumour such a pituitary gland prolactinoma and breast cancer .
store in a refrigerator .
the administration of sevoflurane must be individualise base on the dog & apos ; s response .
the mean increase in olanzapine Cmax follow fluvoxamine be 54 % in female non- smoker and 77 % male smoker .
possible independent risk factor for impulse control disorder include dopaminergic treatment and higher dos of dopaminergic treatment , younger age ( ≤ 65 year ) , not be marry and self-reported family history of gamble behaviour .
Onsets of immunity have be demonstrate 1 week after primary vaccination course for rhinotracheitis , calicivirus and panleucopenia component .
concern mixing or incompatibility with other insulin see section 6.6 .
178 9 .
adverse Drug Reaction
do not chew the tablet .
tell your doctor if you be plan to get pregnant .
insufficiency be associate with negative calcium balance , bone loss , and increase risk of skeletal fracture .
rare case of haemolysis include acute intravascular haemolysis or haemolytic anaemia have be report in patient treat with micafungin .
BATCH NUMBER
this medicinal product do not contain any preservative
in patient also take oral anti-diabetes medicine , a common side effect be sign of allergy .
ciclosporin A : ciclosporin A ( CsA ) pharmacokinetics be unaffected by mycophenolate mofetil .
the rapporteur be Dr Tomas Salmonson ( SE ) and co-rapporteur be Dr Ian Hudson ( UK ) .
expiry DATE
the steady - state peak plasma concentration be approximately 300 ng / ml and be achieve within 1.0 ± 0.5 h .
5000 U / ml 5000 U / ml 5000 U / ml
usual dose The dose will depend on your height and weight .
in the absence of compatibility study this medicinal product must not be mix with other medicinal product .
45a 42a
- severe liver impairment , a it have not be study in this population .
injection site reaction ( include pain , swell , redness or pruritus )
≤ 600,000 IU / ml
immune system disorder
Parkinson & apos ; s disease The use of olanzapine in the treatment of dopamine agonist associate psychosis in patient with Parkinson & apos ; s disease be not recommend .
absorption The maximum plasma concentration of the insulin be reach within 2-18 hour after subcutaneous i dic
discontinuation of treatment Withdrawal symptom when treatment be discontinue be common , particularly if discontinuation be abrupt ( see section 4.8 ) .
instruction ON USE
you may need to read it again .
• OTHER CONDITIONS
take Tarceva with food and drink :
Lietuva UAB sanofi-aventis Lietuva Tel : + 370 5 2755224
CONDITIONS OF THE MARKETING AUTHORISATION
the first injection be give at an age of six to 12 week and the second at least six week later at an age of 14 to 18 week .
subcutaneous SELF administration may lo be use after training by a medical professional . no
85,000
patient should be closely monitor during this period .
detailed information on this product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu / .
Gliolan have be study in one main study involve 415 patient with malignant glioma who be about to undergo brain surgery to remove the tumour .
if possible , take the sachet or the box with you to show the doctor .
tell your doctor about any medical problem or allergy your child have now or have have .
metabolism and nutrition disorder
6 .
acute hypersensitivity reaction ( e.g . , urticaria , angioedema , bronchoconstriction , anaphylaxis ) have be observe rarely during interferon alfa-2b therapy .
see section 4.3 .
method AND ROUTE OF ADMINISTRATION
it be mainly eliminate through the small intestine that suppose an advantage in relation to the rest of tetracycline provide that it be not accumulate in the organism when renal function be diminish since it be not it mainly route of elimination .
Germany
tablet .
a 10 ml polypropylene oral dosing syringe and a polyethylene adapter be also include in the pack .
2 .
such condition should be correct before the administration of Aprovel .
80
clarithromycin 500 mg b. i. d .
Table 1
case with fatal out- come have be observe in post-marketing setting ( see respiratory event and section 4.8 ) .
the expiry date refers to the last day of that month .
reaction with barium hydroxide result in a greater production of compound A than do the reaction with soda lime .
10 IU 2 Presentations
medicinal product subject to medical prescription .
E ) Making the injection
in patient MIRAPEXIN alleviate sign and symptom of idiopathic Parkinson ’ s disease .
7 / 35 The Committee for Veterinary Medicinal Products have recommend the inclusion of mineral oil in Annex II of Council Regulation ( EEC ) No 2377 / 90 in accordance with the follow table :
adopt in March 1997
a .
method OF ADMINISTRATION
20 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS IMMEDIATE PACKAGING / BLISTER
the patient & apos ; s ability to concentrate and react may be impair a a result of hypoglycaemia or hyperglycaemia or , for example , a a result of visual impairment .
Reconcile tablet be use a an aid in the treatment of separation-related disorder in dog , such a destruction and vocalisation and inappropriate defaecation and / or urination .
thus , antacid may be administer up to 2 hour prior to or 2 hour follow Sprycel ( see section 4.4 ) .
lot :
liver function abnormality
© EMEA 1998
what Prialt contains
any unused product or waste material should be dispose of in accordance with local requirement .
SINGULAIR can treat your child ’ s asthma only if he / she continue take it .
what be INCRELEX use for ?
docetaxel must not be use in pregnant or breast-feeding woman .
a with all injectable vaccine , appropriate medical treatment should always be readily available in case of anaphylactic reaction follow the administration of the vaccine .
16 .
do not use Revatio after the expiry date which be state on the carton .
the pharmacokinetic profile of cisplatin administer shortly after docetaxel infusion be similar to that observe with cisplatin alone .
1 mg ( 50 KIU ) , 2 mg ( 100 KIU ) and 5 mg ( 250 KIU ) .
median duration of
Pfizer Hellas Ae Mesogeion 243 New Psychiko 15451 Greece
acute liver failure , hepatitis , abnormal liver function test
ask your veterinary surgeon how to dispose of medicine no longer require .
1 .
6.4 Special precaution for storage
this revaccination result in immunity to equine influenza last at least 12 month .
this medicinal product do not require any special storage condition .
European PUBLIC ASSESSMENT REPORT ( EPAR )
SP Europe , Rue de Stalle 73 , B-1180 Bruxelles , Belgium .
muscle twitching and blepharospasm may be take a early sign to consider levodopa dosage reduction .
the two active ingredient in Irbesartan Hydrochlorothiazide BMS work together to lower blood pressure further than if either be give alone .
in clinical study with 73 previously treat patient ( PTP , define a have more than 100 exposure day ) , follow over four year , no de-novo inhibitor be observe .
• After the initial high level of application for orphan drug designation experience after the introduction of the EU orphan drug policy , number be expect to remain stable
a with other anti-HIV medicine , patient take Reyataz may also be at risk of osteonecrosis ( death of bone tissue ) or immune reactivation syndrome ( symptom of infection cause by the recover immune system ) .
duration of administration & # 91 ; Invented name & # 93 ; 400 mg film-coated tablet should be use for the following treatment duration :
after topical application on the skin , a local anti-inflammatory effect be see , which be accompany by a moderate and reversible adrenal suppression at higher dos .
Uncommon side effect ( occur in at least 1 in 1,000 patient ) be :
pre-filled syringe ( glass ) 0.6 ml with an automatic safety system
dizziness paraesthesia , insomnia , depression , confusion , hypoaesthesia , nervousness , dry mouth , amnesia
the required amount of pre-donated blood depend on the anticipated blood loss , use of blood conserving procedure and the physical condition of the patient .
the reconstituted solution be slightly yellow .
for induction treatment , Trudexa should be give in combination with corticosteroid .
lot
store in a refrigerator .
Rotarix do not protect against gastro-enteritis due to other pathogen than rotavirus .
RISPERDAL be use to treat the following :
Aprovel be use to treat high blood pressure ( essential hypertension ) to protect the kidney in patient with high blood pressure , type 2 diabetes and laboratory evidence of impaired kidney function .
if it occur , appropriate dose adjustment should be make a provided .
53 1 .
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder :
headache , stomach ulcer , vomit , nausea , constipation , excessive gas in stomach or intestine , rash , itch , dizziness , abnormal touch sensation .
ask your pharmacist how to dispose of medicine no longer require .
PHARMACEUTICAL PARTICULARS
antidiabetic agent .
read ENCLOSED PACKAGE LEAFLET
the recommend starting dose for olanzapine be 10 mg / day .
one dose ( 2 ml ) contain :
0.54
a an increased incidence of thrombotic vascular event ( TVEs ) have be observe in cancer patient receive erythropoietic agent ( see section 4.8 ) , this risk should be carefully weigh against the benefit to be derive from treatment ( with Retacrit ) particularly in cancer patient with an increase risk of thrombotic vascular event , such a obesity and patient with a prior history of TVEs ( e. g. deep venous thrombosis or pulmonary embolism ) .
ed with existence of or history of severe psychiatric condition be contraindicate ( see section 4.3 ) .
Debrecen H-4042 Hungary
if not use immediately , in-use storage time and condition prior to use be the responsibility of the user and would normally not be longer than 24 hour at 2 ° C to 8 ° C , unless dilution have take place in control and validate aseptic condition .
effervescent tablet
• if you have / your child have previously have any allergic reaction to Twinrix Paediatric , or any ingredient contain in this vaccine .
section 4.3 Contraindications
Malta GlaxoSmithKline Malta Tel : + 356 21 238131
intravenous use
CE mark pump equivalent to the Synchromed and CADD-Micro pump should be use to deliver ziconotide .
Special STORAGE CONDITIONS
what EMEND IS AND WHAT IT IS USED FOR
combination therapy with ribavirin :
the effect of BYETTA to slow gastric emptying may reduce the extent and rate of absorption of orally administer medicinal product .
the MAHs be of the opinion that the issue identify during the MRP be issue of clinical management and a such can not be address by conduct further clinical trial .
expiry DATE
6.2 Incompatibilities
Lovett House Lovett Road , Staines Middlesex , TW18 3AZ-UK Tel : + 44 ( 0 ) 1784 419615
oedema may occur upon initiation of insulin therapy .
very Common ( ≥ 1 / 10 )
4.2 Posology and method of administration
more severe hypoglycaemia with seizure , loss of consciousness or coma should be treat with IV glucose .
EU / 2 / 98 / 008 / 001
adverse event report within 30 day of initiation of eptifibatide treatment in PURSUIT be report in Table 1 below .
why do hyperglycaemia occur ?
consequently , Truvada should not be administer in combination with lamivudine or zalcitabine for the treatment of HIV infection ( see section 4.4 ) .
a see in Table 2 below , a pooled analysis of 3 of the study for the treatment with both EMSELEX 7.5 mg and 15 mg provide a statistically significant improvement in the primary endpoint , reduction in incontinence episode , versus placebo .
progression-free Survival accord to Binet stage ( ITT )
- a 2 ml syringe ;
term mark with a star ( * ) refer to the adverse reaction that be additionally report in & gt ; 2 % of diabetic hypertensive patient with chronic renal insufficiency and overt proteinuria and in excess of placebo .
do NOT mix OR CO-INFUSE CANCIDAS WITH ANY OTHER medicine , a there be no data available on the compatibility of CANCIDAS with other intravenous substance , additive , or medicinal product .
each 200 mg film-coated tablet contain 200 mg lumiracoxib .
Methacrylic acid - ethyl acrylate copolymer ( 1 : 1 ) Colloidal anhydrous silica Macrogol Titanium dioxide ( E171 )
other substance : plasma concentration of other substance may be increase by amprenavir .
reproduction be authorise provide the source be acknowledge .
the risk of hypokalaemia be greatest in patient with cirrhosis of the liver , in patient experience brisk diuresis , in patient who be receive inadequate oral intake of electrolyte and in patient receive concomitant therapy with corticosteroid or ACTH .
your doctor will test for these change .
a with all interferon , discontinue treatment with PegIntron in patient who develop prolongation of coagulation marker which might indicate liver decompensation .
- Angioedema ( rare ) :
the observed terminal elimination half-life be 142 hour in CKD patient not on dialysis .
since the liver be think to be the principal route of elimination of Aranesp and r-HuEPO , Aranesp should be use with caution in patient with liver disease .
14 .
Aprovel be not recommend in early pregnancy and may cause serious harm to your baby after 3 month of pregnancy , see section Pregnancy and breastfeeding .
- monoamine oxidase ( MAO ) inhibitor ( use to treat depression ) ,
- Pathological gambling , especially when take high dos of MIRAPEXIN
wound infection Common :
SP Europe , 73 , rue de Stalle , B-1180 Bruxelles , Belgium
for a full list of excipients , see section 6.1 .
12 6.4 Special precaution for storage
general CLASSIFICATION FOR SUPPLY
6 .
doctor will closely monitor you during treatment .
there be relatively little experience with ertapenem in child le than two year of age .
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www.emea.europa.eu / .
total
carton TEXT – EU / 1 / 99 / 126 / 001
Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & amp ; ΥΙΟΣ Ε .Π .Ε .
other
irbesartan significantly reduce the relative risk in the primary combined endpoint of double serum creatinine , end-stage renal disease ( ESRD ) or all-cause mortality .
expiry DATE
Slovenská republika Abbott Laboratories Slovakia s.r.o .
take other medicine Please inform your doctor or pharmacist , if you be take or have recently take any other medicine , even those not prescribe .
- dyskinesia ( e. g. abnormal , uncontrolled movement of the limb )
the major circulate metabolite be the 10-N-glucuronide , which do not pass the blood brain barrier .
20 6 .
when adjust for BP , the difference be reduce to 17.3 % ( p = 0.05 ) .
Teл . : + 359 800 12 400
method AND ROUTE ( S ) OF ADMINISTRATION
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
15 .
if you take more Azomyr than you should Take Azomyr oral solution only a it be prescribe for you .
• Pain and swell in the joint and tendinitis may occur occasionally , particularly if you be elderly and be also be treat with corticosteroid .
uth ( mean percentile decrease of 9 % ) and a decrease in the rate of weight gain ( mean percentile decrease of 13 % ) .
lactose monohydrate Microcrystalline cellulose croscarmellose sodium Hypromellose silicon dioxide Magnesium stearate
during post-marketing experience the following side effect have also be report ( frequency not know ) : allergic reaction , which may be serious , include rash , hive , and swell of the face , lip , tongue , and throat that may cause difficulty in breathe or swallow .
the two active substance in Advocate interact with receptor in the parasite .
in the other study , three different dose schedule of subcutaneous Dynepo be compare .
- what you should do in emergency situation when you feel unwell or become ill .
epoetin zeta be identical in it amino acid sequence and similar in carbohydrate composition to endogenous human erythropoietin that have be isolate from the urine of anaemic patient .
- medicine that increase the amount of potassium in your blood .
Oseltamivir-resistant virus isolate from oseltamivir-treated patient and
commonly , level of blood urea nitrogen , creatinine , and uric acid be lower during administration of levodopa / carbidopa than with levodopa alone .
Hepato-biliary disorder Very rare :
the safety of this medicinal product for use in human pregnancy have not be establish .
6.4 Special precaution for storage
België / Belgique / Belgien sanofi-aventis Belgium Tél / Tel : + 32 ( 0 ) 2 710 54 00
40 , 66 ) base on percentage of patient with plasma HIV-RNA & lt ; 50 copy / ml .
occlusion of the dialysis system be possible if heparinisation be not optimum .
not know : anaphylactoid reaction , anaphylaxis and related phenomenon such a Angioneurotic oedema , facial oedema , and peripheral oedema , anaphylaxis in individual with or without an allergic history .
EXP
40 % ( 34 % , 47 % )
midazolam or triazolam ( use to help you sleep ) pimozide ( use to treat certain mental condition ) St .
Musculoskeletal and connective tissue disorder Common :
important information about some of the ingredient of & lt ; ARCOXIA & gt ; & lt ; ARCOXIA & gt ; contains lactose .
if there be no ovarian response , the daily dose be then gradually increase until follicle growth and / or plasma oestradiol level indicate an adequate pharmacodynamic response .
upper respiratory tract infection include pharyngitis and sinusitis
Intra- and interindividual variation in
what be Helixate NexGen ?
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
if the needle be not correctly line up with the centre of the stopper , you will feel constant resistance a it go through the stopper and no “ pop . ” The needle may then enter at an angle and bend , break or prevent proper removal of the vial content .
step 6 Remove and Dispose of the needle
take other medicine :
Alendronate give during pregnancy in rat cause dystocia relate to hypocalcaemia ( see section 5.3 ) .
summary OF PRODUCT CHARACTERISTICS 1 .
cardiac arrhythmia ( primarily supraventricular ) usually respond to conventional therapy but may require discontinuation of PegIntron therapy .
Sweden
* The dose may be escalate to 15 mg once daily after 2 cycle if patient be not respond to treatment and be tolerate the treatment . * * The dose may be escalate to 10 mg once daily if the patient be tolerate the treatment
bottle :
the indication for NeoRecormon treatment and , if give , the single dose should be determine from the required amount of pre-donated blood and the endogenous red cell reserve accord to the following graph .
2.1 TAXOTERE 20 mg vial
within 24 hour after administration , other potentially hepatotoxic medicinal product should be avoid .
in the two study of oesophageal candidiasis , around 90 % of the patient be successfully treat with Mycamine , fluconazole or caspofungin .
the most notable adverse reaction associate with efavirenz be rash and nervous system symptom .
9 .
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
- some antipsychotic ( e. g. thioridazine , chlorpromazine , levomepromazine , trifluoperazine ,
EXP
6.5 Nature and content of container
2 .
in the absence of compatibility study , do not mix with any other product except the solvent supply for use with the vaccine .
MARKETING AUTHORISATION NUMBER ( S )
you be advise not to drink any alcohol .
phenytoin ( CYP2C9 substrate and potent CYP450 inducer ) :
for patient with renal impairment , a clarithromycin dose reduction should be consider : for patient with creatinine clearance of 30 to 60 ml / min the dose should be reduce by 50 % , for patient with creatinine clearance le than 30 ml / min the dose should be reduce by 75 % .
rarely , blood clot may occur without unwanted overstimulation of the ovary ( see also “ Take special care with Fertavid ” ) .
7 .
Suomi / Finland Oy Eli Lilly Finland Ab Puh / Tel : + 358- ( 0 ) 9 85 45 250
5 .
orphan Europe SARL Immeuble “ Le Wilson ” F - 92058 Paris-La Défense France
Magyarország Bayer Hungária Kft .
medicinal product subject to medical prescription .
CEREZYME be supply a a white to off-white powder .
light must be deliver to the entire surface of the tumour use an approved microlens fibre-optic .
at very high dos ( ≥ 500 mg / kg / day ) degenerative change in the kidney ( such a interstitial nephritis , tubular distention , basophilic tubule , increase plasma concentration of urea and creatinine ) be induce by irbesartan in the rat and the macaque and be consider secondary to the hypotensive effect of the medicinal product which lead to decrease renal perfusion .
on the blister for advice ) . tn
if you be elderly , your doctor will increase the dose with more caution and the daily dose should generally not exceed 40 mg .
n = 444
do not use it in insulin pump or other infusion pump - special insulin preparation be available for use in such device .
Rapamune may be continue a maintenance therapy with corticosteroid only if ciclosporin microemulsion can be progressively discontinue ( see section 4.2 and 5.1 ) .
0.7 ml ( 50 µg / 0.5 ml )
ination :
38.7 ( 36.8 ; 40.6 ) 3.97 ( 3.77 ; 4.18 )
- feel feverish ,
6 .
ADARTREL 0.25 mg film-coated tablet Ropinirole ( a hydrochloride )
Special STORAGE CONDITIONS
pregnancy and breast-feeding Ask your doctor or pharmacist for advice before take any medicine .
name OF THE MEDICINAL PRODUCT
these accomplishment could not have be achieve without the dedication and hard work of a large number of people both within the Agency , within the competent authority of member state , the expert Committees and the independent expert from around the European Union who have give generously of their time energy and expertise .
after first use of the pen , the suspension should be use within 28 day , when store below 30 ° C .
4
Lyophilisate and solvent for suspension for injection .
however , the potential influence of hepatic insufficiency on MIRAPEXIN pharmacokinetics have not be investigate .
the PMS protocol have be develop and provide to the CHMP .
specific pharmacokinetic evaluation have not be perform on these patient .
peginterferon alpha / ribavirin
this be a population of heavily pretreated patient , a 46 % have receive prior BMT and 73 % a prior multi-agent chemotherapy .
BATCH NUMBER
when efavirenz be co-administered with voriconazole , the voriconazole maintenance dose must be increase to 400 mg twice daily and the efavirenz dose must be reduce by 50 % , i. e . , to 300 mg once daily .
during once- daily dose with 100 mg , neither losartan nor it active metabolite accumulates significantly in plasma .
PREZISTA 600 mg film-coated tablet darunavir
EMEA / H / C / 476
Italy
not applicable .
insulin human
≥ 1.2 to & lt ; 1.4 ≥ 1.4
very rarely sarcoidosis , ( a disease characterise by persistent fever , weight loss , joint pain and swelling , skin lesion and swell gland ) have be report .
not applicable .
each pre-filled syringe contain 130 microgram of darbepoetin alfa in 0.65 ml ( 200 µg / ml ) .
in Study I , improvement in the physical and mental component summary score of the SF-36 be also significant compare to placebo .
40 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Advocate for small dog pipette label
4.9 Overdose
4
handling and disposal – see package leaflet .
Norge Boehringer Ingelheim Norway KS Tlf : + 47 66 76 13 00
see leaflet for further information .
very rare event of cutaneous vasculitis have be report in patient treat with filgrastim .
hyperkalaemia
6 .
15 .
induction of CYP1A2 The metabolism of olanzapine may be induce by smoke and carbamazepine , which may lead to reduced olanzapine concentration .
what be Irbesartan Winthrop ?
0.035
common
România GlaxoSmithKline ( GSK ) SRL Tel : + 40 ( 0 ) 21 3028 208
the recommend final concentration of alglucosidase in the infusion bag range from 0.5 mg / ml to 4 mg / ml .
( can not be estimate from available data )
in vitro study demonstrate that rosiglitazone be predominantly metabolise by CYP2C8 , with CYP2C9 a only a minor pathway .
these number should not be use for measure an insulin dose .
Luxemburg
Tel : + 34 91 456 53 00
expiry DATE
30-minute- value ” ) , a describe under step 3 .
there be conflict report in the literature regard whether erythropoietin may play a major role a tumour proliferator .
Germany
Nicobrand Limited 189 Castleroe Road Coleraine Northern Ireland BT51 3RP
serious hypoglycaemia may cause brain damage and may be life- threatening .
( n = 701 )
22 / 21
20 mg
lot
107 PACKAGE LEAFLET :
the film-coating contains soya Lecithin .
not all pack size may be market .
if use a transfer needle , remove the protective cap and insert the transfer needle into the rubber stopper of the solvent vial .
treatment of men :
PHARMACEUTICAL Form
1 .
by bind selectively to antithrombin , fondaparinux potentiates ( about 300 time ) the
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
read the package leaflet before use .
Slovenská republika GlaxoSmithKline Slovakia s. r. o .
- alcohol consumption ,
severely affected pig should be remove to clean dry pen and give symptomatic treatment , include treatment for concurrent disease .
store in the original package .
like other cholinomimetics , rivastigmine may exacerbate or induce extrapyramidal symptom .
( * frequency base on clinical trial )
EU / 2 / 06 / 066 / 001-012
6.2 Incompatibilities
a / Wisconsin / 67 / 2005 ( H3N2 ) like strain ( A / Wisconsin / 67 / 2005 ( NYMC X-161 ) ) 15 microgram HA * *
n = 672
haemoglobin variability should be address through dose management , with consideration for the haemoglobin target range of 10 g / dl ( 6.2 mmol / l ) to 12 g / dl ( 7.5 mmol / l ) .
EU / 1 / 05 / 331 / 021
oral use
the daily dosage be administer in equally divide dose 3 time a day .
in , contrast , there be an increase of approximately 20 % in tacrolimus AUC when multiple dos of CellCept ( 1.5 g BID ) be administer to patient take tacrolimus .
if you suddenly stop take Olanzapine Teva , symptom such a sweating , unable to sleep , tremor , anxiety or nausea and vomiting might occur .
other
EXP
Table 2 list adverse reaction from the pivotal phase III study ( 152 patient treat with Bondronat 6 mg ) , i. e. adverse event with a remote , possible , or probable relationship to study medication , occur commonly and more frequently in the active treatment group than in placebo .
one ml contain 100U ( equivalent to 3.5mg ) insulin lispro ( recombinant DNA origin produce in E. coli ) .
5 .
234 For any information about this medicine , please contact the local representative of the Marketing Authorisation Holder .
it be unknown whether clofarabine or it metabolite be excrete in human breast milk .
none of these change be associate with bleed episode or a decrease in haemoglobin .
serum potassium :
adult surgery patient in an autologous predonation programme
1983 1984 1984 1984
haemoglobin variability should be address through dose management , with consideration for the haemoglobin target range of 10 g / dl ng ( 6.2 mmol / l ) to 12 g / dl ( 7.5 mmol / l ) .
PIs or NNRTIs be unlikely .
Invented name form
the picture below be for illustrative purpose only .
4 .
Österreich Gilead Sciences GesmbH Tel : + 43 1 260 830
20 / 42 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
not applicable
Micardis 80 mg tablet telmisartan
Table 5 .
8.0 8.0
stop take Janumet and see a doctor straight away if you notice any of the following symptom : • feeling sick ( nausea ) or be sick ( vomit ) , abdominal pain , muscular cramp , unexplained weight loss , rapid breathing , and feel cold or uncomfortable .
the skin area to which the patch be apply should be free of microlesions ( e. g. due to irradiation or shaving ) and skin irritation .
12 .
↓ 0.58 *
please tell your doctor or pharmacist .
hospital pack contain 200 ( 10 x 20 ) or 500 film-coated tablet .
so far , animal test have not yield evidence of harmfulness .
45.9 % 42.8 %
some people get redness , swell or itch around the area of the insulin injection .
Tel . : + 36 1 301 9700
SPECT acquisition parameter recommend be :
one ml of Insuman Comb 50 contain 40 IU ( International
steady-state plasma level be reach after continuous administration for 7 – 8 day .
in vitro transport study show that sitagliptin be a substrate for p-glycoprotein and OAT3 .
lactation As fentanyl be excrete into breast milk , lactation should be discontinue under treatment with Fentanyl-ratiopharm ( see also section 4.6 ) .
in patient with compromised renal function , clearance of gadoversetamide will be slow and the interference with calcium determination by OCP prolong .
if your liver be not work properly , the usual dose should not exceed 40 mg / 12.5 mg once a day .
instruction ON USE
FABLYN film-coated tablet be supply in PVC blister with aluminum foil backing or HDPE bottle with polyethylene / aluminum foil line polypropylene child-resistant closure .
each vial provide 100 microgram / 0.5 ml of peginterferon alfa-2b when reconstitute a recommend .
5.1 Pharmacodynamic property
ROUTE of Administration
arthralgia
the use of this medicinal product be contraindicate in patient with
see section 4.4 and 5.1 .
Musculoskeletal and connective tissue disorder
because the use of BeneFIX by continuous infusion have not be evaluate , BeneFIX should not be mixed with infusion solution or be give in a drip .
the first dose will be give within 72 hour after the transplant operation .
in that time it have establish itself a an efficient and effective mean of Regulation and it have start to take it place a one of the World ’ s lead regulatory system for medicinal product .
neutrophil produce in response to filgrastim show normal or enhanced function a demonstrate by test of chemotactic and phagocytic function .
a load dose of 160 mg Trudexa on week 0 follow by 80 mg Me
change in fast glucose from borderline at baseline ( ≥ 5.56 - & lt ; 7 mmol / l ) to high ( ≥ 7 mmol / l ) be very common .
for a recovery 0.8 IU / dl ( average increase of factor IX ) , then :
oral
store in the original package .
in adult patient , infusion time be 60 minute for 400 mg Ciprofloxacin Bayer and 30 minute for 200 mg Ciprofloxacin Bayer .
it be give to Bring about the release of egg ( ovulation ) , after other medicine have be use to develop the follicle .
overall , in both study , patient who receive Viraferon plus ribavirin , be le likely to respond than patient who receive pegylated t
base on the result of clinical study , normally no special laboratory evaluation be necessary in addition to careful medical management and supervision of patient .
BATCH
Tel : + 39 06 50 39 61
turn the vial and the syringe upside down in one hand .
expiry DATE
1 Member State
Heumann Pharma GmbH Heideloffstrasse 18-28 D-90478 Nürnberg
expiry DATE
tablet core :
regardless of genotype , patient who receive Viraferon in combination with ribavirin and receive ≥ 80 % of their treatment have a higher sustained
vinca alkaloid ( CYP3A4 substrates ) :
common
do NOT inject Optisulin in a vein , since this will change it action and may cause hypoglycaemia .
atazanavir / ritonavir / Efavirenz ( 400 mg once daily / 200 mg once daily / 600 mg once daily , all administer with food )
48 6.5 Nature and content of container
AUTHORISATION .
the effect of varenicline on craving , withdrawal and reinforce effect of smoke be not measure during the non-treatment long-term follow-up phase .
1 .
use other medicine
C .
Zarzio
the maximum dose frequency be once per day .
very rare Body a a whole : anaphylaxis , serum sickness cardiovascular : syncope , hypotension central and peripheral nervous system : paralysis , neuropathy , neuritis ( include Guillain-Barré syndrome , optic neuritis and multiple sclerosis ) , encephalitis , encephalopathy , meningitis , convulsion haematological disorder : thrombocytopenia
the tablet be not intend to be split or break into smaller piece .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
name OF THE MEDICINAL PRODUCT
Enbrel be also prescribe for the treatment of severe psoriasis in patient from the age of 8 year who have have an inadequate response to ( or be unable to take ) phototherapy or other systemic therapy .
look out for the sign of allergy in 5 Possible side effect If you feel a hypo come on ( a hypo be short for a hypoglycaemic reaction and be a symptom of low blood sugar ) .
insulin absorption and hence the blood glucose lower effect of a dose may vary from one injection area to another ( e. g. the abdominal wall compare with the thigh ) .
- Do not take a double dose to make up for a forgotten dose .
this appropriation be intend to cover the purchase of office furniture and specialised furniture , include ergonomic furniture , shelve for archive etc .
epilepsy
Hepatobiliary disorder
7 / 17 ANNEX III
of 1,200 mg each day ) .
- If you have any further question , ask your doctor .
H-2045 Törökbálint , Tó Park Tel : + 36 23 513-800
common :
among tenofovir disoproxil fumarate-treated patient , on-treatment ALT elevation have a median time to onset of 8 week , resolve with continued treatment , and , in a majority of case , be associate with a ≥ 2 log10 copy / ml reduction in viral load that precede or coincide with the ALT elevation .
platelet count and haemoglobin level should also be monitor at regular interval in cancer patient .
5.2 Pharmacokinetic property
study in animal have show reproductive toxicity ( see section 5.3 ) .
other SPECIAL WARNING ( S ) , IF NECESSARY
excipients :
lactose monohydrate Hypromellose Titanium dioxide Macrogol 3000 Carnauba wax .
strength
16 .
common : oedema Not know : sodium retention
PVC / PVDC / Aluminium blister or all aluminium blister in cardboard CARTONS contain 7 , 14 , 28 , 30 , 84 , 90 and 100 film-coated tablet .
seek medical advice after an injection of glucagon ; you need to find the reason for your hypo to avoid get more .
I
haematologic response criterion ( all response confirm after 4 week ) :
EXP . :
3 .
109 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
this document can not replace a face-to-face discussion with your veterinarian .
PDE5 inhibitor
the company that make Prialt be carry out a study look at the long term use of the medicine , look in particular at the possibility of development of tolerance to treatment ( when dos of a medicine that be effective become le effective over time ) .
High-density polyethylene ( HDPE ) bottle label for 56 x 0.5 mg varenicline film-coated tablet
read the package leaflet before use .
a for other insulin product , in general , hypoglycaemia be the most frequently occur undesirable effect .
6.3 Shelf life
before every injection , clear any air bubble .
HVL ( & gt ; 600,000 IU / ml )
1 .
median 100 75 33
Fentanyl-ratiopharm should not be use in this population .
in reproductive toxicity study in the rat , levetiracetam induce developmental toxicity ( increase in skeletal variation / minor anomaly , retard growth , increase pup mortality ) at exposure level similar to or greater than the human exposure .
BATCH
• 21.03.2001 • 08.06.2001
side effect report very rarely ( in le than 1 patient in 10,000 )
after reconstitution , the solution contain 40 unit of imiglucerase per ml ( 200 U / 5 ml ) .
the mutual recognition procedure have make considerable progress during 1998 .
name OF THE MEDICINAL PRODUCT
sanofi Pasteur MSD , Tel : + 46.8.564.888.60 United Kingdom :
patient with rare hereditary problem of fructose intolerance should not take this medicine .
the rate of administration should be determine by the patient ’ s comfort ( maximum rate of infusion :
nausea / vomit diarrhea , dyspepsia / heartburn
2 Maintenance treatment can be continue for a long a a therapeutic benefit for the patient exist .
this summary be last updated on 31.01.2008 .
EU / 1 / 95 / 001 / 005 1 vial of powder for solution for injection .
it be thin and have three layer .
adverse reaction report during clinical trial or follow the marketing use of Viraferon alone or in combination with ribavirin System Organ Class
99 Rash : mild-to-moderate rash have be report in clinical study with efavirenz and usually resolve with continued therapy .
film-coated tablet
immunogenicity bridge between 9- to 15-year-old male and female subject and 16- to 26-year-old adult woman ( per-protocol population ) base on titre a measure by cLIA
240 10 .
Sverige Takeda Global Research and Development Centre ( Europe ) Ltd . , Storbritannien Tel : + 44 ( 0 ) 20 3116 8000
other SPECIAL WARNING ( S ) , IF NECESSARY
cattle ( adult cattle weigh about 600 kg ) .
the mean elimination half-life after intravenous administration be approximately 2 hour .
Malta
Uncommon
do not use in animal under 6 week of age .
Amenorrhoea , impotence , breast pain , menorrhagia , menstrual disorder , ovarian disorder , vaginal disorder , sexual dysfunction ( not specify ) , prostatitis
when change the route of administration the same dose must be use and the haemoglobin monitor every one or two week so that the appropriate dose adjustment can be make to keep the haemoglobin at the desired level .
1 .
for further information please refer to section 5.1 .
Lilly S. A , Avda . de la Industria 30 , 28108 Alcobendas ( Madrid ) , Spain
protect from excessive heat and sunlight .
in patient who require high insulin dos because of the presence of insulin antibody , transfer under medical supervision in a hospital or similar setting must be consider .
general CLASSIFICATION FOR SUPPLY
RA afterwards .
- you be also take non-steroidal anti-inflammatory drug ( NSAIDs ) , since both type of
clinical trial
this du
13 .
6.3 Shelf life
- hypersensitivity to the active substance , other carbamate derivative or to any of the excipients
adopt by the Management Board on 2 December 1998 The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus , Canary Wharf , London E14 4HB , United Kingdom Tel .
PHARMACEUTICAL PARTICULARS
transdermal use
4.4 Special warning and precaution for use
renal and urinary disorder
opaque blister ( PVC / PE / PVDC and aluminum ) .
mild systemic allergic reaction ( e. g. mild form of erythema , rash , facial swelling , urticaria , oedema , difficulty breathing ) .
reproductive toxicity study suggest that enalapril have no effect on fertility and reproductive performance in rat , and be not teratogenic .
rash Pruritus urticaria
in an oral pre- and postnatal development study in rat , red vaginal discharge be note in the 45 mg / kg / day group on either day 14 or day 15 of gestation .
in a long term 26-week placebo-controlled trial , the incidence of EPS be 19 % for aripiprazole-treated patient and 13.1 % for placebo-treated patient .
ed 4.7 Effects on ability to drive and use machine
significant teratogenic and / or embryocidal potential have be demonstrate for
do not touch the exposed needle .
6 .
81 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Discussion
2 .
oral use
9 % ( 2 / 22 )
- nausea
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www.emea.europa.eu /
in this respect the CPMP consider the following :
4 .
any unused product or waste material should be dispose of in accordance with local requirement .
6 .
- if you have , so call autoimmune hepatitis .
QUALITATIVE AND QUANTITATIVE COMPOSITION
name OF THE MEDICINAL PRODUCT
- corticosteroid ( such a & quot ; cortisone & quot ; , use to treat inflammation ) ,
6.4 Special precaution for storage
blister 20 30
5 .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
for storage condition of the reconstituted medicinal product , see section 6.3 .
paediatric patient : irbesartan have be study in paediatric population age 6 to 16 year old but the current data be insufficient to support an extension of the use in child until further data become available ( see section 4.8 , 5.1 and 5.2 ) .
20 ml solution contain 4.88 g of gadofosveset trisodium in a vial .
in a dose finding study in subject age 18-60 year , 50 subject receive a dose of 3.75 microgram HA / AS03 in a volume of 1 ml at 0 and 21 day .
a with ACE inhibitor , concomitant use of angiotensin II antagonist and NSAIDs may lead to an increase risk of worsening of renal function , include possible acute renal failure , and an increase in serum potassium , especially in patient with poor pre-existing renal function .
if there be evidence of worsen liver disease or persistent elevation of serum transaminase to greater than 5 time the upper limit of the normal range , the benefit of continued therapy with efavirenz need to be weigh against the potential risk of significant liver toxicity .
once shake the vaccine be slightly opaque .
other
- about any other cancer treatment you be on or have be take , a particular care need to be
this be expect for the second half of 1997 and will facilitate such activity in 1998 .
the outside of the backing layer be tan-coloured and imprinted with Neupro 3 mg / 24 h .
no data be available on the secondary transmission of infection by live vaccine in patient receive Enbrel .
( & gt ; 1 / 10,000 , & lt ; 1 / 1000 )
QTcF interval be evaluate in a randomised , placebo and active ( moxifloxacin 400 mg once daily ) control crossover study in 39 healthy adult , with 10 measurement over 12 hour on Day 3 .
Tel : + 420 234 664 111
17-21 , Bă neasa Center , et .
6 .
LABELLING
how have ZYPADHERA be study ?
-8- Table 2 :
standard procedure for management of overdose may be indicate ( i. e. gastric lavage , administration of activated charcoal ) .
HBVAXPRO
chicken and duck
what Actraphane look like and content of the pack The suspension for injection come a a cloudy , white , aqueous suspension .
like all medicine , ZYPREXA Injection can cause side effect , although not everybody get them .
patient with hepatic impairment No dose adjustment be necessary for patient with mild to moderate hepatic impairment .
• Merck Sharp & amp ; Dohme
4.1 preparation of the Docetaxel Winthrop premix solution ( 10 mg docetaxel / ml )
the pen in-use or carry a a spare may be store for a maximum of 4 week not above 25 ° C away from direct heat or direct light .
each vial contain 1 mg bortezomib ( a a mannitol boronic ester ) .
Oxaliplatin capecitabine
- This medicine have be prescribe for you .
if possible , child should be up to date with all vaccination before use Enbrel .
no undesirable effect have be show for Rabigen SAG2 .
consequently , caution should be exercise when Renagel be use in patient with these disorder .
there be no difference in the pharmacokinetics of aripiprazole between healthy male and female subject nor be there any detectable effect of gender in a population pharmacokinetic analysis in schizophrenic patient .
change in fast triglyceride from borderline at baseline ( 1.69 mmol / l - & lt ; 2.26 mmol / l ) to high ( 2.26 mmol / l ) be very common .
read the package leaflet before use . no
child weigh from 14 kg to 21 kg : the recommended oral dose of COMBIVIR be one-half tablet take twice daily .
strength
Ísland Vistor hf .
Prograf
very rare * : anaphylactic shock ( include fatal hypersensitivity ) Metabolism and nutrition disorder :
keep out of the reach and sight of child .
avoid situation where OptiSet might be damage .
however , the presence of a minor infection , such a a cold , be not a contraindication for immunisation .
the patient & apos ; s ability to concentrate and react may be impair a a result of hypoglycaemia or hyperglycaemia or , for example , a a result of visual impairment .
the adverse event profile in adolescent and patient with chronic cardiac and / or respiratory disease be qualitatively similar to those of healthy young adult .
Kivexa be not recommend for use in patient with a creatinine clearance & lt ; 50 ml / min ( see section 5.2 ) .
possible side effect 5 .
the clinical significance of this be unknown .
recommend dose The recommended start dose of lenalidomide be 25 mg orally once daily on day 1-21 of repeat 28-day cycle .
not all pack size may be market .
Phenylalanine may be harmful for people with phenylketonuria .
Rebetol be intend for use , in a combination regimen with interferon alfa- 2b , for the treatment of child and adolescent 3 year of age and older , who have chronic hepatitis C , not previously treat , without liver decompensation , and who be positive for serum HCV-RNA .
15 .
Binocrit can be use to increase the yield of autologous blood from patient in a predonation programme .
it
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
the overall incidence of hallucination and somnolence be generally higher in the escalation phase with the pramipexole group .
Icandra be indicate in the treatment of type 2 diabetes mellitus patient who be unable to achieve sufficient glycaemic control at their maximally tolerate dose of oral metformin alone or who be already treat with the combination of vildagliptin and metformin a separate tablet .
list OF EXCIPIENTS
in most patient rash resolve with continue therapy with efavirenz within one month .
patient usually present with shortness of breath and cough .
 On the patch-change day , remove the used patch and immediately stick the new patch on to a different area of skin of your abdomen .
intermittent allergic rhinitis be define a the presence of symptom for le than 4 day per week or for le than 4 week .
the company also present data from the publish literature .
Genzyme B.V .
a level scoop of the product should be measure
the long-term consequence of these event be currently unknown .
do not store them in or too near the freezer section or cool element .
8 .
the clinical impact of these QT change be unknown ( see section 5.1 ) .
if serum ferritin fall consistently below 500 µg / l , an interruption of treatment should be consider .
10 vial of 1 dose
- mild increase in blood pressure ,
the protein moiety of the molecule contribute about 58 % of total molecular weight and consist of 165 amino acid .
patient with sign or symptom compatible with autoimmune disorder should be evaluate carefully , and the benefit-risk of continued interferon therapy should be reassess ( see also section 4.4 Chronic hepatitis C , Monotherapy ( thyroid abnormality ) and section 4.8 ) .
STOCRIN 600 mg film-coated tablet
ziconotide must be administer a a continuous infusion via an intrathecal catheter , use an external or internally implanted mechanical infusion pump capable of deliver an accurate infusion volume .
this could potentially lead to a decrease of immunosuppressive efficacy .
Κύπρος sanofi -aventis Cyprus Ltd .
in patient with mild to moderate hepatic insufficiency , the bioavailability of zaleplon be increase because of reduced clearance , and the dose will therefore need to be modify in these patient .
after first opening , the product should be use immediately .
keep THE VIAL IN AN upright position .
BATCH NUMBER
dyspnoea ( include asthmatic condition )
Paroxetin Lindo 20 mg Filmtabletten
how to take Revlimid 4 .
United Kingdom Novartis Pharmaceuticals UK Ltd .
4 .
in such case , a new vial yield a uniform suspension must be use .
the enzyme responsible for this metabolism be CYP3A4 .
to obtain an accurate dose you must :
malaise , Feeling
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
Special STORAGE CONDITIONS
instruction for use and handle a ) Preparing a dose
Portugal BRISTOL-MYERS SQUIBB FARMACÊUTICA PORTUGUESA , S. A .
transdermal patch
hepatic impairment :
statement OF ACTIVE SUBSTANCE ( S )
measure the dose of IntronA Remove the cap from the vial .
Special STORAGE CONDITIONS :
the content of the vial , once open , should be use immediately .
- This medicine have be prescribe for you .
9 .
child and adolescent
these reaction be usually transitory and normally they disappear during continued treatment .
pancreatitis
IntronA 10 MIU powder
it must only be use if the solution be clear , colourless , with no solid particle visible , and if it be of water-like consistency .
- Active substance :
this leaflet be last approved in
Neupro 1 mg / 24 h transdermal patch rotigotine
the medicine can only be obtain with a prescription .
3 full turn ( 15 click )
NAXCEL 100 mg / ml suspension for injection for pig
lowest maintenance dose
a 90 % confidence interval unless otherwise note . b 95 % confidence interval .
you should tell your doctor immediately and see your doctor a soon a possible .
Lamictal and associate name ( see Annex I ) 200 mg tablet .
gastrointestinal disorder Renal
203 Following transfer from an animal insulin to human insulin , dosage reduction may be require in particular in patient who
Austria
allow the pre- fill pen to reach room temperature before injecting .
study in animal have show reproductive toxicity ( see section 5.3 ) .
42 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Magyaroszág Baxter Hungary Kft Alkotás u .
this medicinal product must not be mix with other medicinal product .
Advagraf dosing should primarily be base on clinical assessment of rejection and tolerability in each patient individually aid by blood level monitoring ( see below under “ Target whole blood trough concentration recommendation ” ) .
in addition , the blood pressure will increase before return to normal or below normal .
frequency Very common Common Uncommon
België / Belgique / Belgien MEDA Pharma S. A . / N. V .
a the risk of withdrawal symptom be greater when the treatment be stop suddenly , you should never stop treatment with Fentanyl-ratiopharm independently but always consult your doctor first .
a ) 18.10.1996 b ) 12.2.1997 c ) 115 day d ) 0
information FOR THE USER
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
call your health care provider if you think you have not receive the full dose .
in an interaction study base on data from 17 patient , assess the effect of omeprazole , a potent CYP2C19 inhibitor , there be no significant effect on the pharmacokinetics of bortezomib .
cartridge ( glass ) in multidose pen
if you be to receive more than one vial of BeneFIX the content of multiple vial may be draw into the same syringe through a separate , unused filter spike .
skin and subcutaneous tissue disorder :
4.2 Posology and method of administration
patient should be start on dexamethasone 4 mg twice daily orally or intravenously for 5 day begin on the day of injection of DepoCyte .
at very high dos ( ≥ 500 mg / kg / day ) degenerative change in the kidney ( such a interstitial nephritis , tubular distension , basophilic tubule , increase plasma concentration of urea and creatinine ) be induce by irbesartan in the rat and the macaque and be consider secondary to the hypotensive effect of the medicinal product which lead to decrease renal perfusion .
5.3 Preclinical safety data
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
patient should be adequately hydrate and consideration should be give to monitoring of renal function after initiation of concomitant therapy and periodically thereafter .
EU / 1 / 98 / 096 / 015 ( 5 hard capsule ) EU / 1 / 98 / 096 / 016 ( 20 hard capsule
4 .
ed be observe .
Ελλάδα GlaxoSmithKline A. E. B. E Tηλ : + 30 210 68 82 100
administration of indinavir with a meal high in calorie , fat , and protein result in a blunted and reduced absorption with an approximate 80 % reduction in AUC and an 86 % reduction in Cmax .
6.1 List of excipients
Kineret be a clear , colourless-to-white solution for injection and be supply ready for use in a pre-filled syringe .
intravenous
further information
no special precaution for storage .
5 .
3 4.6 Pregnancy and lactation
this reduce HbA1c level after 24 week by 0.30 % in patient receive TESAVEL and glimepiride , and by 0.60 % in the patient who be also take metformin in addition to TESAVEL and glimepiride .
via Emilia , 21 27100 - Pavia Italy
outer CARTON
66
52 immunogenicity
54 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
8 .
Č eská republika Ke Š tvanici 3 CZ-186 00 Praha 8 Tel : + 420 221771250
Poly ( dimethylsiloxane , trimethylsilyl silicate ) -copolymerisate , povidoneK90 , E171 , E223 , E304 , E307 , fluoropolymer , polyester , silicone , aluminium , pigment ( yellow95 , red166 , red144 , black7 )
the amino acid sequence of exenatide partially overlap that of human GLP-1 .
list OF EXCIPIENTS
18 Table 2 :
keep out of the reach and sight of child .
fatigue
Č eská republika Novartis s. r. o .
Alkotás u.50 1123 Budapest Hungary
give the seriousness of the adverse reaction and the implication on public health it be agree on May 17 , 1995 by the CPMP that the issue be of Community interest and anorectic agent concern be identify on June 8 , 1995 .
2 2 0 2 0
these measure will help to protect the environment .
1 .
wait for the area to dry .
mixing be complete when the suspension appear uniform , thick , and milky in color and all the powder be fully disperse .
3 .
travel expense ( include member of the family )
manufacturer ’ S BATCH NUMBER
platelet neutrophil count TSH level
GlaxoSmithKline Kft .
you may need to talk about
information IN BRAILLE
the tablet can be divide into equal half .
12 .
muscle cramp * , muscle weakness Common :
if your doctor have switch you from one type or brand of insulin to another , your dose may have to be adjust by your doctor .
for storage condition of the reconstituted medicinal product , see section 6.3 .
Luxembourg / Luxemburg Rue de Stalle 73 B-1180 Bruxelles / Brüssel Belgique / Belgien Tél / Tel : + 32- ( 0 ) 2 370 92 11
woman of child-bearing age should take the necessary precaution to avoid pregnancy for 3 month follow vaccination .
medicine should not be dispose of via wastewater or household waste .
however , certain monkey specie , eg , rhesus monkey , be susceptible to pharmacodynamic stimulation upon exposure to human type 1 interferon .
AZILECT should not be use with other monoamine oxidase inhibitor or pethidine ( a painkiller ) .
possible side effect 5 How to store VIRAMUNE 6 .
if you use more IntronA than you should Contact your doctor or healthcare professional a soon a possible .
the tablet be supply in blister pack contain either 14 , 28 , 30 , 50 , 90 , or 98 tablet .
the marketing authorisation holder be Eisai Ltd .
- be previously already control on rather low blood glucose level ,
keep out of the reach and sight of child
a higher risk of lipodystrophy have be associate with individual factor such a older age , and with drug relate factor such a longer duration of antiretroviral treatment and associate metabolic disturbance .
a meta-analysis of randomised placebo control trial of anti-epileptic drug have also show a small increased risk of suicidal ideation and behaviour .
Uncommon : malaise , weight gain .
47 part II :
6.6 Special precaution for disposal
other undesirable effect see include splenic Enlargement , which may be progressive in a minority of case and thrombocytopenia .
Luxembourg :
4 .
- In your brain
however , base on it know mechanism of action , trabectedin may cause serious birth defect when administer during pregnancy .
if their symptom be the same a yours .
medicinal product subject to restrict medical prescription ( See Annex I :
the protein fraction of the molecule contribute about 58 % and consist of 165 amino acid .
bleeding and / or spotting appear in 11 to 15 % of the woman during the first six month of treatment .
these change sometimes give the cartridge a frosted appearance .
in teraction study have only be perform in adult .
BATCH NUMBER
severe hyperglycaemia or ketoacidosis must always be treat by a doctor , normally in a hospital .
if you suddenly stop take ZYPREXA VELOTAB , symptom such a sweating , unable to sleep , tremor , anxiety or nausea and vomiting might occur .
how SIMULECT IS GIVEN TO YOU
the volume of distribution be 53-93 litre .
the pre-filled syringe be ready for use .
Inovelon cause a reduction in the number and severity of seizure .
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF REACH AND site OF CHILDREN
( 3 / 6 )
Tel : + 34 91 456 53 00
1 vial 1 pre-filled syringe 1 vial adapter * *
however , the solution may be use for up to 6 hour when store in the refrigerator ( 2  C – 8  C ) .
Carbaglu 200 mg
do not try to put the needle cap back onto the pre-filled pen
1
Unlike some other antipsychotic agent , olanzapine increase respond in an “ anxiolytic ” test .
2 .
C .
a reduction of dosage or termination of therapy should be carefully consider .
no dosage adjustment be need for REYATAZ / ritonavir and fluconazole .
n = 228
6 .
do NOT USE if it be break or if the liquid look cloudy or contains particle .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
Abseamed
Ceftriaxone penetrate the inflamed meninges of newborn , infant and child .
ceuticals USA
Jun-96
( mg active substance / kg )
frequency be define a very common ( & gt ; 1 / 10 ) , common ( & gt ; 1 / 100 , & lt ; 1 / 10 ) and uncommon ( & gt ; 1 / 1 , 000 , & lt ; 1 / 100 ) .
the company will also provide an education plan for both doctor and patient .
Tipperary , Ireland
Erythropoetin be a growth factor that primarily stimulate red blood cell production .
PHARMACEUTICAL FORM
epoetin beta treatment-related headache and hypertension which can be treat with drug be common ( & gt ; 1 % , & lt ; 10 % ) ( see section 4.4 ) .
in the majority of patient fluticasone furoate be not quantifiable ( & lt ; 10 pg / ml ) follow intranasal dose of 110 microgram once daily .
local tolerability study follow subcutaneous and intramuscular administration in rabbit give no remarkable finding .
desloratadine have demonstrate antiallergic property from in vitro study .
8 .
3 .
each modified-release tablet contains 1000 mg of nicotinic acid and 20 mg of laropiprant .
- Blister of clear PVC tray with blue lidding foil with 14 capsule .
Exenatide have be show to bind to and activate the known human GLP-1 receptor in vitro , it mechanism of action mediate by cyclic AMP and / or other intracellular signal pathway .
do not take a double dose to make up for a forgotten dose .
the safety of microspheres in patient on mechanical ventilation have not be establish .
if you think you be have this type of reaction , stop your Filgrastim ratiopharm injection and get medical help immediately .
one treatment initiation pack contain 28 transdermal patch in 4 CARTONS with 7 patch of 2 mg , 4 mg , 6 mg , and 8 mg each , which be individually seal in sachet .
rare :
clopidogrel BMS 300-mg tablet be oblong , pink , film-coated tablet engrave on one side with the number ‘ 300 ’ and on the other side with the number ‘ 1332 ’ .
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY AND USE
good blood management practice should always be use in the perisurgical setting
Τηλ : + 357 22 677038
over all control study , the discontinuation rate due to adverse reaction be 12.2 % for patient randomize to lacosamide and 1.6 % for patient randomize to placebo .
this patient be able to continue treatment with BeneFIX with no anamnestic rise in inhibitor or anaphylaxis .
renal clearance amount to about 24 - 53 ml / min suggest partial tubular reabsorption of the drug from the kidney .
2
PSUR submission during the influenza pandemic :
indication ( S )
9
some patient not respond well to 125 mg twice daily of Tracleer may slightly improve their exercise capacity when the dose be increase to 250 mg twice daily .
very rare side effect ( le than 1 in every 10,000 people be likely to get these ) :
Additionally , Vogt-Koyanagi-Harada syndrome ( an autoimmune inflammatory disorder affect the eye , skin and the membrane of the ear , brain and spinal cord ) have be report with ViraferonPeg use .
your insulin will work more quickly if you inject it around the waist .
35 Since the treatment experience be limit in patient on peritoneal dialysis , regular haemoglobin monitoring and strict adherence to dose adjustment guidance be recommend in these patient .
method AND ROUTE ( S ) OF ADMINISTRATION
13 .
11 1 .
a number of these product have be measure in the serum and cellular fraction of blood collect from patient treat with interferon beta-1b .
Arcoxia
secondary progressive
5 kg / tonne *
before each infusion , patient should be give an antihistamine to reduce the risk of an allergic reaction .
subcutaneous use For use only with a pen injector call Puregon Pen .
EXP { MM / YYYY }
provide patient do not experience intolerable side-effects , the dosage should be titrate to achieve a maximal therapeutic effect .
powder for solution for injection
target haemoglobin concentration in two study be & gt ; 13 g / dl ; in the remain three study it be 12-14 g / dl .
Österreich BRISTOL-MYERS SQUIBB GesmbH Tel : + 43 1 60 14 30
child and adolescents The pharmacokinetic and pharmacodynamic property of insulin glulisine be investigate in child ( 7-11 year ) and adolescent ( 12-16 year ) with type 1 diabetes mellitus .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
before YOU USE Insuman Comb 25
Entertainment and representation expense
Pharmacotherapeutic group :
first degree , Extrasystoles
4.1 Therapeutic indication
therefore , patient receive oral anticoagulant should be closely monitor for their prothrombin time INR , particularly in the first few day when therapy with parecoxib be initiate or the dose of parecoxib be change ( see section 4.4 ) .
Deutschland Servier Deutschland GmbH Tel : + 49 ( 0 ) 89 57095 01
20 October 2003 Date of latest renewal :
R06A X27
201 ( 30.4 % )
darbepoetin alfa be produce by gene-technology in Chinese Hamster Ovary Cells ( CHO-K1 ) .
14 .
6 .
use during lactation
your doctor or nurse will have already advise you where to inject ( e.g . tummy , front of thigh ) .
12 / 17 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
use a second needle and slowly withdraw the desired amount .
Wyeth Europa Ltd . , Huntercombe Lane South , Taplow , Maidenhead , Berkshire , SL6 0PH , United Kingdom .
Table 1 - Dosing for Combination Therapy
what be the precaution for the person who give the medicine or come into contact with the animal ?
Abseamed 8000 IU / 0.8 ml solution for injection in a pre-filled syringe
opaque green body , imprint with ‘ 60 mg ’ and an opaque blue cap , imprint with ‘ 9542 ’ .
clinical trial in Venous thromboembolism ( VTE ) prophylaxis follow major joint replacement surgery :
do not freeze .
- fainting
Janssen-Cilag B. V .
these measure will help to protect the environment .
not applicable .
Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom
dyspnoea * , cough * Epistaxis , respiratory disorder , nasal congestion , rhinorrhea ,
pregnancy and Lactation should be contraindicate and the appropriate wording include in section 4.3 , 4.4 and 4.6 of the SPC , and the relevant section of the Package Leaflet .
also tell your doctor if you have have a kidney transplant or if you have be tell that you have a narrowing of your kidney artery .
19.12.1997 23.7.1998 153 day 63 day
hyperkalaemia have be observe in isolated case .
this dose can be start on the first day of treatment .
9 .
in some case , particular fungal and other opportunistic infection have not be recognise , result in delay of appropriate treatment and sometimes death .
symptomatic hypotension may be expect to occur in patient who be volume and / or sodium deplete by vigorous diuretic therapy , dietary salt restriction , diarrhoea or vomiting .
cardiac ischaemia3 *
this leaflet be last approved in
base on measurement of vardenafil in semen of healthy subject 90 minute after dose , not more than 0.00012 % of the administer dose may appear in the semen of patient .
in contrast to the highly responsive ovary in this rodent model , the human ovary after menopause be relatively unresponsive to reproductive hormonal stimulation .
capsule , hard
3 St John ’ s wort Undesirable effect may be more common during concomitant use of ARICLAIM and herbal preparation contain St John ’ s wort ( Hypericum perforatum ) .
10 mg
pregnancy and breast-feeding Cubicin be not usually give to pregnant woman .
7 Westferry Circus , Canary Wharf , London , E14 4HB , UK Tel .
Str .
very common :
EXP
Dec-95
Karvezide 150 mg / 12.5 mg film-coated tablet irbesartan / hydrochlorothiazide
patient with renal and / or hepatic impairment unless a well-tolerated and effective dosage regimen use oral olanzapine have be establish in such patient , ZYPADHERA should not be use .
specific Obligations TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER
the pharmacokinetics of fesoterodine be not significantly influence by age and gender .
if patient with SCN develop abnormal cytogenetics , the risk and benefit of continue filgrastim should be carefully weigh ; filgrastim should be discontinue if MDS or leukaemia occur .
84 film-coated tablet multipack comprise 3 pack , each contain 28 tablet .
patient remain on stable dos of NSAIDs and or prednisone ( ≤ 0.2 mg / kg / day or 10 mg / day maximum ) .
Danmark Baxter A / S Gydevang 43 DK-3450 Allerød Tlf : + 45 48 16 64 00
film-coated tablet
due to report of interferon alpha exacerbate pre-existing psoriatic disease and sarcoidosis , use of PegIntron in patient with psoriasis or sarcoidosis be recommend only if the potential benefit justify the potential risk .
if you take more Aerius orodispersible tablet than you should Take Aerius orodispersible tablet only a prescribe for you .
this medicinal product contain le than 1 mmol sodium ( 23 mg ) per dose , i. e. essentially “ sodium- free ” .
32
47 Posology
maintenance phase :
Tel : + 48 ( 0 ) 22 594 90 00
powder for Solution for Injection
prolonged-release tablet
patient with myelosuppression may require more intensive monitoring of complete blood cell count , with differential and platelet count .
4.9 Overdose
how to take Diacomit 4 .
if the patient be switch to permanent prophylaxis with oral anticoagulant , protein C replacement be to be discontinue only when stable anticoagulation be obtain ( See 4.5 ) .
13 - Take the 30-gauge needle ( if you be manually inject without use of an auto-injector ) , take it out of it wrapping and place it firmly onto the tip ( nozzle ) of the syringe .
- Stalevo contains sucrose , and therefore patient with rare hereditary problem of fructose
blood and the lymphatic system disorder :
the following statement reflect the pharmacokinetic property of the individual active substance of Icandra .
European Medicines Agency
CPMP / 1357 / 99 Children
treatment should be continue in patient who exhibit negative HCV-RNA .
PHARMACEUTICAL FORM
EU / 1 / 05 / 328 / 001
expiry DATE
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
store in a refrigerator ( 2 ° C - 8 ° C ) .
sweating , itch and dry skin , skin and nail disorder
it be especially important to tell your doctor if you be take any medicine for diabetes , thyroid disorder or any anticonvulsant , ciclosporin or steroid hormone such a oestrogen , progesterone or corticosteroid .
gynaecomastia
Encapsulated cytarabine concentration and the count of the lipid particle in which the cytarabine be encapsulate in DepoCyte follow a similar distribution pattern .
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
change the site with each injection may help to prevent such skin change .
adjustment of their control .
4.6 Pregnancy and lactation
4.2 Posology and method of administration
the substance vildagliptin work by make the pancreas produce more insulin and le glucagon .
6 .
Incompatibility of some prefilled glass syrinx ( include Rapilysin ) with certain needle free connector have be report .
vertigo
• abdominal pain ( belly ache )
1 1
8 .
the intend dose of 1.5 μg / kg of ViraferonPeg to be use in combination with ribavirin may be deliver in weight category with the pen / vial strength accord to Table 1 .
maximum residue limit for old substance
olanzapine be start at 2.5 mg / day and titrate to a maximum of 15 mg / day base on investigator judgement .
- if you have symptom such a tiredness or shortness of breath ( this could mean that your heart be
2 .
Κύπρος Baxter Hellas ΕΠΕ Εθνάρχου Μακαρίου 34 Ηλιούπολη GR-16341 Αθήνα , Ελλάδα Τηλ . : + 30-210-9987000
PHARMACEUTICAL FORM AND CONTENTS
3 ) unscrew the needle all the way by give the large needle cover 3 to 5 complete turn .
your doctor should always adapt the amount of KOGENATE Bayer 1000 IU to be administer and the frequency of administration accord to the clinical effectiveness in your individual case .
these may include monitoring of vital sign and observation of clinical status .
it explain how the Committee for Medicinal Products for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
fosaprepitant be give via an intravenous infusion ( a drip ) , 30 minute prior to chemotherapy .
outer carton
31 In case of acute thrombosis CEPROTIN may be administer to you every 6 hour .
store in a refrigerator ( 2 ° C - 8 ° C ) .
idiopathic or cyclic neutropenia The recommend starting dose be 0.5 MU / kg / day ( 5 μ g / kg / day ) a a single dose or in divided dos .
European Medicines Agency
you should not breast-feed during treatment with Baraclude .
adverse REACTIONS
- you lose carbohydrate due to vomit or diarrhoea ,
August 2001 August 2001 November 2001
before be treat with VFEND , tell your doctor if :  you have have an allergic reaction to other azoles .  you be suffer from , or have ever suffer from liver disease .
1 .
what be the risk associate with CEPROTIN ?
- - - -
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
EXP
in general inhaled corticosteroid remain the first line treatment for most patient .
name OF THE MEDICINAL PRODUCT
15 .
to monitor treatment , your doctor may ask you for a semen analysis to be perform 4 to 6 month after the beginning of treatment .
film-coated tablet
16 .
this be when the ovary over- react to the treatment and develop too many follicle .
any child expose in utero to nucleoside and nucleotide analogue , even HIV-negative child , should have clinical and laboratory follow-up and should be fully investigate for possible mitochondrial dysfunction in case of relevant sign or symptom .
-- - -- - -- - -- - -- - -- -
10 mg
driving and use machine Your ability to concentrate and react may be reduce if you have hypoglycaemia .
name OF THE MEDICINAL PRODUCT
Lietuva Pfizer Luxembourg SARL Filialas Lietuvoje Tel . + 370 52 51 4000
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
57 You must tell your doctor if you think that you be ( or might become ) pregnant .
creatinine ALT / AST
for the full list of all side effect report with Ratiograstim , see the Package Leaflet .
2 .
statement OF ACTIVE SUBSTANCE ( S )
DATE OF REVISION OF THE TEXT
please tell your doctor or pharmacist .
15 .
Ratiograstim be give by injection under the skin or infusion into a vein .
hepatic Impairment :
if you take more REYATAZ than you should
do not stop take your medicine unless your doctor tell you to .
EU / 1 / 00 / 166 / 001 – 2500 U EU / 1 / 00 / 166 / 002 – 5000 U EU / 1 / 00 / 166 / 003 – 10,000 U
a with all injected medicine , caution should be use in patient with bleed disorder or receive anticoagulant therapy .
Tel : + 356 2298 3217
in this study treatment with amlodipine be associate with an increase in pulmonary oedema , although this could not be relate to an increase in symptom .
capsule , hard
lithium : reversible increase in serum lithium concentration and toxicity have be report during concomitant administration of lithium with angiotensin convert enzyme inhibitor .
clinical PARTICULARS
do not use the vial after this time period .
specific single substitution at these residue in gp41 each result in a range of decrease from baseline in recombinant viral susceptibility to enfuvirtide .
you must use the pen a describe in these Instructions for Use .
if normal or decreased value for glycated haemoglobin be note , the possibility of recurrent , unrecognised ( especially nocturnal ) episode of hypoglycaemia must be consider .
the main measure of effectiveness be the number of patient who have a PTH level below 250 microgram per litre at the end of the study .
most minor reaction to insulin usually resolve in a few day to a few week .
method AND ROUTE ( S ) OF ADMINISTRATION
NSAIDs :
apply for authorisation
Norge Pb .
the solution should not be inject directly onto the powder a this will result in foaming .
content BY WEIGHT , BY VOLUME OR BY UNIT lo o
the recommend dose of Tekturna be 150 mg once a day , either take alone or in combination with other medicine for hypertension .
difference
the WORDS “ FOR ANIMAL TREATMENT ONLY ”
Zimbagasse 5 A-1147 Wien Tel : + 43 1 57600-0
65 %
4.1 Therapeutic indication
be 6 .
B .
eptifibatide n ( % )
3 .
• Chronic suppurative otitis medium
method AND ROUTE OF ADMINISTRATION
the potential risk for human be still unknown .
general Committee of Agricultural Cooperation in the EU ( COPA-COGECA )
• OTHER CONDITIONS
the glucuronide of the parent compound be the only metabolite that have be identify in human .
Orion Pharma Eläinlääkeet PL 425 FIN-20101 Turku Puh / Tel :
the text be valid at that time .
Exforge be available in pack contain 7 , 14 , 28 , 30 , 56 , 90 , 98 or 280 tablet and in MULTIPACKS comprise 4 CARTONS , each contain 70 tablet .
Lamictal
not applicable .
elderly exposure to the active metabolite at steady state be 25 to 35 % higher in elderly ( age 65 to 78 year ) compare to adult le than 65 year of age give comparable dos of oseltamivir .
any unused veterinary medicinal product or waste material derive from such veterinary medicinal product should be dispose of in accordance with local requirement .
this will be increase every 5 - 7 day a direct by your doctor until your symptom be control ( maintenance dose ) .
5.2 Pharmacokinetic property
there have be report of tuberculosis in patient receive Humira .
Humalog Mix50 100 U / ml suspension for injection in vial
clinical study
lot
during treatment with olanzapine , adolescent gain significantly more weight compare with adult .
• After the powder have dissolve ( which usually occur immediately ) , check that the resulting solution be clear and do not contain any particle .
- If you have a meningeal infection .
- severe depression - suicidal ideation - non-fatal suicide attempt - aggressive behaviour - paranoid reaction - manic reaction
gastrointestinal disorder :
76 % 74 / 19 / 2 40 31 % 34 % 48 % 4.6 ( 3.5-5.3 ) 239 ( 95-420 )
MARKETING AUTHORISATION NUMBER ( S )
Ελλάδα GlaxoSmithKline A. E. B. E .
important information about some of the ingredient of ViraferonPeg This medicinal product contain le than 1 mmol sodium ( 23 mg ) per 0.7 ml , i.e . , essentially & quot ; sodium-free & quot ; .
frequency not know
- a special type of reduce red blood cell count ( haemolytic anaemia ) ; a dangerous drop in a type
& # 91 ; to be complete nationally & # 93 ; LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
increase in blood potassium have happen in isolated case .
ACR Responsesa
treatment of pregabalin overdose should include general supportive measure and may include haemodialysis if necessary ( see section 4.2 Table 1 ) .
detailed information on this product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu /
adverse reaction frequency estimate :
DATE OF REVISION OF THE TEXT
to prevent the possible transmission of disease , each pen must be use by one patient only .
4 .
these may be sign of a stroke .
body Weight ( kg )
Tel : + 34-91 663 50 00
think you may be allergic , ask your doctor for advice .
for the full list of all side effect report with EMSELEX , please see the Package Leaflet .
1 .
6.6 Special precaution for disposal and other handling
efficacy result for study ACTG 364 and 020
please tell your doctor or pharmacist .
there be limited experience in child with Ph-positive ALL .
the active substance in Enbrel be etanercept .
European PUBLIC ASSESSMENT REPORT ( EPAR )
this be a
2 year .
1.0 mg
you may take it with or without food .
40-50
endogenous red cell reserve = blood volume & # 91 ; ml & # 93 ; x ( PCV - 33 ) ÷ 100
fondaparinux do not cross-react with serum from patient with heparin-induced thrombocytopaenia .
CHAPTER 1 8 — TOTAL
keep out of the reach and sight of child .
alcohol may upset the control of your blood sugar so you be advise to talk to your doctor about drinking alcohol while take Trazec .
6.1 List of excipients
- angiotensin convert enzyme ( ACE ) inhibitor ( use to treat certain heart condition or high
4 .
300mg / 12.5 mg
there be no indication for use of Fertavid during pregnancy .
hypersensitivity ( allergic ) reaction can occur .
6 .
España Abbott Laboratories , S.A .
psychiatric symptom : psychiatric adverse reaction have be report in patient treat with efavirenz .
51 Insulin lispro do not induce fertility impairment , embryotoxicity or teratogenicity in animal study .
due to intra-patient variability , occasional individual haemoglobin value for a patient above and below the desired haemoglobin level may be observe .
the second study include a dose range of 2.0 mg / m2 to 5.2 mg / m2 in child ( n = 8 ) , adolescent ( n = 3 ) , and young adult ( n = 3 ) with leukaemia .
no pharmacological activity have be show for the conjugate .
statement OF ACTIVE SUBSTANCE ( S )
Sverige sanofi-aventis AB Tel : + 46 ( 0 ) 8 634 50 00
• acute exacerbation of chronic sinusitis especially if these be cause by Gram-negative bacteria
37
Annex 1
close monitoring of serum potassium in at risk patient be recommended ( see section 4.5 ) .
read package leaflet .
114 carbohydrate chain be attach via three N-glycosidic bond and one O-glycosidic bond to the protein .
Enbrel have not be study in child age le than 4 year .
keep the curtain drawn and use light bulb of 60W or le .
190 B .
for intravenous use .
37.6 , 98.4 ) , and against HPV 6- , 11- , 16- , 18- related genital wart be 80.3 % ( 95 % CI :
acuity trial
instruction ON USE
therefore , the perfusion of the optic nerve head and intraocular pressure should be monitor .
EXUBERA
not all pack size may be market .
1 .
13 .
the basal metabolic requirement be 40 % to 60 % of the total daily requirement .
the product should then be spray onto the surface of the tissue in short burst ( 0.1-0.2 ml ) to form a thin , even layer .
2 .
1.1 % 1.9 %
85 B .
you should discontinue breast feeding if you be take VIRAMUNE .
this dosage may be adjust , or treatment may be delay depend on your blood cell count and on your general condition .
medicinal product subject to medical prescription .
the treatment consist of eight infusion of one syringe every 24 hour .
ocular change :
insulin requirement may be increase during illness or emotional disturbance .
powder : vial ( glass ) ; solvent : pre-filled syringe ( glass )
insulin in the blood stream have a half-life of a few minute .
- a significant reduction in the absolute risk of diabetes-related mortality : metformin
9 .
common Common Common
the median EC50 of lopinavir against isolates with 0 − 3 , 4 − 5 , 6 − 7 and 8 − 10 mutation at the above amino acid position be 0.8 , 2.7 13.5 and 44.0-fold higher than the EC50 against wild type HIV , respectively .
Pfizer Ltd Ramsgate Road Sandwich , Kent CT13 9NJ United Kingdom
patient , especially child , with risk factor for acute pancreatitis ( e. g. recent chemotherapy , hematopoietic stem cell translplantation ( HSCT ) ) , should be monitor closely during VFEND treatment .
PegIntron be not recommend for use in patient under the age of 18 year .
a personnel database be select in 2000 that will facilitate personnel administration , in particular leave record , evaluation report and other personnel detail .
not all pack size may be market .
Member
CHARACTERISTICS in elderly patient :
the content of vitamin D in FOSAVANCE be not suitable for correction of vitamin D deficiency .
95 5 .
pregnancy
ribavirin capsule
not know :
multipack carton - without the blue Box
chemical and physical in-use stability of the diluted solution in sterile Lactated Ringer ’ s solution and sodium chloride solution 9 mg / ml ( 0.9 % ) , 4.5 mg / ml ( 0.45 % ) , and 2.25 mg / ml ( 0.225 % ) for infusion have be demonstrate for 24 hour at 25 ° C and for 48 hour at 2 to 8 ° C .
Polska MSD Polska Sp.z o.o .
ultrasound imaging must be perform during injection of OPTISON a optimal contrast effect be obtain immediately after administration .
risperidone plasma concentration be normal in patient with liver insufficiency , but the mean free fraction of risperidone in plasma be increase by about 35 % .
in such a case , you may develop severe hypoglycaemia ( and even faint ) before you be aware of the problem .
post-marketing experience : weight loss
10 , 30
this recurrence may be more severe if you have serious liver disease .
1,200 mg )
the time from start of administration of sugammadex or neostigmine to recovery of the T4 / t1 ratio to 0.9 be :
81 Driving and use machine
case of Vogt-Koyanagi-Harada ( VKH ) syndrome have be report in patient with chronic hepatitis C treat with interferon .
vildagliptin Vildagliptin act primarily by inhibit DPP-4 , the enzyme responsible for the degradation of the incretin hormone GLP-1 ( glucagon-like peptide-1 ) and GIP ( glucose-dependent insulinotropic polypeptide ) .
base on information available to date , correction of anaemia with erythropoietin in adult patient with renal insufficiency not yet undergoing dialysis do not accelerate the rate of progression of renal insufficiency .
Pfizer Hellas 243 Messoghion Ave . , Neo Psychiko 154 51 Greece
oral use
- Driving and operating machinery
Table 3
pharmacological PROPERTIES
non-steroidal anti-inflammatory drug : when angiotensin II antagonist be administer simultaneously with non-steroidal anti- inflammatory drug ( i. e. selective COX-2 inhibitor , acetylsalicylic acid ( & gt ; 3 g / day ) and non-selective NSAIDs ) , attenuation of the antihypertensive effect may occur .
after pituitary desensitisation induce by a GnRH agonist , a higher dose of Fertavid may be necessary to achieve an adequate follicular response .
in the PURSUIT trial , there be 9 patient who receive bolus and / or infusion dos more than double that specify in the protocol , or who be identify by the investigator a have receive an overdose .
all of these additive factor of anaemia should also be carefully consider when decide to increase the dose of epoetin alfa in cancer patient .
1 .
the systemic exposure at these level be approximately equivalent to or le than 0.5 time the clinical exposure at the recommended clinical dose of 2 g / day for renal transplant patient and approximately 0.3 time the clinical exposure at the recommended clinical dose of 3 g / day for cardiac transplant patient .
it have an efficacy of 73 % for patient with high titre and 90 % for those with low titre .
due to intra-patient variability , occasional individual haemoglobin value for a patient above and below the desired haemoglobin level may be observe .
Starlix contain lactose monohydrate .
inject Nespo use the pre-filled pen
4.8 Undesirable effect
headache , dizziness Hyperkinesia , tremor , dysphonia , paresthaesia , hypoaesthesia , hyperaesthesia , concentration impair , somnolence no
oral use
change in total fasting cholesterol level from borderline at baseline ( ≥ 4.39 - & lt ; 5.17 mmol / l ) to high ( ≥ 5.17 mmol / l ) be very common .
turn it till the push-button be fully down and you can feel resistance .
31 %
renal insufficiency A single-dose , open-label study be conduct to evaluate the pharmacokinetics of a reduce dose of sitagliptin ( 50-mg ) in patient with vary degree of chronic renal insufficiency compare to normal healthy control subject .
PHARMACEUTICAL Form Solution for infusion Solution for infusion Solution for infusion
select the injection site .
if their symptom be the same a yours .
Penicillin-resistant Streptococcus pneumoniae be cross-resistant to cephalosporin such a cefuroxime through alteration of penicillin binding protein .
3.0 3.0
( 44-20 ) 74 18 84 00 Fax ( 44-20 ) 74 18 84 16 E-mail : mail @ emea . europa . eu http : / / www . emea . europa . eu
PHARMACEUTICAL FORM AND CONTENTS
one ml of the reconstituted solution contain 4 mg basiliximab .
60 A .
Pharmacotherapeutic group :
empty cartridge must not be refill .
do not take Glustin 30 mg tablet :
2 *
60 Κύπρος Boehringer Ingelheim Ellas A. E .
no specific information be available on the treatment of overdose with Irbesartan Hydrochlorothiazide BMS .
when use in subcutaneous infusion pump , treatment with insulin lispro have be show to result in lower glycosylated haemoglobin level compare to soluble insulin .
instruction ON USE
treatment and prevention of respiratory infection cause by Actinobacillus pleuropneumoniae susceptible to trimethoprim and sulfamethoxazole where the disease have be diagnose in the herd .
for child with renal impairment , levetiracetam dose need to be adjust base on the renal function a levetiracetam clearance be relate to renal function .
when you first start your insulin treatment , it may disturb your vision , but the reaction usually disappear .
Profender tablet for small 15 mg praziquantel & amp ; 3
possible side effect 5 .
oral
oral use .
AUC : ↓ 25 % ( ↓ 16 to ↓ 32 ) b Cmax : ↓ 17 % ( ↓ 6 to ↓ 26 ) b Cmin : ↓ 50 % ( ↓ 40 to ↓ 59 ) b
HCV genotype
read the package leaflet before use
Tel . : + 36- ( 1 ) 391 0060
diabetes mellitus be a disease where your body do not produce enough insulin to control the level of blood sugar .
colour overcoat :
the pharmacokinetics of ciprofloxacin 250 mg and 500 mg oral suspension in single-dose sachet be similar to those of tablet .
Baraclude should be take orally , once-daily .
1 ) and Commission Regulation ( EC ) No 847 / 2000 of 27 April 2000 ( OJ L 103 , 28.4.2000 , p .
for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical sign in cattle .
no dosage
Puregon contain a recombinant FSH .
Amgen Europe B. V .
if their symptom be the same a yours .
the dos for dog be base on body surface area .
DATE of first authorisation :
Ethnic origin :
4.1 Target specie
the data review by CHMP include data from 7 study with HBVAXPRO and Procomvax , one of which be on-going at present .
the remain 7 patient make no clinically significant motor gain or be unable to sustain the motor gain make and have very limited motor movement by the last study assessment ( with individual patient treatment duration range from 52 to 142 week ; mean follow-up period of 103 week ) .
lauril Sulfate , and sodium stearyl fumarate .
if you have take Zerit during your pregnancy , your doctor may request regular visit to monitor the development of your child .
no clinical adverse reaction be report .
do not pass it on to others .
close blood glucose monitoring be therefore recommended .
Special STORAGE CONDITIONS
your patient data will be register anonymously – nobody will know it be information about you .
tacrolimus : in liver transplant recipient initiate on mycophenolate mofetil and tacrolimus , the AUC and C max of MPA , the active metabolite of mycophenolate mofetil , be not significantly affect by trough tacrolimus level .
Deutschland Roche Pharma AG Tel : + 49 ( 0 ) 7624 140
Excipient
what Exforge IS AND WHAT IT IS USED FOR
34 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
additional side effect have be report after this medicine be market .
© European Medicines Agency , 2008 .
BATCH NUMBER & # 91 ; For term on BATCH number and expiry date see Appendix IV & # 93 ;
driving and use machine :
if you take more Procoralan than you should :
2 2 0 2 0
how to take Truvada 4 .
the frequency be define a : Uncommon ( ≥ 1 / 1,000 to & lt ; 1 / 100 ) .
Dynepo 2,000 IU / 0.5 ml solution for injection in a pre-filled syringe .
- who be elderly ,
high creatine
4.1 % respectively ) .
1 .
how be Duloxetine Boehringer Ingelheim use ?
119 9 .
a anaphylactoid reaction be observe in isolated case , it be recommend that the first dose be administer under medical supervision .
list OF EXCIPIENTS
for the full description of the side effect report with Dynepo , please see the Package Leaflet .
film-coated tablet
the Committee have establish an AD hoc work group of expert to evaluate the extent of the risk of anti-microbial resistance develop in animal a a result of the use of antibiotic in veterinary medicine and it potential transfer to man .
EU / 1 / 07 / 415 / 006-010
hypoglycaemia .
solution for injection in a cartridge .
23 In case of sign of upper airway obstruction , the problem should be solve by a specialist before start treatment with somatropin .
before you use VISTIDE
film-coated tablet
69 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial label Solvent for ZYPADHERA
an increase in heparin dose during haemodialysis be frequently require during the course of therapy with erythropoietin a a result of the increase packed cell volume .
50 microgram
the expiry date refers to the last day of that month .
patient should brush their teeth thoroughly twice daily and have regular dental examination .
the CHMP adopt the harmonised indication : “ Treatment of hypertension ” .
keep turn the cap until 6 be opposite the dosage indicator .
in reproductive and developmental toxicity study in rodent and rabbit , no teratogenic effect but an increase in number of stillborn PUPs and pup death in the peripartum period , and slightly reduce live litter size and pup body weight be observe at maternal toxic dos in rat correspond to systemic exposure level similar to the expect clinical exposure .
after immediate-release venlafaxine administration , the peak plasma concentration of venlafaxine and ODV occur in 2 and 3 hour , respectively .
3 .
oral use
withdrawal PERIOD
use in patient with hepatic impairment
pharmacokinetic property
pregnancy and breast-feeding Ask your doctor or pharmacist for advice before take any medicine .
Κύπρος Lifepharma ( Z . A. M. ) Ltd Aγ .
6 Metabolism and nutrition disorder
activate charcoal may be useful in the treatment of overdose .
caution should be exercise when prescribe to pregnant woman .
INTERMEDIATE CARTON OF multipack ( without BLUE BOX )
drug which inhibit CYP2C19 Fluvoxamine :
1 vial + 1 pre-filled syringe
possible side effect 5 How to store ABILIFY 6 .
Insuman Comb 15 can be use during breastfeeding .
interferon
pharmacological PROPERTIES
all patient be treat with epoetin alfa should receive adequate iron supplementation ( e. g. oral iron substitution of 200 mg Fe2 + daily ) throughout the course of epoetin alfa treatment .
27 PACKAGE LEAFLET :
consequently , should sign of pulmonary oedema occur when Thelin be administer in patient with pulmonary hypertension , the possibility of associate veno-occlusive disease should be consider .
- if you suffer from mild to moderate low blood pressure ,
in controlled clinical study , use of Aranesp and other erythropoiesis-stimulating agent ( ESAs ) have show :
- 02.01.2000 - 19.04.2000 - 101 day - 7 day
& # 91 ; see Annex I - To be complete nationally & # 93 ;
rash
common :
if you have be tell by your doctor that you have an intolerance to some sugar , contact your doctor before take this medicinal product .
monthly MIRCERA intravenous or subcutaneous dose
B CONDITIONS OF THE MARKETING AUTHORISATION
15 ml
if you have any further question on Silgard after read this leaflet , please ask your doctor or pharmacist .
keep the vial in the outer carton in order to protect from light .
account the policy decision to transfer all telematic service and development to EMEA from January 2003 .
Lietuva Novartis Pharma Services Inc .
release for consultation July 2002
name OF THE MEDICINAL PRODUCT
the indication in pancreatic cancer be base on data from the pivotal Phase 3 study JHAY and the support study JHAZ .
73 % 80 %
disorder Rare Very rare
it also increase CD4 cell count .
liver toxicity consist of increase in liver enzyme , liver weight and microscopic finding include hepatocyte necrosis .
12 .
capsule ( 200 mg )
absorption
the Committee recommend that PROTELOS be give market authorisation .
no clinical study safety data be available in patient below 6 year of age .
patient not demonstrate a pain reduction of 30 % within 60 day of treatment be unlikely to reach this level during further treatment .
paediatric patient : in a randomised trial of 318 hypertensive child and adolescent age 6 to 16 year , the follow related adverse event occur in the 3-week double-blind phase : headache ( 7.9 % ) , hypotension ( 2.2 % ) , dizziness ( 1.9 % ) , cough ( 0.9 % ) .
in patient with diabetes mellitus optimise glycaemic control delay the onset of late diabetic complication .
vomit Constipation Stomatitis Dry mouth diarrhoea
1.3
what be FOSAVANCE use for ?
a case of tuberculosis have be report in patient treat with Enbrel , your doctor will check for sign and symptom of tuberculosis before start Enbrel .
there be no inconsistency between batch and no quality deficiency be identify .
Activity-neutralising antibody ( inhibitor ) be a very rare event in previously treat patient receive factor IX-containing product .
PROTELOS be intend for long-term use .
the Committee for Medicinal product for Human Use ( CHMP ) decide that M-M-RVAXPRO ’ s benefit be greater than it risk for the combined vaccination against measles , mumps , and rubella in individual 12 month or older .
160
oral use
Slovenija Dunajska 22 SI-1000 Ljubljana Tel : + 386 01 3001070
4.8 Undesirable effect
dog , cat
Servier Danmark A / S Tlf : + 45 36 44 22 60 Österreich Servier Austria GmbH Tel : + 43 ( 1 ) 524 39 99
Efexor and associate name ( see Annex I ) 25 mg tablet Efexor and associate name ( see Annex I ) 37.5 mg tablet Efexor and associate name ( see Annex I ) 50 mg tablet Efexor and associate name ( see Annex I ) 75 mg tablet
deliver
open :
- PROTELOS be not intend for use in child and adolescent .
Comparative efficacy of the six currently available statin on lipid and lipoprotein in patient without hypertriglyceridaemia ( adapt from Maron et al .
23 February 1996 Date of latest renewal :
therapeutic and preventive treatment of bovine respiratory disease ( BRD ) associate with Mannheimia haemolytica , Pasteurella multocida and Histophilus somni .
compare to placebo , treatment with Enbrel result in significant improvement in the ASAS 20 , ASAS 50 and ASAS 70 a early a 2 week after the initiation of therapy .
there be some case of more severe neutropenia in patient treat with Ribavirin in combination with 13 peginterferon alfa-2b ( WHO grade 3 :
14 .
prevention during an influenza epidemic in the Community The recommend dose for prevention of influenza during a Community outbreak be 75 mg oseltamivir once daily for up to 6 week .
3 .
tablet
MARKETING AUTHORISATION NUMBERS
treatment success should be evaluate base on height velocity .
proposal to improve EMEA transparency a part of the review of EU pharmaceutical legislation .
Uncommon - Diabetic retinopathy Long-term improved glycaemic control decrease the risk of progression of diabetic retinopathy .
Euphoric mood , confusion , irritability , libido decrease Hallucination , panic attack , restlessness , agitation , depression , depress mood , mood swing , depersonalisation , insomnia exacerbate , word find difficulty , abnormal dream , libido increase , anorgasmia , apathy
because the number of patient with these two form of leukaemia be low , the disease be consider ‘ rare ’ , and Sprycel be designate an ‘ orphan medicine ’ ( a medicine use in rare disease ) on 23 December 2005 .
Synergistic effect of Ceftriaxone and aminoglycosides on certain Gram-negative bacteria have be note in vitro .
medicinal product subject to medical prescription .
Pharmacotherapeutic group :
6 .
statement OF ACTIVE SUBSTANCE ( S )
due to intra-patient variability , occasional individual haemoglobin value for a patient above and below the desired haemoglobin level may be observe .
* p & lt ; 0.01 EFFENTORA versus placebo , in favor of EFFENTORA , by one-sample Wilcoxon sign rank test + p & lt ; 0.0001 EFFENTORA versus placebo , in favor of EFFENTORA , by one-sample Wilcoxon sign rank test PID = pain intensity difference ; SEM = standard error of the mean
DATE OF REVISION OF THE TEXT
pregnancy
oral antidiabetic medicinal product , monoamine oxidase ( MAO ) inhibitor , beta-blockers , angiotensin convert enzyme ( ACE ) inhibitor , salicylate , anabolic steroid and glucocorticoid 79 ( except topical administration ) , oral contraceptive , thiazide , thyroid hormone , sympathomimetics , danazol , octreotide and sulphonamides .
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Ytracis be never give on it own .
aspartame ( E 951 ) 1.2 MG per TABLET .
however , in the study look at improve symptom of advanced head and neck cancer , 28 ( 22 % ) of the 128 patient assess have a significant improvement in their most troubling symptom .
rare :
cisplatin and 5-fluorouracil .
mechanism of resistance :
in clinical study discontinuation be achieve by reduce the dose by approximately 25 % every two day .
& lt ; 1
zidovudine have no effect on it pharmacokinetics .
anaemia and epistaxis have also be report .
these mainly involve the gastrointestinal and central nervous system .
adopt in October 1998
immediately after injection of OPTISON , 10 ml of sodium chloride 9 mg / ml ( 0.9 % ) solution for injection or glucose 50 mg / ml ( 5 % ) solution for injection should be inject at a rate of 1 ml / s .
B .
Tηλ : + 30 2 10 89 06 300
very Common ( & gt ; 1 / 10 )
treatment
5 .
method OF ADMINISTRATION
- yellow skin ( jaundice ) ,
the clinical significance of the change have not be establish .
this leaflet be last approved in { MM / YYYY } .
there be no difference in response to CoAprovel , regardless of age or gender .
XENICAL
EU / 1 / 00 / 134 / 001
if you need to see a doctor or go to the hospital , take the pack with you .
genotype 1 / 4
3 .
Betaferon be a powder and solvent , which be make into a solution for injection .
Pfizer Ltd ( a MA Holder logo )
5 .
treatment with Neoclarityn also significantly reduce interference with sleep and daytime function , a measure by a four-point scale use to assess these variable .
100 Units / ml
take special care with Zerit :
B .
mirtazapine
upon regain consciousness , administration of oral carbohydrate be recommend for the patient in order to prevent relapse .
however , the symptom for which STELARA be prescribe may come back .
information IN BRAILLE
mechanism of action Me
7 .
Abseamed have no influence on the ability to drive and use machine .
for intravenous or subcutaneous use Read the package leaflet before use . no
Nineteen patient who discontinue nevirapine because of rash have be treat with efavirenz .
irbesartan be not remove by haemodialysis .
& # 91 ; to be complete nationally & # 93 ;
essential thrombocythaemia ( ET ) be a disease where the bone marrow produce too many platelet .
interaction with other medicament and other form of interaction .
1 .
name OF THE MARKETING AUTHORISATION HOLDER
6 .
your doctor may prescribe a different dose of IntronA alone or in combination with other medicine ( e.g . , cytarabine , ribavirin ) .
since efavirenz be highly protein bound , dialysis be unlikely to remove significant quantity of it from blood .
during pregnancy :
common : headache
Novartis Farma S. p . a .
filgrastim
- If you have any further question , ask your doctor or pharmacist .
tell your doctor or pharmacist .
9 7 .
the patient should be give a meal a soon a consciousness be recover .
film coating : polyvinyl alcohol macrogol 3350 talc ( E553b ) titanium dioxide ( E171 ) iron oxide red ( E172 ) iron oxide black ( E172 )
6.5 Nature and content of container
keep this leaflet for future reference each time you use OptiSet .
they will have to take it into account before treat you with CYANOKIT . • that you have be treat with CYANOKIT if you need to have any blood or urine test .
PHARMACEUTICAL Form
( 2 / 4 )
a start dose of 4 to 6 g per day can be use in patient who need urgent control of Cushing ’ s syndrome ( a set of symptom of adrenal gland cancer cause by high hormone level ) .
all item for administration or cleaning , include glove , should be place in high-risk , waste disposal bag for high-temperature incineration .
Cystadane 1 g oral powder betaine anhydrous
if you forget to use Insuman Basal
oral use
while the clinical significance of decreased indinavir concentration have not be establish , the magnitude of the observed pharmacokinetic interaction should be take into consideration when Choosing a regimen contain both efavirenz and indinavir .
Slovenská republika Merck spol . s r. o .
clinical particular
the coadministration of vardenafil with nitrate or nitric oxide donor ( such a amyl nitrite ) in any form be contraindicate ( see section 4.5 and 5.1 ) .
QUALITATIVE AND QUANTITATIVE COMPOSITION
• Work also continue in 1997 on the development of a computerised accounting and budgetary system .
this solution can be mix with a FSH preparation in the same syringe .
Page 26
most skin reaction be limit to the application site and result in discontinuation in only 2.4 % of the patient in the Prometax 9.5 mg / 24 h transdermal patch group .
- 14.9 )
therefore medicinal product that be inducer , inhibitor or substrate of CYP3A4 must be use with caution when administer concurrently with Telzir with ritonavir ( see section 4.3 and 4.5 ) .
• If you have mild heart failure and you be be treat with Trudexa , your heart failure status
the most common treatment-related adverse reaction report during clinical trial with ViraferonPeg in combination with ribavirin , see in more than half of the study subject , be headache , fatigue , and injection site reaction .
you should not take Xeloda if you be pregnant or think you might be .
Nederland Janssen-Cilag B. V .
there have be a report of one patient who take an overdose of 3000 mg of lapatinib for 10 day and suffer grade 3 diarrhoea and vomit on day 10 .
LABELLING
if you realise that you forget a dose , administer it a soon a possible .
BATCH NUMBER
Estonia
suspension for injection
plasma raloxifene concentration be approximately 2.5-fold higher than in control and correlate with bilirubin concentration .
the change in iris pigmentation occur slowly and may not be noticeable for several month .
common
injection site reaction usually occur in the first month .
therefore , paclitaxel be not recommend for paediatric use .
for a full list of excipients , see section 6.1 .
since Lantus be a solution , it do not require resuspension before use .
their frequency be not know .
further information
instruction ON USE
angina pectoris ; myocardial infarction
read the package leaflet before use .
ViraferonPeg 80 microgram be supply a :
APIDRA should be give by subcutaneous injection or by continuous subcutaneous pump infusion .
antiretroviral agent :
DATE of first authorisation :
13.5
this document be a summary of the European Public Assessment Report ( EPAR ) .
27 More severe episode with coma , seizure , or neurologic impairment may be treat with intramuscular / subcutaneous glucagon or concentrate intravenous glucose .
Jerini
to analyse the separated carbon dioxide sample gas it molecule must be ionise , form into a beam , accelerate by an electric field , deflect in a magnetic field , and finally detect .
the dose be 1 MU / kg bodyweight .
8 .
very common side effect : upper respiratory tract infection like cough and cold .
2 .
1
list OF EXCIPIENTS
prolong or severe hypoglycaemic episode may be life-threatening .
EVISTA ( n = 317 ) be compare with continuous combine ( n = 110 ) hormone replacement therapy ( HRT ) or cyclic ( n = 205 ) HRT patient in some clinical trial .
take your dose of Lamictal once or twice a day , a your doctor advise .
a leflunomide have a long persistence in the body , a switching to another DMARD ( e. g. methotrexate ) without perform the washout procedure ( see below ) may raise the possibility of additive risk even for a long time after the switching ( i. e. kinetic interaction , organ toxicity ) .
3 .
none
Priapism Erections increase ( prolonged or painful erection )
oral use
the study examine the long-term effect ( 2 year ) of Irbesartan Winthrop on the progression to clinical ( overt ) proteinuria ( urinary albumin excretion rate ( UAER ) & gt ; 300 mg / day , and an increase in UAER of at least 30 % from baseline ) .
this be call a rotation Cycle .
 EMEA 2004
complicate cystitis , Uncomplicated pyelonephritis
MARKETING AUTHORISATION NUMBER ( S )
- If you have any further question , ask your doctor or pharmacist .
for further detail on handling , see section 6.6 .
342 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
store in a refrigerator .
affect more than 1 user in 10 affect 1 to 10 user in 100 affect 1 to 10 user in 1,000 affect 1 to 10 user in 10,000 affect le than 1 user in 10,000 frequency can not be estimate from the available data
your doctor or nurse will advise you where to inject .
in addition , the frequency of medically important adverse reaction report from post-marketing experience be include a not know .
no case of overdose have be report .
115,000
Pfizer Kft .
before YOU TAKE VIMPAT
to reduce the risk of infection , it be important that you follow the Fuzeon Injection Instructions provide below .
you should know these factor so that you be able to react correctly to change in your blood sugar level and to prevent it from become too high or too low .
S Viraferon 30 million IU solution for injection multidose pen interferon alfa-2b
second and third trimester of pregnancy ( see section 4.6 ) .
however , response rate in this trial be show to be dependent also on the dose of ribavirin administer in combination with ViraferonPeg or interferon alfa-2b .
consequently , concomitant administration of Kaletra and these glucocorticoid be not recommended unless the potential benefit of treatment outweigh the risk of systemic corticosteroid effect ( see section 4.4 ) .
BATCH NUMBER lon lot
pharmacological PROPERTIES
patient who for any reason can not receive adequate antithrombotic prophylaxis .
paediatric patient with chronic renal failure
caution should also be exercise when duloxetine be use with medicinal product that may impair it metabolism ( see section 4.5 ) .
what Insulin Human Winthrop Comb 25 contains
eye disorder Very rare case of transient visual disturbance ( flash , flash light , scotoma ) typically occur during infusion of the medicinal product and in association with hypersensitivity reaction have be report .
accumulation of foamy alveolar macrophage in the lung be observe in rat and mouse .
Bovilis BVD
the following side effect have be see with AZARGA :
Norge Abbott Norge AS Po Box 1 , N-1330 Fornebu Martin Linges vei 25 , N-1367 Snarøya Tlf : + 47 81 55 99 20
suspension for injection
manufacturer OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER ( S ) RESPONSIBLE FOR BATCH RELEASE
21 pipette
if insulin have be expel through the needle tip , then the pen and the needle be work properly .
PHARMACEUTICAL FORM
the ability to maintain the erection ( SEP 3 ) in this broad ed population be give a 53 % ( 5 mg ) , 63 % ( 10 mg ) and 65 % ( 20 mg ) compare to 29 % on placebo .
macrolides be generally consider bacteriostatic and mycoplasmastatic .
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder :
DATE OF REVISION OF THE TEXT
1 mg / 1 ml
Estonia
see the package leaflet for further information
emphasis will be give to the implementation of the EU joint audit programme in the coming year .
for infusion , filgrastim should be dilute in 20 ml of glucose 50 mg / ml ( 5 % ) solution for infusion ( see section 6.6 for instruction on dilution ) .
N06DA03
rifampicin ( 600 mg once daily ) decrease ranolazine steady-state concentration by approximately 95 % .
490 ( 88.6 % ) *
MARKETING Authorisation Holder and Manufacturer Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt be Main Germany
efficacy and long term safety of a dose higher than the recommended starting dos have not be establish in patient who continue to smoke cigarette ( see section 4.5 and 5.2 ) .
7 correction OF budgetary imbalance 70 correction OF budgetary imbalance 700
Table 2b – Reduced PegIntron Dosing for Combination Therapy
7 Westferry Circus , Canary Wharf , London , E14 4HB , UK Tel .
other SPECIAL WARNING ( S ) , IF NECESSARY
in order to prevent ovarian hyperstimulation syndrome , treatment with GONAL-f could be discontinue by your physician and the treatment with hCG abandon .
why have Pandemrix be approve ?
7 .
in view of the above , in some clinical situation blood transfusion should be the preferred treatment for the management of anaemia in patient with cancer .
20mg
specific patient group Nateglinide should be use with caution in patient with moderate hepatic impairment .
4.1 Therapeutic indication
infection and infestation meningitis
week 2
see ritonavir row below .
diarrhoea when report be mainly mild or moderate in severity .
pharmacological PROPERTIES
4.8 Undesirable effect
2 .
how have Olanzapine Neopharma be study ?
transdermal patch
the pharmacokinetic finding show that systemic exposure be lower than in adult with pulmonary hypertension ( see section 5.2 ) which may provide
MM / YYYY
sanofi Pasteur MSD SNC
if you have any concern consult your doctor .
tablet hard capsule
EVISTA be indicate for the treatment and prevention of osteoporosis in postmenopausal woman .
open :
name OF THE MEDICINAL PRODUCT
instruction ON USE
Moreover child treat lon with interferon alfa-2b experience a reduced rate of growth and some case of depression be observe .
128 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
below the desired haemoglobin level may be observe .
4.2 Posology and method of administration
detailed information on this medicinal product be available on the website of the European Medicines ed
epoetin alfa should be administer by the subcutaneous route to patient with anaemia ( e. g. haemoglobin concentration ≤ 10 g / dl ( 6.2 mmol / l ) .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Advasure be also study in fatten pig where a single vaccination be give at age 10 week .
reaction ( redness , swell , itch ) at the injection site may occur ( local allergic reaction ) .
L01XX17 .
MIRCERA be use to treat anaemia ( low red blood cell count ) in patient who have chronic kidney disease ( long-term , progressive decrease in the ability of the kidney to work properly ) .
what Neoclarityn contains
treatment of Meconium aspiration Syndrome ( MAS )
au excipients : sodium phosphate monobasic monohydrate , sodium phosphate dibasic heptahydrate ,
- If you have any further question , ask your doctor .
the main study of Atripla include 300 patient whose HIV infection be already be successfully treat with various combination of antiviral medicine .
- hallucination
96 Do not use Fentanyl-ratiopharm after the expiry date which be state on the package .
- In your brain
some medication may interact with CRIXIVAN take in combination with ritonavir .
treatment of heartburn and acid regurgitation : one 15 mg or 30 mg Oro-dispersible tablet for 4 week .
not applicable
name OF THE MEDICINAL PRODUCT
for the full list of all side effect report with CYANOKIT , see the Package Leaflet .
Novartis Hungaria Kft .
340 PACKAGE LEAFLET :
Exenatide have be show to bind to and activate the known human GLP-1 receptor in vitro , it mechanism of action mediate by cyclic AMP and / or other intracellular signal pathway .
{ BLISTER }
do not take Procoralan :
100 200
base on a population pharmacokinetic analysis in patient 19-78 year of age , clearance of TMZ be not affect by age .
a .
11 .
1 .
Triatec COMPOSTO Triatec COMPOSTO Forte
before administration the Nespo solution should be inspect for visible particle .
desloratadine plasma concentration can be detect within 30 minute of administration .
Viraferon 60 MIU pen lp
metabolism rivastigmine be rapidly and extensively metabolise with an apparent elimination half-life in plasma of approximately 3.4 hour after removal of the transdermal patch .
in M
MARKETING AUTHORISATION NUMBER ( S )
54 721 cancer patient receive non-platinum chemotherapy be include in three placebo-controlled study , 389 patient with haematological malignancy ( 221 multiple myeloma , 144 non-Hodgkin & apos ; s lymphoma , and 24 other haematological malignancy ) and 332 with solid tumour ( 172 breast , 64 gynaecological , 23 lung , 22 prostate , 21 gastro-intestinal , and 30 other tumour type ) .
the efficacy of tacrolimus for kidney transplantation have be investigate in a number of study and different regimen and can nowadays be regard a a well-established treatment option , both for primary immunosuppression and for rescue therapy .
there be no evidence of mutagenicity , clastogenicity or carcinogenicity .
95 4 .
8 .
this finding be base on conventional safety pharmacology , repeat dose toxicity , genotoxicity , carcinogenicity , and reproduction toxicity study .
2 .
1 .
consequently , erythropoietin should generally be use during pregnancy and lactation only if the potential benefit outweigh the potential risk to the foetus .
3 .
laboratory test abnormality :
rotigotine be metabolise by N-dealkylation a well a direct and secondary conjugation .
ER Once hypertension be control with more intensified therapy , Dynepo therapy should be re-start at a reduced dose . ng Iron evaluation lo
soft tissue and skeletal variation in the foetus be also observe at 10 and 20 mg / kg / day ..
the risk may vary with the underlying infection , age and general status of the patient so that the contribution of the fluoroquinolone to the increase in INR ( international normalise ratio ) be difficult to assess .
film-coated tablet
the dose of dexamethasone be reduce to 40 mg orally once daily on Days 1 to 4 of each 28-day cycle after the first 4 cycle of therapy .
do not freeze .
insulin requirement may decrease during the first trimester and generally increase during the second and third trimester .
hypertension , flush
3 .
paediatric patient with chronic renal failure
what be the risk associate with Porcilis PCV ?
Wyeth-Lederle Pharma GmbH Storchengasse 1 A-1150 Vienna Austria
1831 Machelen ( Diegem ) Belgium
in several controlled study , epoetins have not be show to improve overall survival or decrease the risk of tumour progression in patient with anaemia associate with cancer .
body System
and resume treatment at a reduced dose of 50 mg twice daily ( second episode ) or 40 mg twice daily ( third episode ) .
patient should be monitor closely to ensure that the lowest approve dose of NeoRecormon be use to provide adequate control of the symptom of anaemia .
if you want more information on the basis of the CHMP recommendation , read the Scientific Discussion ( also part of the EPAR ) .
slowly push the plunger up to force the air bubble out of the syringe .
Insuman Comb 50 must not be administer intravenously and must not be use in infusion pump or external or implanted insulin pump .
year
- thrombotic event ( blood clot ) in blood vessel , such a disturbed blood perfusion of the
13 .
name OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION
however , a with other antipsychotic , patient should be caution about operate hazardous machine , include motor vehicle , until they be reasonably certain that aripiprazole do not affect them adversely .
for any information about this medicine , please contact the local representative of the Marketing Authorisation Holder .
„ Бигла ” 6 София 1407 Teл . : + 359 2 862 53 72
15 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
the study either recruited patient who be be treat with chemotherapy ( two study ) or use patient population in which erythropoiesis stimulating agent be not indicate : anaemia in patient with cancer not receive chemotherapy , and head and neck cancer patient receive radiotherapy .
transdermal patch
in clinical study , the only undesirable effect that be consistently consider to be relate to filgrastim administration be musculoskeletal pain , predominantly mild to moderate bone pain and myalgia .
- Pacemaker dependent
EU / 1 / 97 / 030 / 131
≥ 110
20
it could stop work or fall off .
adrenal insufficiency Anorexia Hypercholesterolemia hypertriglyceridaemia
Insuman Basal
MARKETING Authorisation Holder :
check your blood sugar frequently .
name , PHARMACEUTICAL FORM , strength OF THE MEDICINAL PRODUCT , ANIMAL SPECIES , ROUTES OF ADMINISTRATION , AND MARKETING AUTHORISATION HOLDER
10 .
34.9 % ( 28 % ; 41 % )
follow monthly administration of darbepoetin alfa , at subcutaneous dos range from 0.6 to 2.1 µg / kg , the terminal half-life be 73 hour ( SD 24 ) .
50 µg / kg 50 µg / kg
skin and subcutaneous tissue disorder :
941.4 mg liquid paraffin per dose of 2 ml
study in patient age 13-17 year show various adverse reaction , include weight gain , change in metabolic parameter and increase in prolactin level .
if you drive or use tool or machine : watch out for sign of a hypo .
injection site reaction Pyrexia Allergic / Anaphylactic reaction Blood pressure abnormal Dizziness Pruritus Rash
2 .
 322 9 .
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet .
asthenia , flush , Hot flush , condition aggravate , rigor , tongue discolouration , parosmia , thirst
Special caution must be take when remove and dispose of the needle .
Nature and content of container
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
in this leaflet :
panitumumab may impact the ability of a woman to become pregnant .
do not refrigerate or store above 30 ° C
each NovoSeven package contains : – 1 vial ( 12 ml ) with white powder for solution for injection – 1 vial ( 12 ml ) with solvent for reconstitution
the clinical relevance of a reduction in UACR be not establish in the absence of an effect on blood pressure .
≥ 50 30 to & lt ; 50 15 to & lt ; 30 5 to & lt ; 15 & lt ; 5
EXP :
5 .
• Epididymo-orchitis include case due to Neisseria gonorrhoeae
11 .
2 .
1 .
hypersensitivity to the active substance or to any of the excipients .
kg Elisabeth-Selbert-Str .
7 .
one IU ( International Unit ) correspond to 0.035 mg of anhydrous human insulin .
in the absence of incompatibility study , Aranesp should not be mixed or administer a an infusion with other medicinal product .
 EMEA 2006
the outcome of these development be expect to result in increased effort in specific Post-authorisation activity in the Sector for veterinary marketing authorisation procedure .
cerivastatin be associate with a higher reporting rate of fatal rhabdomyolysis than atorvastatin and the use of cerivastatin in combination with gemfibrozil increase the reporting rate of fatal rhabdomyolysis at lower dos of cerivastatin .
to ensure that the needle be in the vein , check for blood return by pull back very slightly on the plunger of the syringe .
in haemodialysis patient and person with an impair immune system , adequate anti-HAV and anti-HBs antibody titer may not be obtain after the primary immunisation course .
178 ANNEX II
36
Uncommon :
lot
no
the pack also contain 5 x 5 ml syrinx with 0.1 ml graduation from 0 to 5 ml ( 400 / 100 mg ) .
7 .
sign of allergy .
a fall in the UPDRS score indicate an improvement in symptom , while a rise indicate a worsening of symptom .
in clinical study , KOGENATE Bayer have be use in the treatment of bleed episode in 37 previously untreated patient ( PUPs ) and 23 minimally treat pediatric patient ( MTPs , define a have equal to or le than 4 exposure day ) .
d .
each solvent vial contain 2 ml Water for Injections .
base on evidence generate in clinical trial , breast-feeding do not reduce the protection against rotavirus gastro-enteritis afford by Rotarix .
the number of report in older infant be too small to identify a pattern .
very common :
cancer patient on erythropoietin should have haemoglobin ( the part of a red blood cell that carry oxygen ) level measure on a regular basis until a stable level be achieve , and periodically thereafter .
calcium salt : thiazide diuretic may increase serum calcium level due to decreased excretion .
pack size : blister with 14 , 28 , 30 , 56 , 90 or 98 tablet or perforate unit dose blister with 28 x 1 tablet
Uncommon : hypertension
discontinuation of treatment Withdrawal symptom when treatment be discontinue be common , particularly if discontinuation be abrupt ( see section 4.8 ) .
ambrisentan do not inhibit or induce phase I or II drug metabolize enzyme at clinically relevant concentration in in vitro and in vivo non-clinical study , suggest a low potential for ambrisentan to alter the profile of medicinal product metabolize by these pathway .
Contraindications
2 .
serum concentration of theophylline should be monitor and appropriate dose adjustment of theophylline make for patient take theophylline and Pegasys concomitantly .
weight gain9 , elevate triglyceride levels10 , increase appetite .
ic
the WORDS & quot ; FOR ANIMAL TREATMENT ONLY & quot ; AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE , if applicable
film-coated tablet
2 insufficient data on immunogenicity , safety and efficacy ( see section 5.1 ) .
NovoSeven can be use during breast-feeding .
Magyarország sanofi-aventis zrt . , Magyarország Tel . : + 36 1 505 0050
Postural hypotension Postural hypotension be infrequently observe in the elderly in olanzapine clinical trial .
gonadotrophin therapy require a certain time commitment by physician and supportive health professional , a well a the availability of appropriate monitoring facility .
MDS and leukaemia be natural complication of the disease and be of uncertain relation to filgrastim therapy .
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
2H2N ( 13CO ) NH2 + 2H2O
expiry DATE
& lt ; & # 91 ; To be complete nationally & # 93 ; & gt ; & lt ; & # 91 ; See Annex I - To be complete nationally & # 93 ; & gt ; & # 91 ; For referral procedure & # 93 ;
in the overdose case below 140 mg or unknown dose the patient reveal symptom from central nervous system ( confusion , drowsiness , somnolence , vertigo , agitation , aggression , hallucination , and gait disturbance ) and / or gastrointestinal origin ( vomit and diarrhoea ) .
33 %
this medicine do not require any special storage condition .
therefore , do not take SIFROL if you be pregnant unless your doctor tell you to do so .
3
Prometax 4.5 mg hard capsule rivastigmine
method AND ROUTE ( S ) OF ADMINISTRATION
very common : alopecia Common : transient skin change , dry skin , exfoliative dermatitis , pruritis , rash , acne , transient and mild nail change
method AND ROUTE ( S ) OF ADMINISTRATION
there be no relevant difference between Ratiograstim and the reference product with regard to duration of severe neutropenia and incidence of febrile neutropenia .
MARKETING AUTHORISATION NUMBER ( S )
if you have liver or kidneys problem or if you be elderly , speak to your doctor a you may need a lower dose .
Laboratoires G GAM Europarc 33 rue Auguste Perret 94042 creteil Cedex France
severe aluminium overload due to treatment of renal failure may compromise the effectiveness of NeoRecormon .
oral use
Sandoz GmbH Biochemiestr .
no teratogenic effect be observe in the rat or rabbit .
24-fold ; ( relative to Indinavir 800 mg TID alone * ) Ritonavir AUC :
2 .
expiry DATE
5 .
Norge MSD ( Norge ) AS Tlf : + 47 32 20 73 00 msdnorge @ msd . no
whether this be relate to mobilisation of copper store or to natural history of the disease remain unclear .
6.6 Special precaution for disposal and other handling
- if you be pregnant or think you may be pregnant
measurement of plasma concentration of testosterone have demonstrate the persistent pharmacological effect of the continue presence of deslorelin in the circulation for at least six month follow administration of the product .
eye irritation , eye pain , orbital oedema , scleral haemorrhage , retinal haemorrhage , blepharitis , macular oedema
& amp ;
cartridge ( glass ) in pre-filled pen
if you be treat with Actraphane 30 Penfill and another insulin Penfill cartridge , you should use two insulin delivery system , one for each type of insulin .
change in total fasting cholesterol level from borderline at baseline ( ≥ 4.39 - & lt ; 5.17 mmol / l ) to high ( ≥ 5.17 mmol / l ) be very common .
on 6 October 2008 , the Dutch regulatory Agency refer the matter to the CHMP .
swab ;
- This medicine have be prescribe for you .
internal analytical precision must be le than + 0.3 ‰ δ 13C for 20 replicate analysis of the same reference gas sample and remain within 23SD ’ s of the mean for breath analysis .
see also below regard the effect of posaconazole on rifabutin plasma level .
sanofi Pasteur MSD SNC , 8 rue Jonas Salk , F-69007 Lyon , France
how TO STORE NEUPOPEG
PHARMACEUTICAL Form
avoid introduction of contamination during use .
method AND ROUTE ( S ) OF ADMINISTRATION
- jaundice , increase in liver enzyme
for instruction on reconstitution of Nplate , see section 6.6 .
- asthma , respiratory depression or any lung disease
the response to treatment in both of these trial be present in Table 4 .
• consider the data on low immunogenicity available today , the CHMP identify the need for further study to ensure long-term protection against Hepatitis B with the current vaccine in future .
1 .
- you change the area of skin where you inject insulin ( for example from the thigh to the upper
this mean that due to the rarity of the disease it have not be possible to obtain complete information on this medicinal product .
agitation Confusion insomnia Depression hallucination Dizziness Headache somnolence Tremor Syncope Seizures Extrapyramidal symptom ( include worsening of Parkinson ’ s disease )
for general Ziagen information enquiry , contact GlaxoSmithKline … . Tel … … … … … ( local company name and Telephone number will be insert here ) .
adverse reaction observe in animal study with possible clinical relevance be a follow :
insert the needle in the ampoule of solvent and withdraw the total amount of solvent .
B .
Investigations Very common :
ratio for overall survival range between 1.25 and 2.47 in favour of control .
5 .
the pharmacokinetics of irbesartan be evaluate in 23 hypertensive child after the administration of single and multiple daily dos of irbesartan ( 2 mg / kg ) up to a maximum daily dose of 150 mg for four week .
1 / 1
KwikPen .
start dose of 50 IU / kg 2 time per week by the intravenous route .
keep the vial in the outer carton in order to protect from light .
lot .
tachycardia unknown :
Exforge 5 mg / 160 mg film-coated tablet amlodipine / valsartan
10 Effects of rimonabant on pre- and post-natal development be assess in the rat at dose up to 10 mg / kg / day .
depression be associate with an increase risk of suicidal thought , SELF harm and suicide ( suicide-related event ) .
study have demonstrate the link between chronic hepatitis B infection and hepatocellular carcinoma and 80 % of hepatocellular carcinoma be cause by hepatitis B virus infection .
14 .
Ceftriaxone Tyrol Pharma and associate name ( See Annex I ) 2 g powder for solution for infusion & # 91 ; See Annex I - To be complete nationally & # 93 ;
{ Name and address } & lt ; { Tel } & gt ; & lt ; { Fax } & gt ; & lt ; { E-mail } & gt ;
Denmark
Meteor Centre office Park Sokolovskà 100 / 94 a
grade 3 n ( % )
NovoRapid NovoLet be for use by one person only .
12 7 11 12 11 67
possible SIDE EFFECTS
reconstitute solution .
if you use more Vaniqa than you should
sitagliptin 100 mg once daily § ( N = 193 ) Sitagliptin 100 mg once daily ( N = 229 ) Combination Therapy Studies
patient take Efient should also take aspirin at a dose prescribe by their doctor .
the full EPAR for Olanzapine Neopharma can be find here .
249 Sertraline , a medicine use to treat depression , a your doctor may need to change your dose of Sertraline .
- Nefazodone inhibit CYP3A4 .
98 film-coated tablet multipack comprise 2 pack , each contain 49 tablet .
- If you have any further question , ask your doctor or pharmacist .
14 .
Electrophysiological study demonstrate that olanzapine selectively reduce the firing of mesolimbic ( A10 ) dopaminergic neuron , while have little effect on the striatal ( A9 ) pathways involve in motor function .
impotence
not all pack size may be market .
- - -
reproduction be authorise provide the source be acknowledge . measure look at the clinical sign and the number of Demodex mite in skin scraping take every four week , for several week follow monthly administration of the treatment .
method of administration Herceptin be administer a a 90-minute intravenous infusion .
if VKH syndrome be suspect , antiviral treatment should be withdraw and corticosteroid therapy discuss ( see section 4.8 ) .
EMEND , when give a a regimen of 125 mg on Day 1 and 80 mg / day on Days 2 and 3 , increase the AUC of methylprednisolone , a CYP3A4 substrate , by 1.3-fold on Day 1 and by 2.5-fold on Day 3 , when methylprednisolone be co-administered intravenously a 125 mg on Day 1 and orally a 40 mg on Days 2 and 3 .
a lternatively , the injection can be give at the end of the dialysis session via the fistula needle tubing , follow by 10 ml of sodium chloride 9 mg / ml ( 0.9 % ) solution for injection to rinse the tubing and ensure satisfactory injection of the medicinal product into the circulation .
in female versus male subject the mean elimination half life be somewhat prolonged ( 36.7 versus 32.3 hr ) and the clearance be reduce ( 18.9 versus 27.3 l / hr ) .
there be no evidence from study in rat and rabbit that filgrastim be teratogenic .
severe infection be report in about 4 % of patient .
manufacturer OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
VIMPAT treatment have be associate with dizziness or blur vision .
Uncommon
no specific information be available on the treatment of overdosage with Bondenza .
in this leaflet :
the influence of different injection site on the absorption of NovoMix 50 have not be investigate .
4.8 Undesirable effect
heart failure :
1 film-coated tablet contain 15 mg mirtazapine
- Hyperuricaemia
60 – 100
data from clinical study in paediatric patient indicate that the safety and efficacy of filgrastim be similar in both adult and child receive cytotoxic chemotherapy .
with your other hand , pinch a fold of loose skin in the area you have clean for injection .
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
information IN BRAILLE
clinical PARTICULARS
28 tablet
5 Very common Hypercalciuria Common
tumour growth potential
a total of 697 patient be randomize in a 2 : 1 ratio to either irbesartan / hydrochlorothiazide 150 mg / 12.5 mg or to irbesartan 150 mg and systematically force- titrate ( before assess the response to the lower dose ) after one week to irbesartan / hydrochlorothiazide 300 mg / 25 mg or irbesartan 300 mg , respectively .
do not use any Imprida pack that be damage or show sign of tamper .
frequently , these will cease or decrease in intensity with continued use of the medicinal product , a the patient be titrate to the most appropriate dose .
clearance l / hr / kg na
the use of EVICEL be restrict to experienced surgeon .
therefore , administer the product with the syringe onto a portion of the food .
there be no clinical experience with Levemir in child below the age of 6 year .
each blister pack of Docetaxel Winthrop 80 mg concentrate and solvent for solution for infusion contains : • one single-dose vial of concentrate , • one single-dose vial of solvent .
28 However , because human immunoglobulin be excrete in milk , woman must not breast-feed for at least five month after the last Trudexa treatment .
in chronic renal failure patient Binocrit have not to be administer subcutaneously !
keep out of the reach and sight of child .
Tel : + 420 234 664 111 Danmark Eli Lilly Danmark A / S Tlf : + 45 45 26 6100 Deutschland Lilly Deutschland GmbH Tel . + 49- ( 0 ) 6172 273 2222 Eesti Eli Lilly Holdings Limited Eesti filiaal Tel : + 3726441100 Ελλάδα ΦΑΡΜΑΣΕΡΒ -ΛΙΛΛΥ α .Ε .β .Ε .
blister
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
L. pneumophila be highly susceptible to telithromycin in vitro , however , the clinical experience of the dic
European Medicines Agency
81 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
the effect of ketoconazole , a prototype of potent and competitive inhibitor of CYP3A4 , on the pharmacokinetics of repaglinide have be study in healthy subject .
ribavirin capsule
d .
therapy should be initiate by a physician experience in the treatment of renal cell carcinoma or GIST .
four hour after administration , the CSF / plasma ratio be 0.39 ± 0.06 .
Pharmacotherapeutic group : therapeutic antiparasitic agent ; ATCvet code :
blister FOR 75 mg
further information
child and adolescent
the GMTs be , however , lower in woman above 25 year .
list OF EXCIPIENTS
this leaflet be last approved in { MM / YYYY } .
what be Tekturna ?
0.7 2.8
6 .
6 .
all administer
België / Belgique / Belgien Fort Dodge Animal Health Benelux B. V .
2 .
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
how TO USE Insuman Comb 50
no significant effect on methadone concentration be observe .
ReFacto AF OUTER CARTON
cardiac disorder :
if STOCRIN be start because your current treatment have not prevent the virus from multiply , another medicine you have not take before must be start at the same time .
irbesartan BMS at a dose of 150 mg once daily generally provide a better 24 hour blood pressure control than 75 mg .
2 .
- Chronic hepatitis in patient who be be or have be treat recently with immunosuppressive
Casodex
tablet
very rare Very rare
what Mixtard 30 contains – The active substance be insulin human make by recombinant Biotechnology ( 30 % a soluble insulin and 70 % a isophane insulin ) .
if SUSTIVA be start because your current treatment have not prevent the virus from multiply , another medicine you have not take before must be start at the same time .
information IN BRAILLE
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
via Emilia , 21 27100 - Pavia Italy
n = 158
50 %
CPMP / 6214 / 03
treatment be discontinue due to adverse reaction in 0.5 % of patient .
the following special warning and precaution have be actually observe or be potential class effect base on the pharmacological mechanism of action of thrombopoietin ( TPO ) receptor stimulators .
name OF THE MEDICINAL PRODUCT
any medicinal product remain in the pre-filled syringe should be dispose of .
the potential risk for human be unknown .
serum sample be test against the original H5N3 and also a number of H5N1 isolates .
5 .
PHARMACEUTICAL PARTICULARS
GONAL-f may be give a a course of daily injection .
Novo Nordisk A / S
anti-HA antibody
cartridge Before insertion into the pen , Insulin Human Winthrop Basal must be keep at room temperature for 1 to 2 hour and then resuspend to check the content .
2.5 mg / 0.5 ml
if you be use Neupro for Parkinson ’ s disease the following side effect may occur :
36 Do not store above 30 ° C .
an increase in formation of micronucleated polychromatic erythrocyte be observe in vivo in mouse receive a high , toxic intraperitoneal dose of cidofovir ( ≥ 2000 mg / kg ) .
this result be similar to the report value for factor VIII derive from human plasma .
how do EXJADE work ?
no other erythropoietic therapy should be commence because of the risk of cross-reaction .
ABILIFY 10 mg tablet aripiprazole
the mechanism of this event be unknown although a component may be due to autonomic neuropathy .
fungal infection , bacterial infection include sepsis , herpes simplex , otitis medium
in one epidemiological study , a higher incidence of acute coronary syndrome be report in the repaglinide group .
MSD Sharp & amp ; Dohme GmbH Lindenplatz 1 85540 Haar Germany
always take Januvia exactly a your doctor have tell you .
content BY WEIGHT , BY VOLUME OR BY UNIT
Uncommon
outer CARTON
R ACR 50
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
the only plasma-radiolabelled metabolite detect be A771726 .
KOGENATE Bayer 250 IU Powder for solution for injection
4 .
repaglinide be a novel short-acting oral secretagogue .
for patient with multiple symmetrical painful or swollen joint ( e. g. hand , wrist and foot ) , Enbrel can slow down the structural damage to those joint cause by the disease .
content BY WEIGHT , BY VOLUME OR BY UNIT
blister pack ( 14 , 56 or 100 ) and perforate unit dose blister pack ( 100 ) for 150 mg hard capsule
regular monitoring of platelet count and haematocrit be recommend .
Special STORAGE CONDITIONS
driving and use machine :
repeat this movement at
GlaxoSmithKline Biologicals s. a .
- diarrhoea , constipation , stomach pain , feeling or be sick , wind , dry or sore mouth or throat
further information
not know :
oral use .
qualified veterinary surgeon from University College Dublin .
5 .
250 microgram / Solution for injection 0.5 ml
in preclinical safety study , dos produce exposure comparable to that in the clinical therapeutic range cause reduce red cell parameter ( erythrocyte , haemoglobin , haematocrit ) , change in renal haemodynamics ( increase blood urea nitrogen and creatinine ) , a well a increase serum potassium in normotensive animal .
the dose and dosage regimen be dependent on the indication .
a Points to consider document on a common EU
6 .
Venus , 26 can Parellada Industrial 08228 Terrassa Spain
HIV infection be a disease spread by contact with blood or sexual contact with an infected individual .
the recommend dose for adult be 600 mg twice a day .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS
chemotherapy .
EMEA / H / C / 514
one IU ( International Unit ) correspond to 0.035 mg of anhydrous human insulin .
0.3 0.4 0.5 0.4
PHARMACEUTICAL FORM
4 / 8 ( 50.0 % )
138 България Novartis Pharma Services Inc .
the pH may have be adjust with sodium hydroxide and / or hydrochloric acid .
if there be evidence of worsen liver disease in such patient , interruption or discontinuation of treatment must be consider .
PREZISTA be an antiviral medicine .
Special STORAGE CONDITIONS
this leaflet be last approved in { MM / YYYY } .
AVONEX 30 microgram / 0.5 ml solution for injection
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
Table 1 give the adverse reaction observe from spontaneous reporting and in placebo-controlled clinical trial ( comprise a total of 7976 patient , 4370 on duloxetine and 3606 on placebo ) in SUI and other lower urinary tract disorder .
non response to epoetin alfa therapy may have the following cause : iron , folate , or vitamin B12 deficiency ; aluminium intoxication ; intercurrent infection ; inflammatory or traumatic episode ; occult blood loss ; haemolysis , and bone marrow fibrosis of any origin .
however , if you miss a dose , do not take an extra dose .
the polysaccharide be chemically attach ( conjugate ) to tetanus toxoid a a carrier protein because this improve the response to the vaccine .
• To prevent mortality and to reduce clinical sign and lesion of infectious Bursal disease .
0.5 ml
12.5 mg daily ) , the antihypertensive response in black patient approach that of white patient .
outer carton for Cozaar 50 mg HDPE bottle
if you have any further question on the use of this product , ask your doctor or pharmacist .
increase Liver Aminotransferases ( see section 4.4 ) elevation of AST and / or ALT be associate with sitaxentan sodium .
EpiCept GmbH Goethestrasse 4 D-80336 München Germany
this be most likely to occur within the first few week of treatment .
Invented name Atripla
lot : … …
if you administer Raptiva , please read the following instruction carefully and follow then step by step : • wash your hand .
sanofi PHARMA BRISTOL-MYERS SQUIBB SNC 174 avenue de France F-75013 Paris - France
scale
combination Therapy in Renal allograft recipient
valueb
3 .
if refrigerate , the solution must be allow to reach room temperature before administration .
when treat HIV infection , it be not always possible to tell whether some of the unwanted effect be cause by STOCRIN or by other medicine that you be take at the same time , or by the HIV disease itself .
10 .
information IN BRAILLE
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
the treatment-free period , however , should take into account the pharmacokinetic property of the product use previously .
Tel : + 39 06 50 39 61
keep out of the reach and sight of child .
1 ml contains :
BATCH
19.1 % NA
7 .
the vial should be gently swirl and not shake .
before use : store in a refrigerator ( 2 ° C - 8 ° C ) .
very rarely :
severe hyperglycaemia or ketoacidosis must always be treat by a doctor , normally in a hospital .
each film-coated tablet contain 10 mg olanzapine .
4 .
the decision whether to continue the patient on therapy with Competact should be guide by clinical judgement pending laboratory evaluation .
-1.05
metabolism and nutrition disorder
insert the needle and inject a instructed .
C .
26 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS multidose VIAL
R .
Prometax 9.5 mg / 24 h transdermal patch :
& # 91 ; to be complete nationally & # 93 ;
1 ) Directive 2001 / 83 / EC on the Community code relate to medicinal product for human use ( OJ L 311 , 28.11.2001 , p .
if you have the impression that the effect of ViraferonPeg be too strong or too weak , talk to your doctor or pharmacist .
Menopausal symptom
patient must be inform of this and advise to exercise caution while drive or operate machine during treatment with Oprymea .
Uncommon
PHARMACEUTICAL FORM
United Kingdom sanofi-aventis Tel : + 44 ( 0 ) 1483 505 515
Uncommon : heart rate increase , flush , cough , diarrhoea , indigestion / heartburn , sexual dysfunction ( problem with sexual performance ) , chest pain .
MARKETING AUTHORISATION HOLDER
the first dose of fondaparinux be administer intravenously and subsequent dos be administer by subcutaneous injection .
non-responder define a serum / plasma HCV-RNA positive at the end of a minimum of 12 week of treatment .
the incidence of respiratory depression increase a the fentanyl dose be increase .
Summaries of the Agency ’ s budget for 1996 to 1998 be present in Annex 5 .
EU / 1 / 05 / 331 / 012
statement OF THE MRLs
please tell your doctor or pharmacist .
MARKETING AUTHORISATION NUMBER ( S )
0.44
the frequency be arrange accord to the following scheme :
measurement of serum FSH , LH and oestradiol during the study indicate some loss of suppression of ovarian hormonal activity in some woman , although measurement of serum progesterone indicate that there be no hormonal evidence of ovulation in any of the 16 subject .
content BY WEIGHT , BY VOLUME OR BY UNIT
5 day
- Do not use Aclasta after the expiry date which be state on the carton and bottle .
& # 91 ; to BE complete nationally & # 93 ;
8 41470 Neuss , Germany
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
injection site reaction such reaction include redness , pain , itching , hive , swell , or inflammation .
no study on the effect on the ability to drive and use machine have be perform .
severe hepatic impairment , biliary cirrhosis or cholestasis .
similar change be also see in the valsartan alone group ( exposure 8.5 – 11.0 time the clinical dose of 160 mg valsartan ) .
& lt ; 8.5 g / dl
how do I throw away my needle ? • throw away used needle in a puncture-resistant container or a recommend by your healthcare professional .
4 .
( 4th time )
4.6 Pregnancy and lactation
150 mg
Actraphane 50 NovoLet 100 IU / ml suspension for injection in a pre-filled pen Insulin human ( rDNA )
PACKAGING
DATE of first authorisation :
box for the prescribed dose
co-administration of aliskiren with either valsartan ( ↓ 28 % ) , metformin ( ↓ 28 % ) , amlodipine ( ↑ 29 % ) or cimetidine ( ↑ 19 % ) result in between 20 % and 30 % change in Cmax or AUC of Enviage .
although the exact antiviral mode of action of recombinant interferon alfa-2b be unknown , it appear to alter the host cell metabolism .
if an eye irritation persist , seek medical advice . • Wear protective glove while handle the product . • wash hand after use .
people usually stop lose weight a treatment go on .
child and adolescent .
disorder :
more severe reaction may occur .
Predictability of sustained virological response in naïve patient Virological response by week 12 , define a a 2-log viral load decrease or undetectable level of HCV RNA have be show to be predictive for sustained response ( Table 8 ) .
3 .
≥ 10 % ≥ 7.5 % ≥ 5 %
2 .
in most case , the ferritin value in the serum fall simultaneously with the rise in packed cell volume .
4 6.6 Special precaution for the disposal of unused veterinary medicinal product or waste material derive from the use of such product , if appropriate
99 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & amp ; ΥΙΟΣ Ε .Π .Ε .
in a subset define a have le than 20 exposure day at study entry , le than 11 % develop de-novo inhibitor .
MARKETING AUTHORISATION NUMBER ( S )
tablet
- if you be a man who be take ribavirin , do not have sex with a pregnant woman unless you use a
for a full list of excipients , see section 6.1 .
for intravenous or subcutaneous use .
3.0 5.5 8.0 2.3 3.1 4.8 10.3 NA
Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ . : + 30-210 98 97 300
Kelenhegyi út 43 H-1118 Budapest
child from 6 year of age and weigh le than 39 kg Use Telzir oral suspension .
patient should be monitor closely to ensure that the lowest approve dose of Aranesp be use to provide adequate control of the symptom of anaemia .
the main test method use to determine HER2 positivity in this pivotal trial be immunohistochemistry ( IHC ) .
38 cirrhosis who withdraw from treatment be similar to that of the overall population in each treatment group .
14 .
4 .
6 .
content BY WEIGHT , BY VOLUME OR BY UNIT
5 .
this will help to protect the environment .
oral use
Tel : + 420 233 086 111
8 .
during other clinical experience :
- pack size of 1 glass container of powder plus 1 oral applicator of solvent
if you notice any of these symptom please inform your doctor .
Pharmacotherapeutic group : blood coagulation factor VIII ( ATC-Code B02B D02 ) .
Special STORAGE CONDITIONS
3 .
telbivudine be an inhibitor of both HBV first strand ( EC50 = 0.4-1.3 μ M ) and second strand ( EC50 = 0.12-0.24 μ M ) synthesis , and show a distinct preference for inhibit second strand production .
the enzymatic digestion of uric acid to allantoin by rasburicase produce hydrogen peroxide and haemolytic anaemia or methaemoglobinaemia have be observe in certain at risk population such a those with G6PD deficiency .
insulin that you inject in such a site may not work very well .
for single use only
JO5AX Treatment of HIV infection
all precaution must be take to avoid direct illumination of the patient with surgical lamp during these procedure .
Slovac Republic :
do not store above 30 ° C Store in the original package in order to protect from light and moisture
4.1 Therapeutic indication
5 .
- The other ingredient be sodium dihydrogen phosphate dihydrate , disodium phosphate
25 mg
common : blood urea nitrogen increase , creatinine increase and creatine kinase increase .
Special WARNING ( S )
somnolence Headache
please tell the doctor if the person to be vaccinate be take or have recently take any other medicine , include medicine obtain without a prescription or have recently receive any other vaccine .
after switch to 4.6 mg / 24 h transdermal patch , provide these be well tolerate after a minimum of four week of treatment , the dose of 4.6 mg / 24 h should be increase to 9.5 mg / 24 h , which be the recommended effective dose .
Τηλ : + 357 22866700 info _ Cyprus @ merck.com
1 .
blister
there be no known reason for this .
the aetiology have not be define .
Moreover , an autoinjector be use by the majority of patient throughout the study .
capsule content : anhydrous lactose , colloidal anhydrous silica , sodium starch glycolate type A , tartaric acid , stearic acid .
6 bottle of 30 film-coated tablet
information FOR THE USER
these measure will help to protect the environment .
renal and urinary disorder Me
do not store above 30 ° C
not know : erythema nodosum , skin ulcer , petechia , photosensitivity .
sympathomimetics sympathomimetics may reduce the antihypertensive effect of ACE inhibitor .
solution for injection
9 Metabolism Sitagliptin be primarily eliminate unchanged in urine , and metabolism be a minor pathway .
Sverige GlaxoSmithKline AB Tel : + 46 ( 0 ) 8 638 93 00 info.produkt @ gsk.com
withdrawal of isotretinoin may be necessary .
Linearity / non-linearity exposure to aliskiren increase more than in proportion to the increase in dose .
4.8 Undesirable effect
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
detail of membership of the Committee can be find in Annex 6 .
in rat the incidence of pre-implantation loss be increase at a dose of 100 mg / kg / day , ( 10.4 time the human therapeutic exposure follow a dose of 200 mg ) , which cause maternal toxicity .
insulin
& # 91 ; 54 % -91 % & # 93 ; ) for imatinib .
the medicine can only be obtain with a prescription .
the suspension and emulsion vial once mixed form a multidose container .
because of individual variability , titration to ed
International Units be determine by comparison of the activity of the recombinant interferon alfa-2b with the activity of the international reference preparation of human leukocyte interferon establish by the World Health Organisation .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
- Severe , persistent or bloody diarrhoea associate with abdominal pain or fever , which can be a
the negative predictive value for sustained response in HCV / HIV co-infected patient treat with ViraferonPeg in combination with ribavirin be 99 % ( 67 / 68 ; Study 1 ) ( see section 5.1 ) .
Helicobacter pylorus infection be present if the difference in 13C / 12C of baseline-value and 30-minute- value exceed 4.0 ‰ .
be careful when you start or stop take another medicine .
severe rotavirus gastro- enteritis ( 1st year of life ) Rotarix N = 9009 ; Placebo N = 8858 ( § ) Efficacy ( % ) & # 91 ; 95 % CI & # 93 ;
at least 3.6 log10 EID50 ( 1 dose ) per animal by either spray vaccination , drink water or intranasal / ocular administration .
diabetes , hypokalaemia , appetite disorder , malnutrition , hypertriglyceridaemia ,
Ελλάδα Wyeth Hellas A. E. B. E .
efficacy Results for Study BO17705
Hertford Road , Hoddesdon Hertfordshire EN11 9BU United Kingdom
the maximum dose be 21.6 microgram / day .
if you forget to take IntronA If you be SELF -administering treatment , or if you be the caregiver of a child take IntronA in combination with ribavirin , inject the recommended dose a soon a you remember and continue treatment a usual .
name OF THE MEDICINAL PRODUCT
the presence of a few tiny bubble be of no importance and will not affect the dose in any way .
9 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
it work by increase urine output , reduce the amount of fluid in the blood and lower the blood pressure .
4 .
- the scope of the referral be the Harmonisation of the Summaries of Products Characteristics ,
 2 Combination therapy :
this check that insulin come out and clear the air bubble from your KwikPen .
1.35 , 2.06 , 35 trial and 6769 patient ) be observe in patient treat with recombinant human erythropoietin .
4.3 Contraindications
the dose of TESAVEL be 100 mg once daily .
co-
sign of allergic reaction include feel itchy , breathlessness or wheezing , swell of the face , lip , tongue or throat .
renal impairment and kidney transplantation :
none
EU / 1 / 02 / 234 / 017
each ml of solution contain 10 000 IU of epoetin alfa * correspond to 84.0 microgram per ml 1 pre-filled syringe of 0.7 ml contains 7000 international unit ( IU ) correspond to 58.8 microgram epoetin alfa
until further information be available , before seek to conceive , male patient should cease ZAVESCA and maintain reliable contraceptive method for a further 3 month .
6.2 Incompatibilities
Annex I
use Insuman Comb 15 with food and drink
common :
if you be a woman :
via Provinciale Schito 131 I-80058 Torre Annunziata / NA Italy
2
follow concomitant administration of carbamazepine , a potent inducer of CYP3A4 , the geometric mean of Cmax and AUC for aripiprazole be 68 % and 73 % lower , respectively , compare to when aripiprazole ( 30 mg ) be administer alone .
for animal treatment only .
further injection • every time you use a Pen you must use a new needle .
1 1 .
rare :
37 / 137 ( 27 % ) 29 / 137 ( 21 % )
8 .
this regimen be administer every three week for 4 cycle in case at least a minor response ( ≥ 25 % reduction in bidimensionally measure tumour size ) be observe after 2 cycle .
5 .
0.3 ml ( 1667 IU / ml )
subcutaneous use .
summary OF PRODUCT CHARACTERISTICS
the patient must have fast for over 6 hour , preferably overnight .
a study in asymptomatic patient demonstrate that systemic exposure be similar while Cmax be lower and Tmax be prolong when stavudine be administer with a standardised , high-fat meal compare with fasting condition .
in such a case , you may develop severe hypoglycaemia ( and even faint ) before you be aware of the problem .
always use a new pen if you notice that your blood sugar control be unexpectedly get worse .
- if you be pregnant or plan to become pregnant ( see Pregnancy ) .
EXP
content BY WEIGHT , BY VOLUME OR BY UNIT
6.3 Shelf life
4.6 Pregnancy and lactation
information FOR THE USER
in rat , tacrolimus cause toxic effect to the nervous system and the eye .
capsule , hard
CONDITIONS OF THE MARKETING AUTHORISATION
Rapinyl
3 ml
detailed instruction for subcutaneous administration be provide with this leaflet ( see HOW TO SELF INJECT VIRAFERON at the end of the leaflet ) . lon One dose of Viraferon be give on each schedule day .
in view of the significant reduction in the AUC of MPA by cholestyramine , caution should be use in the concomitant administration of CellCept with medicinal product that interfere with enterohepatic recirculation because of the potential to reduce the efficacy of CellCept .
United Kingdom MEDA Pharmaceuticals Ltd .
statement OF ACTIVE SUBSTANCE ( S )
you get a hypo if your blood sugar get too low .
pull the needle out of the vial .
LABELLING
3 year .
clinical PARTICULARS
United Kingdom
if therapy be withhold for more than 7 day , MabCampath should be reinstituted with gradual dose escalation .
the average molecular mass be approximately 31,300 dalton of which the protein moiety constitute approximately 19,300 .
Linearity :
other common side effect include rash , cramp in the muscle , pain in the muscle and joint , and headache .
1 / 1
Abraxane should not be use in combination with other anticancer agent .
1 .
base on these trial result , INTELENCE be not recommend for use in combination with N ( t ) RTIs only in patient who have experience virological failure on an NNRTI- and N ( t ) RTI-containing regimen .
& gt ; 32 week
- you change the area of skin where you inject insulin ( for example from the thigh to the upper
statement OF ACTIVE SUBSTANCE ( S )
strength
when a dose adjustment be necessary , this should be do in step of at least four week .
6 .
if the haemoglobin continue to increase , the dose should be reduce by approximately 25 % .
327 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
there be no adequate data from the use of interferon alfa-2b in pregnant woman . study in animal have show reproductive toxicity ( see section 5.3 ) .
human Papillomavirus Vaccine & # 91 ; type 6 , 11 , 16 , 18 & # 93 ; ( Recombinant , adsorb ) .
undesirable effect in clinical study in paediatric patient infection and infestation
7 h post-ref .
unopened cartridge Store in a refrigerator ( 2 ° C - 8 ° C ) .
Novo Nordisk A / S
do not put Insuman Basal next to the freezer compartment or a freezer pack .
PHARMACEUTICAL FORM
the new Head of Sector for CVMP and Veterinary procedure and Head of Sector for Conferences take up their duty in the course of the year .
Mitratapide have no central effect .
age have no clinically meaningful effect on pharmacokinetics of nicotinic acid ( prolonged-release formulation ) base on a composite analysis of subject age 18-65 year .
immediately prior to administration this last rib of the plunger should be align with the dose line to ensure the delivery of the appropriate dose .
patient who be receive kidney dialysis and have a very high blood pressure and low blood volume might experience a sudden drop in their blood pressure when they take Nifedipine Pharmamatch retard .
information FOR THE USER
well control epidemiological study with systemic use of beta-blockers do not indicate malformative effect , but some pharmacological effect such a bradycardia have be observe in foetus or neonate .
ketoconazole / itraconazole : the AUC and Cmax of ketoconazole be increase by 44 % and 19 % , respectively when give with amprenavir alone .
survival and tumour progression have be examine in five large control study involve a total of 2833 patient , of which four be double-blind placebo-controlled study and one be an open- label study .
aspartame provide a source of Phenylalanine and , therefore , may not be suitable for person with phenylketonuria .
no drug interaction study have be perform for the co-administration of Norvir with benzodiazepine .
if the insulin pen be damage or not work properly ( due to mechanical defect ) it have to be discard , and a new insulin pen have to be use .
8 .
42 5.2 Pharmacokinetic property
6.4 Special precaution for storage
Merck Sharp & amp ; Dohme GmbH Donau-City-Straße 6 A-1220 Wien Austria
viral infection ( e. g. influenza , herpes virus infection ) Uncommon :
Methicillin-resistant staphylococci ( MRS ) be resistant to all currently available β -lactam antibiotic include cefuroxime .
do not use Puregon after the expiry date which be state on the label after & apos ; EXP : & apos ; .
ed 3 .
powder : vial ( glass ) ; solvent : syringe ( glass )
see 4 What to do in an emergency for more about hypo .
blister ( PVC / PE / Aclar / alu )
ADAS-Cog Prometax
study 2 ( P02080 ) be a randomized , single centre study that enrol 95 previously untreated adult patient with chronic hepatitis C who be co-infected with HIV .
a lower maintenance dose of three MIRAPEXIN 0.088 mg tablet a day be also possible .
herbal PRODUCTS
step 4 - Inserting the needle Pinch the skin a little .
elimination be predominantly in the faeces , mostly a metabolite .
general INFORMATION
oral use Oral use
Preclinical data reveal no special hazard for human base on conventional study of safety pharmacology , repeat dose toxicity , toxicity to reproduction or genotoxicity .
5.2 Pharmacokinetic property
3 .
in case of overdose with FOSAVANCE , milk or antacid should be give to bind Alendronate .
the film-coated tablet also contain lactose monohydrate .
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder .
summary of ESS in trial 1
3.8 % ; placebo :
EU / 1 / 07 / 400 / 013
method OF ADMINISTRATION
if air bubble do form , wait until the solution have settle and rod
your doctor may need to change your dose and / or to take other precaution if you be take one of the following medicine :
Uncommon :
Janssen Pharmaceutica N. V .
stomatitis , mouth ulceration , gastrointestinal haemorrhage5 , eructation , melaena , oesophagitis , ascites , gastric ulcer , haematemesis , cheilitis , dysphagia , pancreatitis
a connection between visceral lipomatosis and protease inhibitor and lipoatrophy and nucleoside reverse transcriptase inhibitor have be hypothesise .
J05AF05 .
hyperglycaemia can lead to diabetic ketoacidosis .
the aetiology have not be define .
any unused product or waste material should be dispose of in accordance with local requirement .
6 .
reduction in the dose of alfentanil and other short act opiate similar in structure to alfentanil and metabolise by CYP3A4 ( e. g fentanyl and sufentanil ) should be consider when co-administered with voriconazole ( see section 4.5 ) .
patient hypersensitive to Insulin Human Winthrop Comb 50 for whom no better tolerate preparation be available must only continue treatment under close medical supervision and – where necessary – in conjunction with anti-allergic treatment .
N. V .
blood lactate dehydrogenase increase
2 year .
Pfizer Limited
a le than proportional increase in oral absorption at dos beyond 600 mg be observe ; the mechanism for this be unknown .
myocardial infarction , severe arrhythmic disorder .
Preliminary evidence from a small number of patient treat concomitantly with filgrastim and 5-fluorouracil indicates that the severity of neutropenia may be exacerbate .
since the risk for human be unknown Ciprofloxacin Kabi must not be administer during pregnancy ( see section 4.3 ) .
EXP
4 .
48.3 ( 269 / 557 )
Pfizer Luxembourg SARL , branch office Dubravska cesta 2 , 841 04 Bratislava , Slovak Republic
this document can not replace a face-to-face discussion with your veterinarian .
Viani Evohaler and associate name ( see Annex I ) 25 / 50 microgram / dose pressurise inhalation , suspension & # 91 ; See Annex I – To be complete nationally & # 93 ;
- If you have any further question , ask your doctor or your pharmacist .
read the package leaflet before use .
immune system disorder Allergic reaction Metabolism and nutrition disorder Weight gain1
glycerol Phenol Metacresol zinc acetate Disodium phosphate dihydrate Sodium chloride Hydrochloric acid 2N ( pH adjustment ) Sodium hydroxide 2N ( pH adjustment ) Water for injection
Tel : + 48 ( 0 ) 22 440 33 00
3 .
5.1 Pharmacodynamic property
section 5.1 of the SPC be amend to note that the optimum medical strategy for a patient at low risk of disease progression , particularly in the adjuvant setting follow radical prostatectomy , might be to defer hormonal therapy until sign that the disease be progress .
medicinal product subject to medical prescription . ct
beta-blocking agent may mask the symptom of hypoglycaemia and delay recovery from hypoglycaemia .
treatment have be initiate only in patient with baseline liver transaminase level up to 5 time the upper limit of the normal range ( see section 5.2 ) .
EXP
keep out of the reach and sight of child .
SoloStar delivers insulin in dos from 1 to 80 unit in step of 1 unit .
excipients :
the prevention strategy should include effort to eliminate the infection from the parent generation .
under no circumstance should Liprolog Mix50 be give intravenously .
QUALITATIVE AND QUANTITATIVE COMPOSITION
20.10.95 14.02.96 15.02.96 OJ No C.54 of 23.02.96
173 D-55216 Ingelheim be Rhein Germany
250 D
Neupro
PHARMACEUTICAL FORM
DATE of first authorisation :
- if creatinine clearance be between 10-30 ml / min , the initial dose be 1.25 mg / day and the maximal
the elimination half-life be approximately two hour .
in woman undergo fertility treatment there may be a slightly higher risk of miscarriage .
anaemia and epistaxis have also be report .
Nespo 20 µg Darbepoetin alfa IV / SC
60 In patient with renal impairment , insulin requirement may be diminish due to reduced insulin metabolism .
11 .
during maintenance treatment , corticosteroid may be taper in accordance with clinical Practice guideline .
the liver , and improve pyruvate utilisation .
child age from 6 to 12 year :
12 .
the main measure of effectiveness be the improvement in symptom between the start and end of the study , measure use two standard scale .
the undesirable effect see with hepatitis C be representative of those report when IntronA be administer in other indication , with some anticipated dose-related increase in incidence .
instruction ON USE
Hyponatremia may be due to a syndrome of inappropriate anti-diuretic hormone secretion ( SIADH ) .
hive ) while on this medication , seek medical help immediately .
in other case , Exelon have be discontinue ( see section 4.8 ) .
Ophthalmologic disorder , include retinal haemorrhage , cotton wool spot , and retinal artery or vein obstruction have be report in rare instance after treatment with alpha interferon ( see section 4.8 ) .
38 Common :
further injection • every time you use a Pen you must use a new needle .
do not freeze .
concomitant treatment with potent CYP3A4 inhibitor , which may increase sunitinib plasma concentration , should be use with caution and the dose of SUTENT reduce ( see Section 4.2 and 4.5 ) .
MicardisPlus be contraindicate during lactation since it be not know whether telmisartan be excrete in human milk .
what Enbrel be and what it be use for 2 .
Renagel do not contain calcium .
tell your pharmacist if you notice any change in the appearance of the capsule .
4.7 Use during pregnancy or lactation
in child whose mother take nucleoside and nucleotide analogue during pregnancy , the benefit from the reduced chance of be infect with HIV be greater than the risk of suffer from side effect .
do not freeze .
2 .
the pharmacokinetics of sildenafil in patient with severely impaired hepatic function have not be study .
follow repeat administration , steady state be achieve within 24 to 48 hour .
the dose of individually dose-titrated CYP2D6 substrate may need to be reduce when treatment with celecoxib be initiate or increase if treatment with celecoxib be terminate .
6 .
9 .
8 .
Elisabethhof 19 2353 EW Leiderdorp Netherlands
a theoretical risk for the development of systemic activation of the coagulation system in patient suffer from underlie disease predispose them to DIC can not be totally exclude .
MANUFACTURING AUTHORISATION HOLDER ( S ) RESPONSIBLE FOR BATCH RELEASE
Alternatively , in patient not on dialysis , an initial dose of 0.75 μ g / kg may be administer subcutaneously a a single injection once every two week .
-2.0
84 film-coated tablet multipack comprise 3 pack , each contain 28 tablet .
Latvija BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT .
a total of 283 / 1351 ( 21 % ) of patient have advance fibrosis or cirrhosis , 85 / 1351 ( 6 % ) have cirrhosis .
therefore , prior to and during Dynepo therapy , the patient & apos ; s iron store , include transferrin saturation and serum ferritin , should be evaluate .
Leukopenia , Neutropenia
Organon , Kloosterstraat 6 , Postbus 20 , 5340 BH Oss , The Netherlands
possible SIDE EFFECTS
rarely report side effect ( at least 1 in every 10,000 patient , but le than 1 in every 1,000 patient ) : pneumonia rod
pharmacological PROPERTIES
read all of this leaflet carefully before you start use this medicine .
België / Belgique / Belgien Pfizer S. A . / N. V .
5 .
EXP :
4 .
( also see ribavirin SPC if IntronA be to be administer in combination with ribavirin in patient with chronic hepatitis C ) .
MARKETING AUTHORISATION NUMBER ( S )
80 To minimise any possible risk , men wish to father a child should contact their doctor who may advise you to stop take Arava and take certain medicine to speed up the removal of Arava from your body .
what PhotoBarr be and what it be use for 2 .
since there be a potential for an increase in the risk of dose-related adverse reaction , a decrease in rosiglitazone dose may be need .
the plastic bottle come with a child resistant cap and should be open a follow :
TRAVATAN be not recommend for patient age le than 18 year .
limit data be available on the safety and efficacy of 10 mg adefovir dipivoxil in patient with chronic hepatitis B , co-infected with HIV .
4.2 Posology and method of administration
PHARMACEUTICAL FORM AND CONTENTS
it be important that the diagnosis be make early and treatment be initiate immediately to improve the survival and the clinical outcome .
film-coated tablet
4.8 Undesirable effect
2 x administer IU body weight ( kg )
name OF THE MEDICINAL PRODUCT
TSH ) .
how to store EXJADE 6 .
4 .
M1 and m2 be the only metabolites relevant in human , both be microbiologically inactive .
what Karvea look like and content of the pack Karvea 150 mg film-coated tablet be white to off-white , biconvex , and oval-shaped with a heart debossed on one side and the number 2872 engrave on the other side .
25 % dissolved insulin , 75 % crystalline protamine insulin
PHARMACEUTICAL Form
only use needle that have be approve for use with OptiSet .
ask your doctor or pharmacist for advice before take any medicine .
Special population
hypoglycaemia be also more likely to occur if :
usually , 7 to 14 day of treatment be sufficient to reach this state .
4.10 Overdose ( symptom , emergency procedure , antidote ) , if necessary
it use in this indication must be balance against the report risk of thromboembolic event .
11.9
adverse REACTIONS
within it shelf-life , for the purpose of transport and / or to facilitate ambulatory use the non-reconstituted product can be keep at or below 25 ° C for a period up to four week before use .
Česká republika Eli Lilly ČR , s.r.o .
11 .
sustain carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery .
very rarely :
128 Marketing Authorisation Holder
rare :
≥ 0.5 to & lt ; 0.8 ≥ 0.8 to & lt ; 1.2
an important initiative in 2000 to improve regulatory transparency be the Publication of Summaries of opinion on the granting of marketing authorisation , both positive and negative , 15 day after their adoption by the EMEA scientific Committees .
common : bleeding ( gastrointestinal , haematuria , haematoma , epistaxis , haemoptysis , utero-vaginal haemorrhage , haemarthrosis , ocular , purpura , bruise ) Uncommon : anaemia , thrombocytopaenia Rare : other bleeding ( hepatic , retroperitoneal , intracranial / intracerebral ) , thrombocythaemia
oral use
tablet administration Patients should remove the tablet from the blister unit and immediately place the entire Effentora tablet in the upper portion of the buccal cavity ( above an upper rear molar between the cheek and gum ) .
→ Don ’ t breast feed while you & apos ; re take Volibris .
10 tocilizumab ( 28 – 34 % ) compare to 1 – 12 % of control patient at 24 week .
3 .
non-clinical data reveal no special hazard for human base on conventional study of safety pharmacology and genotoxicity .
information IN BRAILLE
each hard capsule contain 20 mg temozolomide
other SPECIAL WARNING ( S ) , IF NECESSARY
approximately 75 % of the administer & # 91 ; 14C & # 93 ; nateglinide be recover in the urine within six hour post-dose .
in the four placebo-controlled study the hazard ratio for overall survival range between 1.25 and 2.47 in favour of control .
2 .
this summary be last updated in 02-2007 .
this medicine have be prescribe for you .
soft capsule
no effect on fertility or embryofoetal development be observe in rat and rabbit , except at dos relate to maternal toxicity .
3 ml ; solvent :
− If you have a severe heart or liver problem .
clinical PARTICULARS
the systemic availability and half-life in dialysis-dependent diabetic patient be comparable with healthy subject .
eye disorder :
BATCH NUMBER
Novartis Europharm Limited Wimblehurst Road Horsham West Sussex , RH12 5AB United Kingdom
in these case SIFROL may affect your ability to drive and operate machinery .
tho A number of medicinal product be know to interact with the glucose metabolism .
Annex I
2 .
in the Nespo group , 83 % be receive dialysis and 17 % be not receive dialysis . ct
further INFORMATION
dog tolerate single oral dose up to 100 mg / kg without mortality .
Tygacil be indicate for the treatment of the following infection ( see section 4.4 and 5.1 ) :
nervous system disorder Respiratory , thoracic and mediastinal disorder
why the comparison of all the individual stage be not more discriminative to detect difference between formulation that may have clinical relevance b .
not all pack size may be market in all country .
in dog renal tubular dilation and atrophy be observe .
second and third trimester of pregnancy ( see section 4.4 and 4.6 ) .
4
especially of the large tendon at the back of the ankle ( Achilles tendon ) ( see Section 2 :
186 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
what MIRAPEXIN IS AND WHAT IT IS USED FOR
België / Belgique / Belgien / Luxembourg / Luxemburg Genzyme Belgium NV / SA ( Belgique / Belgien ) , Tél / Tel : + 32 2 714 17 11
a polar fraction propose to be serine derivative account for approximately 20 % in urine , but be detect only in small amount ( 0-2 % ) in human plasma of some subject .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
a above
during use : do not refrigerate .
13 .
16 .
the efficacy of Irbesartan BMS be not influence by age or gender .
EU / 1 / 00 / 131 / 027
Uncommon
therefore , concomitant use of Tracleer and tacrolimus or sirolimus be not advisable .
hypertension
instruction ON USE
check with your doctor or pharmacist if you be unsure .
psychiatric disorder
adverse reaction report during clinical trial or follow the marketing use of IntronA alone or in combination with ribavirin System Organ Class infection and infestation
concentrate for solution for infusion 400 mg / 20 ml 1 vial of 20 ml 4 vial of 20 ml
skin + fat Liver Kidney
if use of SIFROL be unavoidable , breast-feeding should be stop .
sustain virologic response rate for treatment group treat for one year with IntronA alone or in combination with ribavirin ( from two study ) be show in Table 3 .
neuroleptic malignant Syndrome ( NMS ) :
tinnitus
2 .
respiratory tract bleeding ( haemoptysis , pulmonary haemorrhage ) , bronchospasm , interstitial pneumonitis
therefore , special care should be take during the titration process in patient with moderate or severe hepatic or renal impairment .
- enhance the uptake of potassium into cell .
you may be give other medicine ( anti-emetics ) to take before and / or after take Temodal to prevent or control nausea and vomiting .
Tel . + 36 1 488 37 00
nervous system disorder
26 A .
pioglitazone ( a hydrochloride )
- Keep this leaflet until your child have finish the complete vaccination course .
slowly pull the plunger back to draw the liquid into the syringe ( see Diagram 7 ) .
Uncommon : tinnitus
possible side effect 5 .
when Tasmar be give together with levodopa / carbidopa and desipramine , there be no significant change in blood pressure , pulse rate and plasma concentration of desipramine .
PHARMACEUTICAL Form
these trial evaluate a total of 100 patient with lipo and leiomyosarcoma and 83 patient with other type of sarcoma .
the Committee recommend that CYANOKIT be give market authorisation .
sodium citrate Sodium chloride Disodium edetate Polysorbate 80 Sodium hydroxide Water for injection
this alert card contain important safety prior to Remicade treatment : information that you need to be aware of before • Remicade should not be use if you have you be give Remicade and during treatment with Remicade .
expiry DATE
10 mg
71 %
Rue du Tilleul , 13 B-1332 Genval Belgium
the elimination of sevoflurane be biphasic in nature , with an initial rapid phase and a second , slower phase .
advise your physician in case of :
Cmax be reach after 10-16 hour .
Tel : + 39 06 50 39 61
Special precaution to be take by the person administer the veterinary medicinal product to animal
the terminal half-life ( t ½ ) be therefore a measure of the absorption rather than of the elimination per SE of insulin from plasma ( insulin in the blood stream have a t ½ of a few minute ) .
study in animal have show reproductive toxicity ( see section 5.3 ) .
lactate woman may require adjustment in insulin dose and diet .
such situation may result in severe hypoglycaemia ( and possibly loss of consciousness ) prior to the patient & apos ; s awareness of hypoglycaemia .
România Servier Pharma SRL Tel : + 40 21 528 52 80
e. g. a Class III antiarrhythmic ( e. g. amiodarone , sotalol ) .
MabThera 500 mg concentrate for solution for infusion rituximab
if a drop miss your eye , try again .
5.2 Pharmacokinetic property
51 − If you have ever have loss of vision due to non-arteritic anterior ischaemic optic neuropathy ( NAION ) .
7 .
Caelyx must not be use to treat AIDS-KS that may be treat effectively with local therapy or systemic alfa-interferon .
252
no significant accumulation of stavudine be observe with repeated administration every 6 , 8 , or 12 hour .
PHARMACEUTICAL PARTICULARS
157 170
3 .
not all pack size may be market .
 EMEA 2004
renal and urinary disorder
Prague Czech Republic
MARKETING AUTHORISATION NUMBER ( S )
4.4 Special warning and precaution for use
BATCH { number }
